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ABSTRACT 
Mesenchymal stem cells (MSCs) have the ability to differentiate towards cartilage, 
bone, fat and muscle, and therefore have great therapeutic potential. Human MSCs 
reside under hypoxia (4-7% oxygen) in vivo and recent investigations have described 
an increase in population doublings and maintenance of differentiation capacity upon 
culture under these conditions. The reason for these differences may be related to their 
cellular metabolism. This thesis examines MSC metabolism during proliferation, 
chondrogenic and osteogenic differentiation. Furthermore, MSCs were cultured under 
uninterrupted and controlled hypoxia (5% or 2% oxygen) to observe its effect on 
proliferation and differentiation.  
 
The production of lactate and consumption of oxygen by MSCs indicated a mixed 
metabolism, with the cells utilising both oxidative phosphorylation and glycolysis 
under 20% oxygen or normoxic conditions. The majority of cellular ATP production 
was through glycolysis, whilst the full oxidative capacity of the mitochondria was not 
fully utilised. During chondrogenic differentiation, oxygen consumption was 
significantly reduced with time in culture and the cells became highly glycolytic, 
whilst osteogenic differentiation maintained the mixed metabolism of expanded 
MSCs. 
 
Fewer colonies were formed at 5% oxygen, compared to 2% and 20% oxygen. 
Hypoxic culture induced fewer cells per colony compared with normoxia. However, 
MSCs expanded under hypoxia had reduced cellular senescence after five passages, 
potentially due to the reduced utilisation of oxidative phosphorylation that has been 
shown to lead to the production of reactive oxygen species (ROS). The oxygen levels 
during expansion did not affect chondrogenic potential but expansion under hypoxia 
prevented ostoegenic differentiation. Osteogenesis was also inhibited for MSCs 
expanded at normoxia and differentiated under hypoxia. These results may be related 
to the initial colony formation under hypoxia and the changes in cellular metabolism 
during osteogenic differentiation. 
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Glossary of  terms 
Anoxia (anoxic): Cells cultured below 2% oxygen. 
Apoptosis: Programmed cell death controlled through extrinsic and intrinsic cellular 
signals.  
Asymmetric division: Cell divides into one identical daughter cell and one 
unidentical daughter cell. 
Bone marrow stromal cells: Adherent fraction of the bone marrow containing both 
fibroblastic cells and cells of the hematopoietic lineage.   
Differentiation: The process from which an immature cell matures to a specific cell 
phenotype. 
Hypoxia (hypoxic): Cells cultured between 2-8% oxygen. 
Mesenchymal stem cells: Adherent cells of the bone marrow with fibroblastic 
morphology purified through analysis of cell surface antigens or passaged culture. 
Mulipotent: Stem cells with the ability to differentiate to all the cell phenotypes 
within their germ layer. 
Normoxia (normoxic): Cells cultured at 20% oxygen. 
Plasticity: Ability of a cell to differentiate towards cell types of a variety lineages. 
Pluripotent: Stem cell with the ability to differentiate into cells of each the three 
germ layers. 
Quiescent: A cell in a state of rest or inactive state. 
Stem cell: A quiescent and undifferentiated cell capable of proliferation, self-
maintenance and multilineage differentiation.  
Symmetric division: Cell divides into two identical daughter cells.  
Transdifferentiation: The change in lineage commitment from one cell phenotype to 
a different cell phenotype without dedifferentiation 
Transgermal plasticity: Stem cell from a specific tissue with the ability to acquire a 
differentiated cell phenotype of a different germ layer. 
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List of  abbreviations 
AER  Apical ectodermal ridge 
ATP  Adenosine triphosphate 
BMP  Bone Morphogenic protein 
CFU-F  Colony forming unit-fibroblast 
CCCP  Carbonyl cyanide-m-phenylhydrazone 
CO2  Carbon dioxide 
DMEM Dulbecco’s Modified Eagle Medium 
DMSO  Dimethyl Sulphoxide 
ESC  Embryonic stem cells 
FAD  Flavin  adenine dinculeotide 
FADH2 Reduced flavin adenine dinucleotide  
FGF  Fibroblast growth factors 
GAG  Glycosaminoglycan 
HIF-1 Hypoxia inducible factor -1 alpha 
HIF-2 Hypoxia inducible factor -2 alpha 
hTERT Human reverse telomerase reverse transcriptase 
MAPC  Multilineage adult progenitor cells 
MIAMI Marrow isolated multilineage inducible cells 
MSC  Mesenchymal stem cells 
NAD  Nicotinamide adenine dinucleotide 
NADH  Reduced nicotinamide adenine dinucleotide 
O2  Oxygen molecule 
ROS  Reactive oxygen species 
SOX  Sry type HMG box protein 
TGF-  Transforming growth factor-beta 
VEGF  Vascular endothelial growth factor 
ZPA  Zone of polarising activity 
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1 INTRODUCTION 
1.1 Tissue engineering and regenerative medicine 
Tissue engineering may be described as the “application of biology and engineering 
principles to the development of functional tissue and organs” (Langer and Vacanti, 
1993). There are various tissue engineering approaches for the regeneration of tissues 
that may be broadly placed into three categories. Cell-based tissue engineering 
approaches involve the implantation of cells alone into an area of damaged tissue. 
Examples of this approach include autologous chondrocyte transplantation, whereby 
chondrocytes from a patient are injected under a periosteal flap into an area of 
damaged cartilage, or bone marrow transplantation to initiate bone regeneration 
(Bruder et al., 1998a; Brittberg, 1999; Horwitz et al., 2002). Material-based tissue 
engineering involves the use of biomaterials that either recruit cells in vivo or act as a 
delivery system for growth factors. Biomaterials such as osteoinductive scaffolds for 
bone regeneration are examples of this form of tissue engineering (Yuan et al., 1998; 
Eniwumide et al., 2007). 
 
Figure 1.1. Schematic diagram of the basic principles of tissue engineering using a cell-scaffold 
approach. 
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The final tissue engineering approach is the combination of cells and scaffold 
materials, whereby cells are seeded into materials that allow the exchange of growth 
factors and various nutrients (e.g. oxygen and glucose) to enable tissue regeneration 
through cell proliferation or differentiation and secretion of macromolecules for tissue 
matrix formation (Figure 1.1). The technique has been used for the regeneration of 
cartilage and have shown potential in the development of whole organs such as the 
liver (Domm et al., 2002; Ogawa et al., 2004; Mauck et al., 2006). The use of 3D cell-
scaffolds has been utilised to investigate processes that increase the rate of tissue 
formation such as mechanical stimulation (Lee and Bader, 1997; Mauck et al., 2000). 
In recent years, tissue engineering has come under the umbrella of regenerative 
medicine, which has been defined as “the replacement or regeneration of human cells, 
tissues or organs to restore or establish normal function” (Mason and Dunnill, 2008). 
 
 
Figure 1.2. (a) Schematic diagram describing the seeding of cells within a 3D construct 
environment and (b) the changes in oxygen concentration with depth towards centre of the 
construct in the described example (adapted from Muschler et al., 2004 and Malda et al., 2004a). 
 
In order to achieve functional tissue engineering systems, specifically for a cell-seeded 
approach, factors such as scaffold chemistry, material mechanical properties and cell 
source need to be optimised to regenerate tissues (Muschler et al., 2004). A limitation 
of cell-seeded scaffolds is the development of nutrient and metabolic gradients, 
particularly oxygen, that lead to poor tissue development and cell death within the 
centre of the construct (Figure 1.2). The development of these gradients are associated 
with cellular consumption of metabolites and diffusion distances within the construct, 
although the resulting biological response is dependent upon cell type and conditions 
(Muschler et al., 2004; Malda et al., 2004a; Heywood, 2005). 
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Studies have begun to investigate the effect of hypoxic culture conditions on various 
cell types and measured the cellular consumption of various metabolites to enable the 
development of strategies that would help to produce improved tissue formation 
within central regions of 3D scaffolds (Smith et al., 1973; Balis et al., 1999; 
Komarova et al., 2000; Lennon et al., 2001; Heywood et al., 2006; Grayson et al., 
2006; Follmar et al., 2006). Particular emphasis within this area has focussed on 
scaffold architecture, specifically scaffold porosity, growth factor delivery and the use 
of enzymes for controlled degradation of the scaffold (Malda et al., 2004a; Buxton et 
al., 2007). However, a balance between scaffold integrity and its mechanical 
properties for its use in vivo needs to be made, particularly when used in 
mechanically-loaded tissues.  
 
The cells used within tissue engineering and regenerative medicine applications may 
originate from various sources. Autologous cell sources involve cells originating from 
the patient, whilst allogeneic sources involve cells derived from another human. 
Allogeneic approaches enable the formation of cell banks or off-the-shelf products for 
tissue engineering. However, a disadvantage of allogeneic cell sources is patient 
rejection of cells, particularly cells directly removed from mature tissues, e.g. 
osteoblasts, chondrocytes, neurons. A number of authors have suggested that stem 
cells may have features that make them attractive for allogeneic approaches (Caplan 
and Bruder, 2001). 
 
There are various types of stem cell defined in part, by their ability to differentiate to 
various lineages. Examples include mesenchymal and embryonic stem cells (Caplan, 
1991; Thomson et al., 1998). Mesenchymal stem cells (MSCs) have the ability to 
differentiate towards cells of the mesodermal lineage, such as bone, cartilage, muscle 
and tendon, and are derived from various tissues including adipose, umbilical cord 
and, primarily, bone marrow (Bianco and Gehron, 2000; Zuk et al., 2001; Hutson et 
al., 2005). Embryonic stem cells (ESCs) are derived from the early-stage blastocyst 
and have the ability to differentiate to cells of each germ layer (Assady et al., 2001; 
Rambhatla et al., 2003; Stojkovic et al., 2004). Due to their ability to differentiate to 
various cell phenotypes, stem cells are an attractive cell source for regenerative 
medicine applications.  
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However, there is only a small population of stem cells within the body, in particular 
within the bone marrow, where only 0.01-0.001% of the total population are MSCs 
(Thomson et al., 1998; Pittenger et al., 1999). To produce the required number of cells 
for various tissue engineering applications, expansion techniques are used to generate 
the requisite stem cell population (Koller et al., 1993; Koller et al., 1995; Obradovic et 
al., 1999; Gerecht-Nir et al., 2004; Ulloa-Montoya et al., 2005). These may involve 
traditional and well-established cell culture techniques or more automated processing, 
involving the use of a bioreactor system that needs to be optimised with regards to 
culture conditions such as oxygen tension, mechanical stimulation, medium flow rate 
and nutrient consumption (Vunjak-Novakovic et al., 1999; Martin et al., 2000; 
Cartmell et al., 2003; Wernike et al., 2008). In particular, studies have begun to 
investigate the effects of cultured oxygen tension on MSCs and ESCs, in terms of 
their proliferation and subsequent differentiation capacity (Ezashi et al., 2005; Csete, 
2005; Grayson et al., 2007).  
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1.2 Stem cells 
A human organism arises from a single fertlised egg cell or zygote.  A series of cell 
divisions occurs that lead to the formation of smaller specialised cells described as 
blastomeres and they collectively form the blastocyst. The cells begin to change their 
positions relative to each other within the blastocyst and through the process of 
gastrulation, the embryo develops three germ layers: ectoderm, endoderm and the 
mesoderm (Gilbert, 2003). The cells migrate and interactions occur between the germ 
layers to develop the tissues and organs, through the process of organogenesis. The 
cells during organogenesis develop towards more mature and specialised cell types 
through the process of differentiation. The specialised cells have a finite lifetime and 
thus continuously proliferate and die through apoptosis (programmed cell death) 
during the lifetime of the human organism.  
 
The regeneration of a tissue relies upon whether the cells are able to proliferate and 
whether they produce a tissue similar to the existing tissue. Certain tissues that are 
damaged through injuries such as bone fractures or skin wounds, provide examples of 
tissue repair that lead to complete regeneration through cell proliferation and tissue 
formation around the site. However, specialised cells such as neurons may be 
irreversibly damaged or in the case of articular cartilage, restoration of the damaged 
area produces fibrocartilage that has different structural and mechanical properties 
(Caplan et al., 1997; Bruder et al., 1998a; Johnstone and Yoo, 1999; Bielby et al., 
2007). Thus, certain tissues rely upon a reservoir of immature and undifferentiated 
cells for growth and repair of the tissue that are known as stem cells. These cells are 
derived from various sources such as the blood, bone marrow, umbilical cord blood, 
adipose and neuronal tissue, although properties are variable dependent upon their 
derivation and in vivo utilisation  (Spangrude et al., 1988; Thomson et al., 1998; Zuk 
et al., 2001; Pittenger and Marshak, 2001; Kogler et al., 2004; Zhu et al., 2005).   
 
Stem cells have been defined as quiescent (resting stage) and undifferentiated cells 
that are capable of proliferation, self-maintenance and differentiation towards specific 
cell phenotypes (Potten and Loeffler, 1990; Morrison et al., 1997; Loeffler et al., 
1997; Weissman, 2000; Reya et al., 2001). Other definitions for a stem cell include 
unlimited self-renewal extending throughout the lifetime of the adult and regeneration 
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of tissues from their point of derivation (Hall and Watt, 1989; Potten and Loeffler, 
1990). However, these latter criteria are very specific and would exclude many 
defined stem cells and include cells derived from stem cells or subsets, e.g. T-cells 
derived from hematopoietic stem cells.   
 
The concept of self-maintenance refers to the ability of a stem cell to maintain its 
population. Normal cell division produces two identical daughter cells, and is known 
as symmetric division (Figure 1.3a). However, if stem cells solely utilised symmetric 
division, then the stem cell population would increase rather than being preserved and 
more importantly, no differentiated cells can be formed (Potten and Loeffler, 1990). In 
order, for the stem cell population to be preserved, the cells need, at least partially, to 
undergo asymmetric cell division, whereby one identical and one unidentical daughter 
cell are produced (Figure 1.3b). The identical daughter cell produced from asymmetric 
division is a stem cell, whilst the non-identical daughter cell differentiates towards its 
specific cell phenotype.  
 
 
Figure 1.3. The types of cell division involved in the self-maintenance of the stem cell population 
are (a) symmetric divisions and (b) asymmetric divisions. S represents stem cell and M represents 
a differentiated cell. (diagram adapted from Potten and Loeffler, 1990). 
 
Models have been described for stem cell division. The steady state or deterministic 
concept states that the number of cells exiting the stem cell population and 
differentiating towards a specific cell phenotype is equal to the remaining number of 
stem cells in the population. This model solely utilises the concept of asymmetric cell 
division and the cells divide at a steady rate (Potten and Loeffler, 1990). Potten and 
Loeffler (1990) described the probability of self-maintenance (psm), to determine if the 
stem cell population is in a steady state, psm = 0.5 (Figure 1.4). The value of psm varies 
for a stem cell population dependant upon conditions.   
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Figure 1.4. The deterministic concept of self-maintenance. S is the stem cell pool and M is a cell 
removed for differentiation. Self-maintenance of the population is maintained if psm = 0.5. 
(diagram adapted from Potten and Loeffler, 1990). 
 
However, the first model does not take into account, how the cell changes from 
symmetric and asymmetric divisions. The stochastic model for stem cell proliferation 
observes that the cell may divide in three ways either producing two stem cells 
(symmetric (P)), a stem cell and either a differentiated cell or a cell lost via apoptosis 
(asymmetric (Q)) or a cell that produces two differentiated cell types (R) (Figure 1.5).  
This model observes the options given to the cells on a cellular level and steady state 
is achieved through a cell producing an average situation similar to asymmetric 
division (Potten and Loeffler, 1990; Loeffler et al., 1997). The combined probabilities 
of these alternate situations occurring in the stem cell population, equate to 1, (P + Q 
+ R = 1) and ensure self-maintenance of the stem cell population.  
 
 
Figure 1.5. The stochastic concept of stem cell self-maintenance. S represents a stem cell and M is 
a differentiated cell phenotype (diagram adapted from Potten and Loeffler, 1990). 
 
The models described take into account, the proliferation properties and the concept of 
self-maintenance but stem cells have been defined as having the capacity for 
differentiation, commonly multi-lineage differentiation. The term given to the theory 
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of multi-lineage differentiation is plasticity. Plasticity describes the ability of a cell to 
differentiate towards cell types of a variety lineages. During the development of an 
organism, the stem cell population reduces and their ability to differentiate towards 
multiple lineages reduces and leads to development of adult stem cells with limits in 
terms of their differentiation potential. Stem cells with the ability to produce cells for 
each of the three germ layers are often described as pluripotent stem cells (Eckfeldt et 
al., 2005). As the organism develops, multipotent, bipotent and unipotent stem cells 
are produced, progressively reducing lineage differentiation and becoming specifically 
associated with either a  tissue or germ layer (Weissman, 2000; Pittenger and 
Marshak, 2001; Martin-Rendon and Watt, 2003; Fortier, 2005; Lakshmipathy and 
Verfaillie, 2005).  Examples of multipotent stem cell systems are hematopoietic stem 
cells that mature into cells of the blood and lymph lineage and MSCs towards cells of 
the mesodermal lineage (Pittenger and Marshak, 2001; Martin-Rendon and Watt, 
2003). ESCs are derived from the inner cell mass of the blastocyst and are considered 
to be pluripotent stem cells due to their ability to produce all three germ layers of the 
body (Thomson et al., 1998; Itskovitz-Eldor et al., 2000; Assady et al., 2001; 
Shirahashi et al., 2004; Segev et al., 2004). 
 
A model has been developed to include the concept of stem cell self-maintenance, 
differentiation and plasticity, known as the ‘Screw model’ (Mackey and Dormer, 
1982; Potten and Loeffler, 1990). The top of the screw represents the quiescent stem 
cell population. Once a cell exits the population and begins to differentiate, there is a 
time-frame whereby cells mature towards a specific phenotype and enable the stem 
cell population to reach a steady state (self-maintenance). Thus, the resulting time-
frame allows for the concept of intermediary stages between the stem cell and mature 
cell phenotype. A cell entering the intermediary stages of the screw model is termed a 
transit cell (Potten and Loeffler, 1990). The transit cells are proliferating and 
differentiating towards a specific cell phenotype and are assumed to have reduced 
self-maintenance and plasticity during progression towards terminal differentiation. 
They are commonly known as progenitor cells. The model describes the self-
maintenance of the cell in the horizontal plane, whilst the vertical plane represents the 
progression through differentiation towards a mature cell phenotype or tissue (Figure 
1.6).  
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Figure 1.6. The ‘screw model’ for stem cell self-maintenance and differentiation (diagram 
adapted from Potten and Loeffler, 1990). 
 
The transit cells at the first stage of transition (T1), help in the self-maintenance of the 
stem cell population and thus maintain steady state (psm ≥ 0.5). However, as the cell 
proliferates and differentiates towards its desired phenotype within the spiral, transit 
cells have reduced self-maintenance (reduced spiral diameter) and plasticity with 
progression through each transition stage, until reaching their desired cell phenotype 
(T4). The model describes the reduction in self-maintinance through psm that equates 
to zero, on reaching the desired cell phenotype.  
 
The stochastic and screw models are based upon analysis of stem cells derived from 
intestinal crypts, hematopoietic stem cells and organisms such as Drosophilia 
melanogaster and Caenorhabditis elegans. Therefore, it is a general model based on 
the behaviour of these stated stem cell populations (Hall and Watt, 1989; Potten and 
Loeffler, 1990; Morrison et al., 1997; Loeffler et al., 1997). However, a further 
limitation of the screw model is that it does not take into account the concepts of 
pluripotency and the ideas of transgermal plasticity or transdifferentiation (Baksh et 
al., 2004; Fortier, 2005; Lakshmipathy and Verfaillie, 2005; Mikkers and Frisen, 
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2005). Transgermal plasticity is defined as a stem cell from a specific tissue with the 
ability to acquire a differentiated cell phenotype of a different germ layer. 
Transdifferentiation is considered to be the ability of a cell to change lineage 
commitment from one cell phenotype to a different cell phenotype without 
dedifferentiation (Martin-Rendon and Watt, 2003; Eckfeldt et al., 2005).  
 
ESCs utilise the concept of transgermal plasticity, as they have the ability to produce 
progenitor cells for the development of tissues for different germ layers. Thus, these 
stem cells are seen as ideal for therapeutic and regenerative medicine applications. 
However, the concept of transgermal plasticity was garnered from studies analysing 
multipotent stem cell types such as hematopoietic and MSCs producing neuronal  
stem cells and neuronal stem cell types induced towards hematopoietic progenitor 
cells (Woodbury et al., 2000; Martin-Rendon and Watt, 2003; Lakshmipathy and 
Verfaillie, 2005). Evidence of transdifferentiation has been shown for cells of the 
hematopoietic lineage, as they have the ability to change their commitment due to 
production of common cell progenitors for different cell phenotypes (Martin-Rendon 
and Watt, 2003). The studies were conducted in vitro and thus evidence may be 
considered artifactual, as their functionality in vitro was difficult to assess (Phinney 
and Prockop, 2007).  
 
However, in vivo evidence of neurons and epithelial cells derived from MSCs and 
analysis of damaged tissues, shows that the triggering of specific cues that act on stem 
cells around the damaged areas induces them to undergo trangermal plasticity or 
transdifferentiation (Krause et al., 2001; Spees et al., 2003; Nakagawa et al., 2005). 
The cues for the exploitation of this concept have yet to be elucidated but it is felt to 
be controlled at the molecular level through signalling pathways and co-factors that 
are found and modulated under in vivo conditions (Mikkers and Frisen, 2005; Phinney 
and Prockop, 2007). 
 
The triggers for the differentiation and self-maintenance of stem cells in vivo are 
controlled by a micro-environment described as the ‘niche’. The concept of the stem 
cell niche was proposed by Schofield (1978) and initial evidence of the presence of a 
niche environment surrounding stem cells was derived from the bone marrow, which 
contains both hematopoietic stem cells and MSCs within its structure (Fuchs and 
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Segre, 2000; Li and Xie, 2005). In vitro co-culture of hematopoietic stem cells with 
bone marrow, resulted in greater survival of these cells compared with medium 
supplemented culture, indicating evidence of factors and pathways that control stem 
cell survival in vivo (Fuchs and Segre, 2000). Analysis of stem cells derived from 
drosophilia, intestinal crypt and mammal testis provided further examples of self-
maintainance  pathways but also demonstrated the controlled differentiation of these 
cells towards a mature cell phenotype within the niche and their location within the 
tissue (Spradling et al., 2001; Ohlstein et al., 2004; Li and Xie, 2005).  
 
 
Figure 1.7. Structure of the stem cell niche and control of self-maintenance. (a) Stem cells within 
their niche are attached to a basement membrane and niche cell at their resting state. Dependent 
upon their positioning with respect to the niche cell and basement membrane, they may either 
undergo (b) symmetric divisions to produce identical stem cells or (c) asymmetric divisions to 
produce one identical stem cell and a cell that detaches from the membrane to undergo cell 
differentiation (committed progeny/transit/differentiated cell).  The balance between these types 
of division within the niche controls stem cell self-maintenance (diagram adapted from Spradling 
et al., 2001). 
 
The stem cell niche has been defined as “a specific location in a tissue where stem 
cells reside for an indefinite period of time and produce progeny cells while self-
renewing” (Ohlstein et al., 2004). The niches control self-renewal and differentiation 
dependant upon their location and orientation within the niche. A stem cell orientated 
in contact with the basement membrane and niche cells, results in either symmetric or 
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asymmetric division to maintain the stem cell population or differentiate towards a 
specific cell phenotype (Figure 1.7b). However, if the stem cell attaches perpendicular 
to the basement membrane and niche cell, then one cell retains stem cell properties but 
the other cell is detached from the niche membrane and begins to differentiate, 
allowing self-maintenance of the stem cell pool (Spradling et al., 2001) (Figure 1.7c). 
The model has been demonstrated for murine bone marrow, testis and spleen and 
drosophilia but not all stem cell niches are controlled through this method (Ohlstein et 
al., 2004; Li and Xie, 2005).  
 
The control of self-maintenance and differentiation within the stem cell niche is 
through intercellular and extracellular signalling pathways and factors (Caplan, 1991). 
Sonic hedgehog, Notch and Wnt signalling pathways have been proposed for the self-
renewal of stem cells and have also been shown to regulate differentiation of stem 
cells towards mature cell phenotypes and tissues (DeLise et al., 2000; Church et al., 
2002; Reya et al., 2003; Anakwe et al., 2003; de Boer et al., 2004a; Hardingham et 
al., 2006). Thus, cells in vivo could demonstrate transgermal plasticity and 
transdifferentiation due to the in vivo niche environment, but these pathways are 
difficult to replicate in vitro due to the absence of the ‘niche’. These pathways are also 
associated with cancer, as disruption of these pathways results in uncontrolled self-
renewal and thus these intercellular signalling pathways need to be tightly controlled 
to prevent oncogenesis (Reya et al., 2001; Reya et al., 2003). The embryological 
development of cartilage and bone is a process whereby these signalling pathways 
play a critical role in stem cell behaviour to enable tissue development.      
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1.3 Embryology of cartilage and bone 
The embryological development of the mesodermal tissues and therefore limb 
development is a process involving multiple stages.  As decribed in section 1.2, the 
formation of the blastomeres leads to the process of gastrulation yielding the 
formation of the three germ layers: ectoderm, endoderm and mesoderm (Figure 1.8). 
The interactions of these germ layers leads to the formation of tissues and organs that 
are controlled through a series of genetic, biochemical and biomechanical events 
within the cellular microenvironment (Carter and Beaupre, 2001; Gilbert, 2003).  
 
Figure 1.8. The process of gastrulation for tissue formation (adapted from Gilbert, 2003). 
 
1.3.1 Embryonic limb bud formation 
Skeletal tissues are primarily derived from the mesodermal layer that is developed 
during gastrulation between the endodermal and ectodermal layers (Figure 1.8). The 
development of the skeleton is associated with three distinct regions formed through 
the gastrulation process: paraxial mesoderm, lateral plate mesoderm and cranial neural 
crest. The development of the limb bud that initiates the development of the axial 
skeleton emanates from the lateral plate mesoderm (Gilbert, 2003). 
 
The limb bud is a group of mesenchymal cells surrounded by ectodermal tissue 
(Cancedda et al., 1995; Karsenty, 1998). The ectodermal tissue is thickened in the 
apical region of the limb bud, forming a structure known as the apical ectodermal 
ridge (AER). The initial formation of the AER involves Fibroblast Growth Factors 
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(FGF), FGF-8 and FGF-10. FGF-10 is produced by the mesenchymal cells to induce 
the formation of the AER, whilst the epithelial cells in the developing AER produce 
FGF-8, to maintain the mesenchymal cells in an uncommitted state and enable 
maintenance of the AER through FGF-10 production (Crossley et al., 1996; Karsenty, 
1998; Gilbert, 2003).  
 
The proliferation and differentiation of the mesenchymal cells in limb growth is due to 
interactions between the AER and the underlying limb bud mesenchyme, termed the 
progress zone. Growth factors and cytokines controlling these processes involved in 
limb growth, include Bone Morphogenic Protein-2 (BMP-2) and have been shown to 
inhibit or stimulate cell proliferation or prevent ectopic formation of cartilage or bone 
(Ganan et al., 1996; Karsenty,1998; Pizette et al., 2001).  
 
Mesenchymal cells within the progress zone are thought to be assigned position and 
direction information prior to limb pattern development. The area that induces limb 
patterning in the anterior/posterior axis is described as the zone of polarising activity 
(ZPA) (Cancedda et al., 1995; Karsenty, 1998; Gilbert, 2003). The limb pattern and 
growth formation is controlled through various intercellular signals and growth factors 
dependent upon axis orientation. Thus, anterior-posterior limb development is 
controlled by Sonic hedgehog signals and Hox genes, dorsoventral patterning is 
mediated through Wnt signalling, en-1 transcription factors and FGFs stimulate limb 
growth and patterning in proximodistal axis (Riddle et al., 1993; DeLise et al., 2000). 
  
1.3.2 Pre-cartilage condensations and chondrocyte differentiation 
Cells within the progress zone proliferate rapidly within the zone and maintain their 
uncommitted mesenchymal cell characteristics. However, cells near the ZPA begin to 
condense after the mesenchymal cells are stimulated to the chondrogenic lineage 
through induction of transcription factors, Pax-1 and scleraxis (Cserjesi et al., 1995). 
The cellular condensations provide the model or analgens for the development of the 
cartilage and bone within the limb (Summerbell and Wolpert, 1972; Ahrens et al., 
1977).  
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Prior to condensation, cells synthesize extracellular matrix containing hyaluronan, 
collagen type I, tenascin and fibronectin (Dessau et al., 1980; Mackie et al., 1987; 
DeLise et al., 2000). The presence of these matrix molecules prevents cell-cell 
interactions, although the presence of hyaluronidase breaks down the hyaluronan, 
enabling cell-cell interactions and initiating chondrogenic pathways (DeLise et al., 
2000). 
 
The cell-cell interactions in the chondrogenesis pathway require cell adhesion 
molecules to initiate cell condensations. Examples of these include N-Cadherin and 
Neuronal cell adhesion molecule (N-CAM) and their inhibited expression results in 
reduced cellular condensations (DeLise et al., 2000). The cell-cell interactions which 
are required for cellular condensations to invoke chondrogenesis have been exploited 
in the development of in vitro chondrogenesis systems (section 1.4.3). Extracellular 
matrix molecules are reformed during condensations and their interactions help to 
regulate cell proliferation and chondrogenic differentiation, through utilisation of 
signalling pathways transmitted between the cell and matrix (DeLise and Tuan, 2002). 
Fibronectin is formed between the cells in the intercellular space during condensation 
and remains throughout chondrogenesis, although its maximal level is reached 
subsequent to condensation and reduces once cartilage is formed. Hyaluronan directly 
influences mesenchymal cells during chondrogenesis and is required for cell adhesion 
to commence and directs the assembly of the pericellular matrix around the 
chondrocyte (Maleski and Knudson, 1996; DeLise et al., 2000). 
  
As chondrogenesis progresses, cell-matrix interactions enable the transition in 
morphology of an immature mesenchymal cell into a rounded chondrocyte. The 
process involves members of the Sry-type HMG box proteins (SOX) family of 
transcription factors, specifically SOX-5, SOX-6 and SOX-9 (Lefebvre and 
Crombrugghe, 1998; Akiyama et al., 2002). Studies have demonstrated the up-
regulation of SOX-9 expression during chondrogenesis of embryonic limb chick 
mesenchymal cells, whilst murine embryos stimulated collagen type II expression that 
may be stimulated and regulated by SOX-9 (Ng et al., 1997; Kulyk et al., 2000). The 
expression of SOX-9 has been used as an early marker for chondrogenesis in studies 
using MSCs. SOX-9 expression results in expression of collagen type IIa and then the 
chondrocyte-specific, collagen type IIb, along with synthesis of collagen type IX, XI, 
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Gla protein and chondrotin-sulphate rich aggrecan molecules (Karsenty, 1998; DeLise 
et al., 2000).  
 
Chondrocyte hypertrophy prior to endochondral ossification is prevented through the 
presence of parathyroid hormone related peptide (PTHrP) and the Indian hedgehog 
signalling pathway (Karsenty, 1998).  PTHrP has been shown to be under the 
regulation of the Indian hedgehog pathway. Indian hedgehog is expressed in pre-
hypertrophic cells and its secretion stimulates PTHrP synthesis, thereby preventing 
chondrocyte hypertrophy and regulating chondrocyte differentiation (Vortkamp et al., 
1996; Wagner and Karsenty, 2001).  
 
1.3.3 Endochondral ossification and intramembranous ossification for bone 
formation 
 
Figure 1.9. The stages in the process of endochondral ossification. (a) Mesenchymal cells condense 
and differentiate into chondrocytes that mature into hypertrophic chondrocytes, which (b) induce 
mineralisation of the matrix and leads to invasion of blood vessels. (c) This results in the 
formation bone and creation of growth plates for further bone generation (adapted from Gilbert, 
2003).  
 
During the phase of cartilage formation, the cells on the periphery of the out-growth 
or anlagen create a barrier between the chondrogenic tissue and non-chondrogenic 
mesenchyme, known as the perichondrium. The perichondrium develops into the 
periosteum during the process of endochondral ossification (Figure 1.9). The 
periosteum contains progenitor cells and acts as a reservoir for these in adults (Hanada 
et al., 2001).  
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The chondrocytes that develop from the cell condensations to form cartilaginous 
tissue have a rounded morphology and are quiescent. The cells proliferate and 
synthesize the collagen types II, IX and XI, which lead to an increase in tissue 
volume. The cells become organised into columns along the longitudinal axis in the 
epiphyseal regions of the long bone to form the growth plates separating the regions of 
bone and cartilage (Karsenty, 1998). The growth plate chondrocytes undergo a 
process of proliferation and ultimately differentiate into hypertrophic chondrocytes 
that synthesize type X collagen (Kielty et al., 1985; Carter and Beaupre, 2001; 
Gilbert, 2003).  
 
The synthesis of collagen type X enables calcification of the matrix. Chondrocyte 
hypertrophy marks the end-stage in cartilage development and cell apoptosis occurs, 
before the process of matrix mineralisation (Carter and Beaupre, 2001). The 
hypertrophic chondrocyte secrete Vascular Endothelial Growth Factor (VEGF) to 
enable formation of blood vessels through the process of angiogenesis (Gerber et al., 
1999), that are derived from the perichondium and enter the developmental limb 
(Rajpurohit et al., 1996; Shapiro et al., 1997). The tissue becomes populated with 
progenitors, that enter via the blood vessels or cells surrounding the cartilage and 
differentiate into osteoblasts, leading to bone formation, through the process of 
endochondral ossification (Karsenty, 1998; Gilbert, 2003). The osteoblasts express 
CBFA-1/Runx-2, resulting in the stimulation of the osteogenic associated genes, 
osteocalcin, osteopontin, osteonectin and bone sialoprotein (Ducy, 2000). 
Angiogenesis is required for the process of osteogenesis, as deficiencies in 
angiogenesis inhibit bone formation (Yin et al., 2002). In addition, deficiencies in 
CBFA-1 lead to limb formation without mineralisation of the tissue (Otto et al., 1997; 
Komori et al., 1997).  
 
Bone can also be formed directly from the initial grastulation process, through the 
process of intramembranous ossification that is associated with the development of the 
skull. The cranial neural crest contains mesenchymal cells that proliferate and 
condense into nodules with cells either developing into capillaries or becoming 
osteoblasts. These osteoblasts secrete and synthesize an extracellular matrix 
containing type I collagen that undergoes calcification. The osteoblasts become 
embedded within the calcified matrix and evolve into osteocytes. A membrane is 
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formed around the bone and contains osteoblasts that remodel the bone extracellular 
matrix, producing layers of bone. This region is known as the periosteum. The process 
of intramembranous ossification is controlled through the entry of BMPs in the neural 
crest region that activate the transcription factor, CBFA-1, and the subsequent 
expression of bone extracellular matrix genes such as osteocalcin, osteopontin and 
osteonectin (Ducy, 2000). The activation of the genes through the application of 
BMPs directly instructs the mesenchymal cells to differentiate into osteoblasts without 
a cartilaginous intermediary. 
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1.4 Mesenchymal stem cells (MSCs) 
1.4.1 Origin of MSCs 
The bone marrow contains two common cell types: parenchymal cells and stromal 
cells. Parenchymal cells are those cells involved in the functioning of the tissue, whilst 
the stromal cells provide the connective tissue framework and secreted factors that 
enable the tissue to function. There are many cell systems within the bone marrow but 
the three main systems are the hematopoietic, endothelial and stromal cell systems. 
The framework provided by the stromal cell system enables the hematopoietic cells to 
produce new blood cells through the process of hematopoiesis and meet the primary 
function of the bone marrow in adult tissue.  
 
The stromal cells are non-hematopoietic cells with a distinctive morphology compared 
with hematopoietic cell types (Prockop, 1997).  Prockop (1997) reviewed an article by 
Cohnheim (1867) that examined wound repair of tissues. Cohnheim observed that the 
cells appearing at the site of wound repair consisted of cells primarily from the 
bloodstream but also a set of fibroblastic cells that had the ability to migrate to the 
repair site and deposit collagen fibres to facilitate repair (Prockop, 1997).  
 
However, early studies did not examine the inherent properties of these fibroblastic 
cells but continued examining their role in collagen formation during wound repair 
(Ross et al., 1970; Bucala et al., 1994). Friedenstein et. al. (1970) cultured stromal 
cells in culture vessels in vitro and observed the presence of cells with a distinct 
fibroblastic morphology after a few days of culture and later formed colonies after 9-
12 days in culture. These cells were described as colony forming unit-fibroblasts 
(CFU-F) or fibroblast colony forming cells (FCFC) (Friedenstein et al., 1976).  
 
The in vivo function of these cells was demonstrated through co-culture of these CFU-
Fs with hematopoietic stem cells (Dexter et al., 1977; Verfaillie et al., 1994; Fuchs 
and Segre, 2000; Li and Xie, 2005). Dexter et. al. (1977) showed that the 
hematopoietic cells were controlled by the presence of the stromal cells which 
secreted growth factors and therefore acted as a feeder layer for the hematopoietic 
cells, controlling their proliferation and differentiation during hematopoiesis. The in 
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vivo function of the stroma has been exploited in patients who have hematological 
deficiencies to provide a network, enabling hematopoiesis (Koc et al., 1999; Koc et 
al., 2000). The infusion of bone marrow stromal cells enabled the regeneration of the 
hematopoietic system through production of hematopoietic progenitors, platelets and 
neutrophils. 
 
Studies prior to the discovery of CFU-Fs demonstrated the presence of cells within the 
bone marrow that are able to differentiate towards the osteogenic lineage (Friedenstein 
et al., 1966; Friedenstein et al., 1968). It was assumed that there may be a cell 
population within the marrow that had the ability to differentiate towards cells of the 
mesodermal lineage such as bone and cartilage. Studies utilised diffusion chambers to 
examine the properties of cells within the marrow population (Ashton et al., 1980; 
Bab et al., 1984; Bab et al., 1986; Friedenstein et al., 1987). These chambers were 
made of two filters glued together with isolated bone marrow placed between the 
filters. The chamber was placed in a site that is highly vascularised and allowed to 
grow. The filters allow nutrients to enter the chamber but prevents interactions 
between bone marrow, host cells and surrounding vasculature (Bab et al., 1986; 
Caplan, 1991).  
 
The studies show that within the bone marrow, the hematopoietic stem cells slowly 
die within the first week of culture, leaving stromal cells with a fibroblastic or 
polygonal morphology remaining inside the chamber (Ashton et al., 1980; Bab et al., 
1984; Bab et al., 1986). These cells develop a fibrous tissue that initially forms 
alongside the filters of the chamber and extends towards the centre of the chamber, 
with cells towards the centre of the chamber developing into cartilage and areas 
adjacent to the filter in close proximity to the vasculature forming bone. Histological 
analysis of the tissue formed within the diffusion chamber confirmed these 
observations and proved that the marrow contains stromal cells with the ability to 
differentiate towards cells of the mesenchymal lineage (Ashton et al., 1980; Bab et al., 
1984; Bab et al., 1986; Friedenstein et al., 1987). These studies also indicate that the 
environmental conditions could influence the differentiation of a cell towards a 
specific lineage (Bassett and Herrmann, 1961; Ahrens et al., 1977; Von der Mark and 
Conrad, 1979; Solursh et al., 1981). 
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In vitro studies provided further evidence that these cells were able to differentiate 
into osteoblasts and chondrocytes (Luria et al., 1987; Kujawa et al., 1989).  Pre-
clinical studies also demonstrated that bone defects may be repaired with calcium 
phosphate scaffolds loaded with bone marrow stromal cells to heal critical bone 
defects (Ohgushi et al., 1989a; Ohgushi et al., 1989b; Bruder et al., 1998b). There is 
also evidence that bone marrow stromal cells could differentiate towards adipocytes, 
as marrow tissue is replaced with adipose tissue with age, due to the fact that 
osteogenic and adipogenic cells may share a common progenitor cell (Bennett et al., 
1991; Prockop, 1997).   
 
The in vitro and clinical evidence from previous studies, led to the term, 
‘Mesenchymal stem cells’ (MSCs) being used to describe the set of bone marrow 
stromal cells that differentiate towards osteogenic, chondrogenic or various 
mesenchymal lineages in both embryonic and adult tissues (Caplan, 1991). Since the 
term was first coined, they have been defined as stem cells due to their properties of 
self-maintenance (section 1.1) and ability to differentiate to multiple lineages for 
utilisation in cell therapies (Bruder et al., 1997; Wakitani et al., 1998; Bruder et al., 
1998c).   
 
1.4.2 Isolation and characterisation of MSCs 
Studies have shown that MSCs may be isolated from bone marrow, peripheral blood, 
umbilical cord blood and adipose tissue sources (Maniatopoulos et al., 1988; Bianco 
et al., 2001; Zuk et al., 2001; Hutson et al., 2005). The common source of MSCs 
originates from the bone marrow, typically isolated from the iliac crest (Lennon and 
Caplan, 2006a; Lennon and Caplan, 2006b). The technique utilised by Friedenstein et. 
al., separated the hematopoietic cell portion from the stromal cells through adherence 
of the stromal cells and thereby yielding colonies of fibroblastic cells or CFU-Fs 
(Friedenstein et al., 1968; Friedenstein et al., 1970). However, it was noted in these 
and subsequent studies, that the morphology, phenotype and bone formation was 
variable within the cell population and between donors (Friedenstein et al., 1970; 
Friedenstein et al., 1982; Phinney et al., 1999; DiGirolamo et al., 1999; Phinney, 
2002). Thus, studies have utilised techniques that may be used to purify the MSC 
population (Phinney, 2002; Baksh et al., 2004). 
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Castro-Malaspina et. al. (1980) isolated the CFU-F fraction by separating the 
hematopoietic cells from stromal cells via a density-cut separation technique. The 
cells isolated from the fractions below a density of 1.070g/ml were considered to be 
the MSCs, although this did not produce a homogeneous population. A technique 
developed from the principle of density-cut was the density-gradient technique 
(Pertoft et al., 1977; Pertoft, 2000). Bone marrow was placed on top of a Percoll 
gradient and centrifugation lead to the formation of bands or sediments within the 
Percoll dependant upon their size or buoyant density. The buoyant density fraction 
containing the MSCs was between 1.063-1.065 g/ml (Pertoft and Laurent, 1982; 
Jagannath et al., 1987; Pertoft, 2000; Lennon and Caplan, 2006a). However, the cell 
population derived from the technique contained hematopoietic cells and thus studies 
have utilised techniques to isolate the MSCs from the hematopoietic cell population 
(Conget and Minguell, 1999; Phinney, 2002; Baksh et al., 2004).  
 
Studies have assessed the profile of cell surface proteins responsible for interactions 
within and between cells, that act as the receptors for growth factors, cytokines or 
extracellular matrix molecules (Conget and Minguell, 1999; Pittenger and Marshak, 
2001; Jones et al., 2002; Baksh et al., 2004; Jones et al., 2006). The profiling is 
conducted through the use of antibodies and can be assessed through the use of flow 
cytometry. Cells are analysed for the presence (positive) and absence (negative) of 
specific markers and then passed through a fluorescence activated or magnetic 
activated cell sorter to isolate the specific cell population. However, the antigen 
profiles for selecting a homogeneous MSC population requires a variety of antigen 
markers that are associated with endothelial, epithelial and mesenchymal cell types 
and indicate the function of the cells (Conget and Minguell, 1999; Pittenger and 
Marshak, 2001; Baksh et al., 2004; Kolf et al., 2007).  
 
The antigen surface receptors CD14, CD34 and CD45 are recognised markers of 
hematopoietic cells and stem cells (Conget and Minguell, 1999). Majumdar et. al. 
(1998) compared expression of hematopoietic receptors, CD14, CD34 and CD45 
between populations of MSCs isolated through Percoll gradient separation with bone 
marrow stromal cells. The results showed neither cell population expressed CD34, 
which would indicate the presence of hematopoietic stem cells. However, MSCs did 
not express CD14 and CD45 (markers of hematopoietic cells) antigens, whilst bone 
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marrow stromal cells positively expressed these markers, indicating the heterogenetic 
nature of the cell population.  
 
Co-culturing of hematopoietic stem cells (CD34+) with either MSCs or bone marrow 
stromal cells, showed that both cell populations were able to support the proliferation 
and differentiation of hematopoietic stem cells, although stromal cells were more 
effective for the described process (Majumdar et al., 1998). Haynesworth et. al. 
(1996) showed that MSCs secrete growth factors and cytokines for the maintenance, 
proliferation and differentiation of hematopoietic stem cells. Thus, studies show that 
MSCs and bone marrow stromal cells support hematopoeisis within the bone marrow 
in vivo (section 1.4.1) (Majumdar et al., 1998). However, both marrow stromal cells 
and MSCs cannot be solely isolated for negative markers of hematopoietic cells, as 
endothelial and epithelial cells remained within the cell population (Haynesworth et 
al., 1992a; Conget and Minguell, 1999). Antigen profiling of cellular adhesion 
molecules showed that a number of molecules are produced by both mesenchymal and 
hematopoietic stem cells such as intracellular cell adhesion molecule (ICAM-1), 
vascular cell adhesion molecule (VCAM-1) and integrins  (e.g. VL- chain) 
(Simmons et al., 1992; Tremain et al., 2001). The analysis of the adhesion molecules 
suggests that MSCs are involved in cell-cell and cell-matrix interactions within the 
bone marrow (Conget and Minguell, 1999).  
 
Haynesworth et. al. (1992) assessed the monoclonal antibodies, SH-2 (CD105), SH-3 
and SH-4 (CD73) for antigen marking of the MSC population within the bone 
marrow. However, the study showed that the antibodies separate the mesenchymal 
and hematopoietic cell fractions within the bone marrow but does not isolate the stem 
cell population. In addition, Barry et. al. (2001) showed that the monoclonal 
antibodies, SH-3 and SH-4, attached to the antigen CD73, which was shown to isolate 
both the MSCs within the bone marrow and lymphocyte populations in the same 
region. The antibody, SH-2, attaches to a cell surface receptor related to the TGF- 
receptor (CD105) that controls chondrogenic differentiation (Barry et al., 1999). 
CD105 has been recognised as an antigen which is positively expressed by the MSC 
population and separates it from the hematopoietic cell population (Majumdar et al., 
2000). The antibody, SB-10, recognises the adhesion molecule, CD166 and is 
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activated by leukocyte cell adhesion molecule (ALCAM) on the cell surface. ALCAM 
is thought to be involved in osteogenic differentiation and thus is positively expressed 
by MSCs and not expressed by hematapoietic cells within the bone marrow stromal 
cell population (Bruder et al., 1998d; Barry et al., 1999). Differentiation of MSCs 
undergoing either chondrogenesis or osteogenesis results in these epitopes 
disappearing and so these antibodies recognise undifferentiated MSCs. 
 
A further marker expressed by MSCs is CD44, a receptor controlling extracellular 
matrix production within the bone marrow, specifically hyaluronan and osteopontin 
(Yamazaki et al., 1999; Minguell et al., 2001). The utilisation of these antigen 
markers provides an indication of the in vivo function of the marrow stromal cells 
within the bone marrow. However, in order to isolate the MSC population, the antigen 
markers need to be combined. Thus, MSCs are isolated from the bone marrow stromal 
cell population through positive expression of antigens, CD29, CD44, CD105 and 
CD166 and negative expression for antigens, CD14, CD34 and CD45 (Pittenger et al., 
1999). 
  
However, studies are trying to find a single antigen marker for the MSC population. 
The monoclonal antibody, STRO-1, has been shown to attach to the fibroblastic cell 
population with the within the bone marrow and STRO-1+ cells were positive for 
CD29 and CD44. The isolated progenitors are able to differentiate towards smooth 
muscle cells, adipocytes and osteoblasts (Simmons and Torok-Storb, 1991; Gronthos 
et al., 1994). However, the STRO-1+ cell population also contained elements of the 
hematopoietic cell lineage including nucleated red blood cells and B-lymphocytes. 
CD166 was required to produce a purer MSC population (Gronthos et al., 2003). 
 
Di Girolamo et. al. (1999) showed that within the CFU-Fs there were variations in the 
size, morphology and growth rates of the cells, indicating the heterogeneous nature of 
MSCs. However, it was only through the use of flow cytometric and cell sorting 
analysis that subsets of MSC populations were discovered (Reyes and Verfaillie, 
2001; Reyes et al., 2001; Jiang et al., 2002). Multilineage adult progenitor cells 
(MAPCs), were isolated by negative expression of CD34, CD45, CD117 and 
glycorphin-A, when isolated and cultured in serum-free conditions (Reyes and 
Verfaillie, 2001; Reyes et al., 2001). The cells developed small clusters of adherent 
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cells that had the ability to differentiate towards cells of each mesodermal lineage and 
hepatocytes (Jiang et al., 2002; Schwartz et al., 2002). MAPCs have the ability to 
undergo extensive population doublings, as the cells were found to be telomerase 
positive, unlike MSCs that have been described as telomerase negative and undergo a 
limited number of population doublings (Zimmermann et al., 2003).  
 
MSC populations have also been isolated or purified through clonal expansion. 
(Muraglia et al., 2000; Banfi et al., 2000; d'Ippolito et al., 2006b).  This involves the 
isolation of MSC colonies and the generation of clones from these colonies. The 
clones are created upon detachment of the cells from the culture flask and then using 
limiting dilution; cells were plated into 96-well plates with each well containing a 
single cell colony. Each colony produces clones of cells, which have been shown to be 
able to differentiate into each of the mesodermal lineages. D’Ippolito et. al. (2004) 
initiated cells under low oxygen conditions (3% oxygen) and clonally expanded the 
cells. These cells that were termed as Marrow Isolated Adult Multilineage Inducing 
(MIAMI) cells and were found to have the ability to differentiate towards cells of the 
mesodermal, enctodermal (neural) and endodermal (pancreatic islet cells) lineages, 
thus displaying pluripotent features similar to MAPCs (d'Ippolito et al., 2006b).  
 
However, these cells and MAPCs, may have been influenced by their culture 
conditions, as MIAMI cells were cultured under low oxygen conditions (3%) on 
fibronectin-coated flasks, whilst MAPCs were cultured in serum-free culture 
conditions, in the presence of epidermal growth factor (EGF) and platelet derived 
growth factor (PDF) (Reyes et al., 2001; d'Ippolito et al., 2004). Studies have shown 
that culture conditions could influence the behaviour of MSCs (Lennon et al., 1995; 
Lennon et al., 1996). 
 
Colter et. al. (2000 and 2001) described the existence of three types of MSCs, 
generated through clonal expansion or limiting dilution, based upon their morphology: 
RS-1 cells (small and fibroblastic), RS-2 cells (larger and fibroblastic) and mature 
MSCs. The RS-1 and RS-2 cells created the colonies that led to the development of 
mature MSCs. However, the RS-1 cells were quiescent compared to RS-2 cells due to 
the later development of their cell colonies. In stationary cultures, there was a high 
population of mature MSCs and a small population of RS-1 cells. Once the cultures 
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were re-started,  RS-2 cells were generated, then declined in number once mature 
MSCs developed in culture and the population of RS-1 cells increased (Colter et al., 
2000). The authors of the study came to the conclusion that the RS-2 cells were 
generated from mature MSCs and the RS-2 cells were generated from and regenerated 
RS-1 cells (Colter et al., 2000; Colter et al., 2001). These sub-sets of the MSC 
population have not been shown to be present in vivo but recent and previous studies 
show that stem cells derived from the bone marrow meet the requirement of self-
maintenance, although this is also variable dependent upon the expansion conditions 
(Mets and Verdonk, 1981; Bruder et al., 1997; Colter et al., 2000; Baksh et al., 2004). 
A summary of these various MSCs populations are described in Table 1.1. 
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Table 1.1. Summary of the types of bone marrow-derived MSCs and MSC sub-set populations 
(adapted from Kolf et al., 2007). 
Mesenchymal Stem Cell 
type 
Isolation and cell characteristics References 
Bone marrow stromal 
cells 
 Adherent cell fraction of bone marrow 
containing fibroblastic colonies and 
hematopoietic cells.  
 CD45-, CD14+ 
 Percoll gradient isolation (1.07g/ml) 
 
Castro-Malaspina et al., 
1980 
Mesenchymal stem cells 
(MSCs) 
 Adherent cell fraction of bone marrow 
containing fibroblast colonies 
 Percoll gradient isolation (1.07g.ml) 
 Cell sorting analysis: SH2+, SH3+, 
CD29+, CD44+, CD71+, CD90+, 
CD106+, CD120a+, CD124+,CD14-, 
CD34-, CD45-. 
Pittenger et al., 1999 
Multipotent adult 
progenitor cells (MAPCs) 
 Serum-free culture conditions: platelet 
derived growth factor,, epidermal growth 
factor. 
 Ficoll-density gradient (1.077g/ml) 
 Clonal expansion. 
 Cell sorting analysis: CD34-, CD45-, 
CD117-, glycorphin-A- 
Reyes et al., 2001 
Marrow-isolated 
multilineage inducible 
(MIAMI) cells  
 Cells grown and isolated under hypoxia 
(3% oxygen) and fibronectin coated 
dishes. 
 Clonal expansion. 
 Flow cytometric analysis: CD34-, CD45-, 
CD117-, CD54-, CD109-, CD36-, CD29+, 
CD49e+, CD63+, CD81+, CD122+, 
CD164+  
d'Ippolito et al., 2006b 
Recycling stem cells  
(RS-1, RS-2) 
 Clonally expanded sub-populations. 
 RS-1 cells: small, thin spindle-shaped cells 
 RS-2 cells: large, thin spindle-shaped cells 
 mMSCs: wider, spindle-shaped cells 
Colter et al., 2000 
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1.4.3 Differentiation of MSCs 
The isolation and clonal expansion of MSCs has led to in vitro studies that have 
demonstrated the multi-lineage capacity of these cells (Pittenger et al., 1999). Studies 
using diffusion chambers showed that bone marrow stromal cells had the ability to 
differentiate into both bone and cartilage tissue within the chambers (Ashton et al., 
1980; Bab et al., 1984; Bab et al., 1986; Friedenstein et al., 1987). In addition, the 
culture of MSCs on calcium phosphate scaffolds and inserted into intramuscular sites, 
enabled bone formation in vivo (Haynesworth et al., 1992b; Yuan et al., 1998; Yuan et 
al., 2006). However, the studies did not examine the influence of co-factors such as 
cytokines and growth factors that could influence the differentiation of MSCs towards 
their mature phenotypes.  
 
Osteogenic differentiaton of MSCs in vitro was demonstrated by rat bone marrow 
stromal cells in the presence of dexamethasone, ascorbic acid and -glycerophosphate 
(Maniatopoulos et al., 1988). Dexamethasone is a hormone that induces the cells to 
differentiate towards the osteogenic lineage but inhibited the proliferation of the cells 
(Grigoriadis et al., 1988; Cheng et al., 1994). The initiation of osteogenesis results in 
a cascade effect, whereby the transcription factor, CBFA-1, is expressed by the MSCs 
and results in the expression of osteogenic genes such as alkaline phosphatase, 
osteocalcin and osteopontin (Otto et al., 1997; Ducy, 2000). The presence of 
dexamethasone enhanced the expression of these osteogenic genes (Cheng et al., 
1994).  
 
The presence of ascorbic acid and -glycerophosphate enabled synthesis of collagen 
type I and minerisalisation of the extracellular matrix. Jaiswal et. al. (1997) and 
Bruder et. al. (1997) demonstrated in vitro osteogenesis of MSCs in the presence of 
the same culture conditions described for rat bone marrow stromal cells. BMPs were 
identified as cytokines that enabled areas of damaged bone to undergo the process of 
endochondral ossification and subsequently produce new bone formation (Urist, 
2002). The presence of the cytokines, BMP-2 and BMP-6, promoted osteogenesis 
through initiation of the SMAD signalling pathway, resulting in expression of  the 
genes controlling osteogenic extracellular matrix formation, CBFA-1 and osteocalcin, 
thereby enhancing bone matrix formation (Rickard et al., 1994; Hanada et al., 1997; 
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Diefenderfer et al., 2003; Friedman et al., 2006). Studies have shown that the 
osteogenic potential of the cells is unaffected by the process of cryopreservation but 
there are variations in bone forming capacity between donors and their respective age 
(Bruder et al., 1997; Phinney et al., 1999; Mendes et al., 2004; Kotobuki et al., 2005; 
Siddappa et al., 2007).  
 
Earlier studies demonstrated the production of extracellular matrix proteins associated 
with bone and cartilage through the use of Transforming Growth Factor-s (TGF-1, 
TGF-2 and TGF-3) and BMP-2 within an embryonic chick limb MSC model, which 
also helped to establish and examine the process of MSC chondrogenesis (Kulyk et 
al., 1989; Caplan, 1991; Roark and Greer, 1994). The injection of TGF-1 or TGF-2, 
sub-periosteally in the growing limb resulted in a cascade effect, whereby 
chondrogenesis was initiated and leads ultimately to new bone formation (Joyce et al., 
1990). However, TGF-s are unable to initiate ectopic bone formation in 
subcutaneous muscle, whereas BMPs have the ability to initiate this process and thus 
their mechanisms for instigating the process of chondrogenesis are distinct (Roark and 
Greer, 1994; Fromigue et al., 1998).  
 
Caplan et. al. (1991) described the formation of a high density chick limb MSC 
micromass or pellet culture that when cultured in the presence of a serum-free 
medium consisting of DMEM, bovine serum albumin, transferrin and insulin, resulted 
in the production of the cartilage-specific extracellular matrix molecules, collagen 
type II and the glycosaminoglycans (GAGs), chondroitin sulphate and keratan 
sulphate. The system resembles the formation of cartilage during the embryological 
process in vivo and has been utilised to analyse the mechanisms contributing to 
cartilage development. The application of TGF-s to the micromass culture system 
resulted in greater accumulation of extracellular matrix molecules and elicited 
increased expression of specific genes associated with chondrogenesis, collagen type 
II and aggrecan (Kulyk et al., 1989). The BMPs, BMP-2, BMP-3 and BMP-4, were 
also shown to induce cartilage tissue formation in various micromass culture systems 
(Carrington et al., 1991; Chen et al., 1991; Hanada et al., 2001). However, the BMPs 
were found to act on the cultures, once cell condensations were formed between the 
cells, whereas TGF-s were involved prior to the condensations forming within the 
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pellet and enabled the production of fibronectin by the cells within the pellet resulting 
in differentiation (Carrington and Reddi, 1990; Leonard et al., 1991; Roark and Greer, 
1994; Hanada et al., 2001). BMPs stimulated greater promotion of cartilage 
extracellular matrix production involving collagen type II and aggrecan, after cartilage 
differentiation is initiated compared with cultures treated with TGF- (Roark and 
Greer, 1994). The presence of TGF-s prevents the formation of hypertrophic 
chondrocytes that are induced in the presence of BMPs, leading to bone formation in 
vivo (Hanada et al., 2001). It was elucidated from these studies, that TGF-s and 
BMPs work together in vivo to control chondrogenic differentiation of MSCs.  
 
In vitro culture systems for chondrogenesis have utilised TGF-s rather than BMPs 
due to their ability to initiate chondrogenesis through the formation of cell-cell 
interactions through fibronectin production (Carrington and Reddi, 1990; Leonard et 
al., 1991). However, the development of serum-free culture systems based on the 
chick embryo model described by Caplan et. al. (1991) has yielded further 
components that have been added to the system. Dexamethasone and insulin supplied 
to dedifferentiated chondrocytes, subsequently led to their redifferentiation and 
formation of hypertrophic chondrocytes (Quarto et al., 1992).  
 
Johnstone et. al. (1998) and Mackay et. al. (1998) developed a culture system 
involving rabbit and human MSCs, based upon these previous investigations. The 
cells were induced to chondrogenic differentiation when cultured in a micromass or 
pellet culture system in the presence of high glucose serum-free conditions 
supplemented with insulin-transferrin-sodium selenite, dexamethasone, sodium 
pyruvate, ascorbate and either TGF-1 or TGF-3. Pellets cultured in the presence of 
dexamethasone alone did not exhibit chondrogenic differentiation and only with the 
addition of either TGF-1 or TGF-3 was chondrogenesis observed (Johnstone et al., 
1998; Barry et al., 2001).  
 
Ahrens et. al. (1977) analysed the effects of varying cell density on the differentiation 
of embryo chick-derived mesenchymal cells. The results showed that cultures plated 
at a high cell density (2 x 106 cells/cm2) were able to spontaneously differentiate 
towards chondrocytes. Further studies showed that high cell plating densities 
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stimulated chondrogenesis, whereas low cell plating densities resulted in osteogenesis 
(Ahrens et al., 1977; Osdoby and Caplan, 1979; Caplan, 1991). Thus, chondrogenesis 
was found to be optimal in cultures that were hyper-confluent either in monolayer 
cell-clusters or in pellet cultures thereby replicating conditions associated with limb 
development (Caplan, 1970; Yoo et al., 1998). The development of the pellet culture 
system has lead to analysis of the pathways controlling chondrogenesis and the 
synthesis of various cartilage matrix molecules. 
 
The resultant cartilage matrix contains sulphated GAGs, aggrecan, collagen type II 
and collagen type X. The pellet culture system produces greater amounts of GAG in 
the presence of TGF-3 compared with TGF-1 (Barry et al., 2001). The production of 
collagen type X is an indicator of hypertrophic chondrocytes and this could lead to 
bone formation, indicated through analysis of alkaline phosphatase activity (Johnstone 
et al., 1998; Hanada et al., 2001). Mackay et. al. (1998) cultured chondrogenic-
induced MSCs in the presence of dexamethasone and thyroxine, a hormone associated 
with chondrocyte hypertrophy, but without TGF-3. The conditions resulted in the 
development of hypertrophic chondrocytes with subsequent collagen type X 
production. The production of collagen type X occurred without the presence of 
thyroxine in the culture medium, although it appeared after collagen type II matrix 
synthesis (Mackay et al., 1998; Yoo et al., 1998).  
 
The earliest indicator of chondrogenesis is often reported to be the expression of the 
gene, SOX-9 (Lefebvre and Crombrugghe, 1998). SOX-9 induces and regulates the 
expression of collagen type II but is repressed once collagen type X gene is expressed. 
GAG production occurs in parallel with collagen type II synthesis and is associated 
with aggrecan gene expression (Ng et al., 1997; Bell et al., 1997; Barry et al., 2001; 
Okubo and Reddi, 2003). The expression of collagen type X in the pellet culture 
system has been reported not to be associated with significant hypertrophic 
chondrocyte development. Collagen type X is a component associated with cartilage 
tissue and could lead to bone formation, but is prevented through the Indian hedgehog 
pathway and PTHrP receptors (Barry et al., 2001; Sekiya et al., 2002b). Recent 
studies have also re-visited the use of BMPs in cartilage development for use in vitro, 
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specifically in their effect on extracellular matrix production compared with TGF- 
containing systems (Sekiya et al., 2005). 
 
 
Figure 1.10. Diagram showing the plasticity of MSCs and postulated steps of transdifferentiation 
(----) (adapted from Aubin, 1998). 
 
The presence of hypertrophic chondrocytes within in vitro pellet culture systems could 
lead to bone formation and thereby the development of osteoblasts. This provides 
evidence for the principle of transdifferentiation (Figure 1.10) (Cancedda et al., 1995; 
Aubin, 1998). However, the lineage that best demonstrates the transdifferentiation 
concept of MSCs is the adipogenic lineage, as in vivo bone marrow develops 
adipogenic tissue with age (Prockop, 1997; Pittenger and Marshak, 2001). Bianco et. 
al. (1988) confirmed this observation through analysis of alkaline phosphatase activity 
that was shown to be present amongst adipocytes. Diffusion chamber studies showed 
that CFU-Fs which developed adipogenic colonies in vitro, had the ablility to generate 
bone formation within the chamber in vivo. This suggests that there is a common 
precursor cell between osteogenic and adipogenic cells (Bennett et al., 1991).  
 
Further evidence of the adipogenic phenotype being derived from an osteogenic 
precursor was demonstrated by Beresford et. al. (1992). The study showed that 
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continuous treatment of stromal cells with dexamethasone, resulted in the 
development of the osteoblastic cell phenotype and expression of the osteogenic 
genes, osteocalcin, osteopontin and bone sialoprotein. However, the initial removal of 
dexamethasone caused the development of adipocytes in the culture indicating an 
inverse relationship between pathways of adipogenesis and osteogenesis (Bennett et 
al., 1991). 
 
Clonal analysis of trabecular bone derived MSCs demonstrated that cells grown in 
dexamethasone and vitamin D3 medium formed osteoblasts and were able to express 
osteocalcin. However, the presence of isobutylmethylxanthine (IBMX) and 
dexamethasone resulted in lipid vacuole formation, eliminating expression of 
osteocalcin and suggesting differentiation towards the adipogenic lineage (Nuttall et 
al., 1998). Pittenger et. al. (2001) demonstrated the adipogenic induction of MSCs, 
using medium supplemented with 1-methyl-3-isobutylxanthine, insulin, indomethacin 
and dexamethasone. Induction was confirmed through the appearance of lipid 
vacuoles and the expression of adipogenic specific genes, peroxisome proliferator-
activated receptor- (PPAR-) and lipoprotein lipase.  
 
The early indicator of adipogenesis, PPAR-, has been shown to have a relationship 
with the early osteogenic marker, Runx-2 or CBFA-1 (Lecka-Czernik et al., 1999). 
PPAR- has been shown to reverse the osteoblastic phenotype of MSCs through 
stimulation of adipogenic differentiation that leads to the terminal adipocyte 
phenotype and inhibition of the osteogenic marker, CBFA-1, and vice versa. Recent 
studies have described the transcriptional modulator, TAZ, that functions to activate 
Runx-2 and repress PPAR-, thereby promoting osteogenesis and inhibiting 
adipogenesis (Hong et al., 2005). These studies demonstrate the inter-relationship 
between adipogenic and osteogenic lineages on a molecular and mechanistic level. 
 
The adipogenic-osteogenic and hypertrophic chondrocyte-osteoblast relationships 
challenge the recognised hierarchical model for MSC differentiation (section 1.1). 
Thus, recent stem cell lineage models have taken into account these studies and also 
the concept of a hierarchy of lineage potential for various progenitor cells (Aubin, 
1998; Minguell et al., 2001). Muraglia et. al. (2000) derived clones of MSCs to 
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investigate the ability of the cells to undergo adipogenesis, chondrogenensis and 
osteogenesis. Each of the clonal populations had the ability to differentiate towards 
osteogenesis and only 80% of the clones were able to differentiate to both osteogenic 
and chondrogenic lineages. However, smaller fractions had the ability to differentiate 
towards each of the mesodermal lineages (17%) and only osteogenesis (3%). It was 
reported in the study that there were no sub-populations with the ability to exhibit 
chondro-apidogenesis, osteo-adipogenesis, or solely chondrogenesis and adipogenesis 
(Muraglia et al., 2000). However, the STRO-1+ fraction of the bone marrow stromal 
stem cell population was shown to have the ability for osteo-adipogenic lineage 
differentiation, although this may have been associated with the concepts derived from 
investigations analysing the osteo-adipogenic inter-relationship (Gronthos et al., 
1994). 
 
Sekiya et. al. (2002) analysed cloned MSCs sub-populations and showed that early 
progenitor cells had the greatest potential towards adipogenesis, while mature MSCs 
had reduced adipogenic potential and differentiated towards the chondrogenic 
phenotype. These observations, associated with the adipogenic lineage are confirmed 
in previous studies, as cells up to passage 3 differentiated towards the adipogenic 
lineage, whereas late passage cells underwent only osteogenesis (Conget and 
Minguell, 1999). Studies have also shown that late passage MSCs can spontaneously 
differentiate toward the osteogenic lineage due to the presence of cytokines and 
growth factors in the culture medium during expansion (DiGirolamo et al., 1999; 
Banfi et al., 2002). 
 
These investigations have led to the development of the stochastic 
repression/induction model based on the in vitro differentiation potential of MSCs and 
utilising the screw-based model described by Potten et. al. (1990) (Aubin, 1998; 
Minguell et al., 2001; Dennis and Charbord, 2002). The model is based upon the 
concept that differentiation is controlled through a series of molecular events during 
development, resulting in MSCs with sets of non-silenced genes available for 
activation. The model proposes two events that utilise the stochastic concept, 
repression events whereby a cell does not progress toward a defined lineage pathway 
and activation events that allow a cell to retain plasticity for other cell phenotypes. 
These repression and activation events could occur concurrently, as a cell may 
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undergo a series of repression/activation events, leading to cell commitment towards 
various lineages rather than one cell lineage derived from a series of repression events. 
The reason for the concurrent activation of several repression/activation events is due 
to simultaneous or sequential expression of genes within the cell.  
 
The model involves two compartments, an MSC compartment for 
repression/activation of the genes and a differentiation compartment. The 
differentiation compartment contains hormones, growth factors and cytokines that 
regulate the lineage shifts. The model utilises the concept of master regulatory 
activation and repressor genes that control differentiation towards specific phenotypic 
pathways, although in the case of MSCs, there is no single gene that controls 
differentiation towards specific lineages rather there are individual transcription 
factors for each lineage. In addition, there are multiple repressive genes that are 
associated with each pathway. An example is PPAR-2 acting as a repressor for 
osteogenesis (Jaiswal et al., 2000; Hong et al., 2005). Thus, it was assumed that these 
activator and repressor genes simultaneously control the expression of markers for 
various cell lineages, although further investigations are required to identify the 
specific activation and repressor genes involved within the model (Dennis and 
Charbord, 2002).  
 
The control of the differentiation of various cell lineages, in vivo, occurs through 
intercellular signalling pathways such as Wnt, Notch and Sonic Hedgehog (section 
1.2). Wnt signalling has been implicated in osteogenesis, although the cellular 
response is dose dependant (de Boer et al., 2004a; de Boer et al., 2004b). Wnt and 
Notch signalling have also been implicated in the chondrogenic pathway, with Notch 
signalling involved during cellular condensation at the initiation of chondrogenesis 
and Wnt signalling controlling the terminal differenation of chondrocytes towards 
either hypertrophic or pre-hypertrophic phenotypes (Church et al., 2002; Hardingham 
et al., 2006).  
 
These intercellular signalling pathways have been implicated in the differentiation of 
MSCs towards endodermal and ectodermal lineages in vivo, for example 
differentiation of MSCs towards the neuronal and hepatocyte lineages when engrafted 
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into tissue-specific areas, which suggests transgermal plasticity in vivo  (Kopen et al., 
1999; Theise et al., 2000). Related studies have described the in vitro differentiation 
of MSCs towards hepatocyte and neuronal lineages (Woodbury et al., 2000; Sanchez-
Ramos et al., 2000; Schwartz et al., 2002; Lee et al., 2004). The morphology and 
functionality of the cells was demonstrated for the differentiated phenotype but these 
features may be artefacts associated with the culture conditions.  
 
Studies have also described in vitro differentiation towards other mesodermal lineages 
such as muscle and tendon. Wakitani et. al. (1995) and Makino et. al. (1999) describe 
MSCs differentiating towards skeletal and cardiomyocte cells, when cultured in the 
presence of 5-azacytidine. Recent studies have used transfection techniques to activate 
the Notch pathway ligand, Jagged-1, resulting in MSC differentiation towards 
functional muscle when transplanted into damaged muscle areas in vivo. Further 
studies have investigated the mechanisms of action for muscle and cardiomyocyte 
differentiation (Dezawa et al., 2005; Kolf et al., 2007). 
 
The differentiation of MSCs towards the tenocyte lineage has been initiated through 
implantation of a MSC seeded collagen-matrix into a donor site, which subsequently 
leads to the production of tissue that mimics the properties of normal tendon (Young 
et al., 1998). Further studies have reported that the cells, when placed under 
mechanical load, produce a functional collagen matrix and fibre alignment that is 
associated with tendons. Wnt signalling may also be implicated in the control of 
tenogenesis (Altman et al., 2002; Chen et al., 2006; Kuo and Tuan, 2008). A summary 
of these differentiation stimuli and markers are described in Table 1.2.   
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Table 1.2. Summary table of in vitro MSC differentiation stimuli and the molecular and cellular 
markers of differentiation for the described lineages (adapted from Minguell et al., 2001). 
Mature 
phenotype 
Stimuli 
Terminal 
phenotype: 
Molecular 
Terminal 
phenotype: 
Cellular 
References 
Adipocytes 
Dexamethasone + 
isobutylmethylxanthine 
+ indomethacin + 
insulin 
PPAR-2 
aP2 
Lipoprotein 
lipase 
Lipid droplet 
accumulation 
(Oil-red-O or 
Nile red staining) 
Pittenger et al., 
1999 
Chondrocytes 
Dexamethasone + ITS 
premix + sodium 
pyruvate + L-ascorbic 
acid-2-phosphate + 
TGF-3 or TGF-1 
SOX-9, 
Collagen type II, 
Collagen type X, 
Aggrecan 
GAG (Toludine 
blue staining) and 
collagen type II 
matrix 
Yoo et al., 1998 
Osteoblasts 
Dexamethasone + b-
glycerophosphate + L-
ascrobic acid-2-
phosphate 
CBFA-1, 
Alkaline 
Phosphatase, 
Osteocalcin, 
Osteonectin, 
Osteonectin, 
Collagen type I 
Calcium 
deposition within 
matrix (alizarin 
red staining) 
Jaiswal et al., 
1997; 
Maniatopoulos et 
al., 1988 
Tenocytes Mechanical tension N.D. 
Fibrallar collagen 
(collagen type I 
and II), 
fibronectin and 
GAG 
accumulation 
Kuo and Tuan, 
2008 
Skeletal 
muscle cells 
5-azacytidine 
MyoD 
Myogenin 
Myosin 
Multinucleated 
contractile cells 
Ferrari et al., 1998 
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1.5 Energy metabolism 
Energy is required by cells to enable catabolic and anabolic reactions to occur. 
Carbohydrates, lipids and proteins are substrates metabolised to produce energy for 
various cell processes. These substrates undergo a series of oxidation and reduction 
reactions that lead to the generation of the energy storage molecule, adenosine 
triphosphate (ATP). ATP is a temporary energy storage molecule that diffuses from 
the site of production and is utilised for various cellular reactions. The sites of action 
for energy metabolism are the cell cytoplasm and mitochondria (Figure 1.11). 
 
 
Figure 1.11. A flow diagram summarising the stages involved in the metabolism of substrates for 
ATP generation (adapted from Alberts et al., 2002 and Voet, 2004). 
 
A range of initial substrates may be used for the processes outlined in Figure 1.11. 
Lipids may be separated into its constituent components, glycerol and fatty acid 
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through oxidation. However, the two components are metabolised through different 
starting mechanisms. Fatty acids are initially converted into fatty acetyl-Co-A and 
then through the process of -oxidation, it is broken down into acetyl-co-enzyme A 
and smaller carbon sugar molecules that re-enter the cycle of -oxidation. The acetyl-
co-enzyme A and secondary product, reduced nicotinamide adenine dinucleotide 
(NADH) diffuse into the cell mitochondria and the energy released from these 
products is utilised in both oxygen-glucose and amino acid pathways to generate ATP. 
These processes are the Krebs’ or citric acid cycle and electron transport chain, with 
the latter involving the process known as oxidative phosphorylation. The secondary 
component of fatty acid, glycerol, is converted into the 3-carbon sugar molecule, 
glyceradehyde-3-phosphate, which then enters the glycolysis pathway and then 
subsequently the Krebs’ cycle and electron transport chain  for ATP production (Voet, 
2004). 
 
The metabolism of proteins initially involves breakdown into their constituent amino 
acids such as glutamine, cysteine and alanine. These molecules are then converted into 
carbohydrate molecules such as pyruvate and oxaloacetate that enter the Krebs’ cycle 
for ATP production. A by-product of deaminating amino acids is the production of 
ammonia. This is converted to urea through entry into the Urea cycle within the 
cytoplasm of the cell, which also generates intermediary products of glycolysis and 
the Krebs’ cycle (Alberts et al., 2002). 
 
In the described processes, lipids and proteins are converted into carbon sugars before 
entering the pathways of glycolysis, Krebs’ cycle and electron transport chain for 
generation of ATP. Carbohydrates are broken down into glucose that directly enters 
the pathways for ATP generation. There are two primary methods through which 
glucose is metabolised: oxidative phosphorylation and substrate phosphorylation. 
Oxidative phosphorylation is ATP production through consumption of oxygen during 
the electron transport chain. ATP generation through only consumption of glucose or 
other metabolites is termed as substrate phosphorylation and utilises only the 
glycolysis pathway. In terms of net ATP yield, oxidative phosphorylation yields 30 
ATP molecules, whilst substrate phosphorylation produces only 2 ATP molecules for 
each glucose molecule entering the system (Alberts et al., 2002). Sections 1.5.1 - 1.5.3 
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describes the processes of (1) glycolysis, (2) Krebs’ cycle and the (3) electron 
transport chain in the context of ATP production through glucose metabolism. 
     
1.5.1 Glycolysis 
 
Figure 1.12. The pathway of glycolysis for ATP generation (adapted from Voet, 2004). 
 
Glycolysis occurs within the cytoplasm of the cells and converts a molecule of 
glucose via a series of phosphorylation events to generate two molecules of pyruvate 
and two molecules of ATP (Figure 1.12). In conjunction with these end-products, 
glycolysis also produces two molecules of NADH through oxidation of nicotinamide 
adenine dinculeotide (NAD+). NADH is utilised in the metabolic processes of the 
  Chapter 1: Introduction 
 - 41 -  
Krebs’ cycle and electron transport chain for further ATP production. However, in the 
absence of oxygen, the latter processes do not occur, thus the net yield is two ATP 
molecules, whilst pyruvate is converted into lactate and NADH is converted back to 
NAD+ and re-utilised in the glycolysis pathway (Alberts et al., 2002; Voet, 2004). 
This form of metabolism under hypoxic or anoxic conditions is known as substrate 
phosphorylation.  
 
1.5.2 Krebs’ cycle or citric acid cycle 
Pyruvate generated from the glycolysis pathway through the breakdown of glucose 
diffuses from the cell cytoplasm into the mitochondria. The mitochondria contain the 
enzymes and co-factors that enable the release of free energy from the oxidation of 
pyruvate and then conserve it, through the production of NADH and reduced flavin 
adenine dinucleotide (FADH2). The process is known as the citric acid or Krebs’ cycle 
(Krebs, 1972; Alberts et al., 2002).  
 
Pyruvate is converted into acetyl-coenzyme A (acetyl-CoA) that enters the cycle. The 
acetyl group on the co-enzyme undergoes a series of oxidation reactions and goes 
from citrate to oxaloacetate during one cycle, before the process restarts. At specific 
steps of the process, the electrons released from the oxidation process are coupled 
with the reduction of either NAD+ or flavin adenine dinculeotide (FAD+) to NADH 
and FADH2 (Figure 1.13). In conjunction with these reactions, some molecules are 
carboxylated on oxidation resulting in the production of carbon dioxide (CO2). A turn 
of the citric acid cycle yields one molecule of FADH2, three molecules of NADH and 
two molecules of ATP and CO2 (Voet, 2004). 
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Figure 1.13. Flow diagram describing the stages in the Krebs’ or citric acid cycle (adapted from 
Voet, 2004). 
 
1.5.3 Electron transport chain and oxidative phosphorylation 
The FADH2 and NADH molecules yielded from the Krebs’ cycle are then passed into 
the inner membrane or cristae of the mitochondria. The inner membrane of the 
mitochondria is invaginated to provide a large surface area to enable electron carriers 
to be located and to control the respiratory rate along the membrane.  The series of 
electron carriers within the membrane release the free energy stored within the NADH 
and FADH2 molecules to drive ATP synthesis through the conversion of adenine 
dinculeotide phosphate (ADP) into ATP (Figure 1.14). The electron carriers in the 
electron transport chain are complexes I, II, III and IV. NADH and FADH2 are 
oxidised to release the electrons from the molecules and reform FAD+ and NAD+ that 
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are recycled back into the Krebs’ cycle (Newsholme and Leech, 1991; Voet, 2004). 
Complex I catalyses the oxidation of NADH, while complex II catalyses the oxidation 
of FADH2. Coenzyme Q (Q) transports the electrons to complex III, where they 
undergo a series of reduction-oxidation (redox) reactions before they are passed onto 
cytochrome c (Cyt C). Complex IV is the final electron carrier along the electron 
transport chain. Cytochrome c oxidation is catalysed at complex IV. The released 
electrons from cytochrome c reduce a molecule of O2 to enable the formation of water 
(Voet, 2004).     
 
 
Figure 1.14. A diagram showing the stages involved in the electron transport chain and oxidative 
phosphorylation (adapted from Voet, 2004). 
 
As the passage of electrons through each complex occurs, protons (H+) are transported 
out of the mitochondrial membrane and into the intermembranous space, resulting in 
the formation of an electrochemical proton gradient. Complex V or ATP synthase then 
pumps the hydrogen ions back into the mitochondrial membrane from a high proton 
concentration to a low proton concentration. On re-entry of the protons, the free 
energy released from the gradient is utilised for the synthesis of ATP that is catalysed 
by ATP synthase. This process is known as oxidative phosphorylation and it generates 
30 ATP molecules if glucose is fully oxidised by the cell (Alberts et al., 2002; Voet, 
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1.5.4 In vitro cellular metabolism – Warburg, Crabtree and Pasteur effects 
Krebs (1972) described distinct phenomenon through which cell metabolism may be 
regulated through either glucose concentration or oxygen tension. Many cell types 
predominantly use oxidative phosphorylation when oxygen levels are high. However, 
reduced oxygen levels result in increased ATP production through glycolysis. This has 
been described as the Pasteur Effect. Conversely, there are some cell types that only 
utilise the glycolysis pathway for ATP production, despite the presence of high levels 
of oxygen (Krebs, 1972). This phenomenon has been described as aerobic glycolysis 
or the Warburg effect. 
 
However, cellular oxygen consumption may decrease in association with an increase 
in glucose utilisation. This process is known as the Crabtree Effect and has been 
described as “the inhibition of respiration through glycolysis” (Krebs, 1972). An 
example of this occurrence has been described for chondrocytes, whereby their 
oxygen consumption in the absence of glucose is greater than when glucose levels are 
maintained at 5 mM, the level normally associated with blood plasma (Krebs, 1972; 
Otte, 1991; Heywood et al., 2006). The Crabtree effect is similar to the negative 
Pasteur effect, which has been described as a reduction in the rate of glycolysis, as 
oxygen supply increases (Lee and Urban, 1997; Heywood et al., 2006). It has been 
assumed that the Crabtree effect is used as a survival mechanism for cells in the 
absence of glucose, to enable them to meet their ATP requirements through increased 
oxidative phosphorylation (Otte, 1991; Heywood et al., 2006).  
 
In vitro studies using chondrocytes have demonstrated the Crabtree and Warburg 
effects (Otte, 1991; Rajpurohit et al., 1996; Lee and Urban, 1997; Heywood et al., 
2006) and the Warburg effect for ascite tumour cells (Krebs, 1972). In vivo, these cells 
reside under hypoxic culture conditions similar to MSCs. However, previous studies 
have suggested that MSCs primarily utilise oxidative phosphorylation for their ATP 
generation (Wang et al., 2005).      
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1.6 Oxygen and Stem cells 
1.6.1 Oxygen tension of in vivo tissues  
The oxygen levels within the bone marrow have been measured in humans and dogs 
(Grant and Smith, 1963; Tondevold et al., 1979; Kofoed et al., 1985). Grant and 
Smith (1963) measured the gas tensions within human bone marrow. The arterial bone 
marrow oxygen tension was measured to be between 10-14% (64-90 mmHg), whilst 
the bone marrow was measured to be between 4-7% oxygen (35-50 mmHg). Thus, 
cells within the stromal compartment of the bone marrow containing the MSCs reside 
under hypoxic conditions.  
 
However, MSCs are not the only cell type residing under low oxygen conditions. 
Chondrocytes have been measured to reside at oxygen levels between 7.5% oxygen in 
the hypertrophic zone and 3.2% oxygen in the superficial zone. The oxygen tension 
within the the deep zone of cartilage is much lower and so their phenotype and matrix 
synthesis varies between these zones due to the oxygen tension (Brighton and 
Heppenstall, 1971; Malda, 2003). Measurements for the developing embryo have 
shown that the oxygen tension ranges between 1.5-5.3% during blastocyst 
development (Fischer and Bavister, 1993).  Therefore, due to their conception under 
low oxygen conditions, ESCs are affected by the cultured oxygen tension (Harvey et 
al., 2004; Ezashi et al., 2005).  
 
1.6.2 Role of oxygen and its effect on chondrocytes and osteoblasts 
The role of oxygen in cultured cells and organisms is primarily associated with cell 
viability and metabolism, whereby it acts as an electron acceptor at complex IV of the 
electron transport chain to drive ATP synthesis, through the process of oxidative 
phosphorylation (section 1.5.3). The earliest investigations assessing the effect of 
variable oxygen conditions were conducted on diploid fibroblast cell lines (Cooper et 
al., 1958; Zwartouw and Westwood, 1958; Balin et al., 1976; Packer and Fuehr, 1977; 
Balin et al., 2002). These studies showed that the lifespan of the cells was extended 
under 5% and 2% oxygen compared with normoxia due to a reduction in the 
production of reactive oxygen species (ROS) and activity of anti-oxidant enzymes. 
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Zwartouw and Westwood (1958) and Balin et. al. (1976) showed that it was glucose 
that was the limiting factor for these cells, as they ceased growth under limiting 
glucose conditions and were unable to utilise glycolysis for ATP production.  
However, oxygen is also involved in the developmental processes of embryonic 
tissues and maintenance of tissue with age.  
 
Bassett and Hermann (1973) showed that embryo chick MSCs cultured under 35% 
oxygen conditions, differentiated to bone tissue, whilst hypoxic (5%) oxygen 
conditions, produced chondrogenic tissue. These results were confirmed in other 
studies, whereby embryo chick limb bud cells cultured under low oxygen tension 
formed cartilaginous tissue without the presence of a vascular network (Pawelek, 
1969). Caplan and Koutroupas (1973) showed that vascularisation of tissues only 
occurred in the presence of high oxygen and led to the formation of muscular tissues, 
whereas low oxygen stimulated the production of sulphated GAGs for cartilage 
formation. 
 
The reason for the differences in tissue formation was postulated to be associated with 
the metabolism of the cells under these conditions (Rajpurohit et al., 1996; Shapiro et 
al., 1997). Rajpurohit et. al. (1996) cultured chondrocytes under hypoxia and showed 
their adaptation to these conditions, through their production of lactate and unaltered 
ATP production compared with cells cultured under normoxia (20% oxygen). 
Measurements of oxygen consumption confirmed that on initial culture, the cells have 
a low cellular oxygen consumption but this gradually increases upon culture in 
monolayer with cells utilising oxidative phosphorylation for their ATP production 
(Heywood and Lee, 2008). Recent studies have reported that glucose is the limiting 
factor in cell survival of chondrocytes, demonstrating their preferentially glycolytic 
nature (Otte, 1991; Heywood et al., 2006). Shapiro et. al. (1982) showed that 
hypertrophic chondrocytes within bone growth plate cartilage are not under hypoxia 
and are assumed to alter their metabolism to utilise oxidative phosphorylation.  
 
However, the use of oxidative phosphorylation has proven to produce ROS such as 
oxygen free radicals and hydrogen peroxide (Moussavi-Harami et al., 2004; Martin et 
al., 2004; Heywood and Lee, 2008). ROS are involved in intercellular signalling that 
control cell growth and differentiation (Sauer et al., 2001). However, the production 
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of ROS may also be associated with cartilage degeneration and diseased states such as 
osteoarthritis (Henrotin et al., 2005). Cells are protected from ROS through cellular 
anti-oxidant systems. These systems involve a series of enzymes, initiated on the 
production of ROS. Examples of anti-oxidant systems are superoxide dismutase, 
catalase and glutathione peroxidase enzymes (Henrotin et al., 2005). However, they 
may be overcome if the enzymes are damaged through ROS production, leading to the 
formation of an oxidative stress that may lead to DNA damage within the cells, 
resulting in premature cell aging through the phenomena of premature cellular 
senescence (Moussavi-Harami et al., 2004; Martin et al., 2004; Henrotin et al., 2005).  
 
The monolayer expansion of chondrocytes results in the adoption of a fibroblastic 
morphology with time, associated with dedifferentiation, which results in the synthesis 
of type I collagen rather than type II collagen and an increase in the generation of 
ROS (Murphy and Sambanis, 2001a; Martin et al., 2004). However, encapsulation of 
these passaged chondrocytes within alginate or agarose constructs or culture under 
low (5 %) oxygen conditions results in re-expression of the chondrocyte phenotype 
and thus synthesis of type II collagen and sulphated GAGs (Grimshaw and Mason, 
2000; Murphy and Sambanis, 2001a; Domm et al., 2004; Malda et al., 2004b).   
 
A recent investigation has shown that chondrocytes cultured continuously under 
hypoxia exhibited significant increases in proteoglycan synthesis and collagen type II 
expression (Coyle et al., 2009). However, previous studies using embryo chick and 
growth plate chondrocytes show that culture under hypoxia, reduced their 
proteoglycan synthesis, although the rate of proliferation increased and the cells 
preserved their phenotype for a longer period under these conditions (Nevo et al., 
1988; Clark et al., 1991). These investigations provide evidence of the recovery in 
chondrocyte phenotype under hypoxia due to the increased glycolytic metabolism and 
expression of cartilage specific genes, SOX-9, collagen type II and aggrecan 
(Grimshaw and Mason, 2001; Murphy and Sambanis, 2001a; Domm et al., 2002; Tew 
et al., 2005). 
 
Studies analysing the effects of oxygen on osteoblasts demonstrated an inverse 
relationship with regards to their function upon culture under hypoxia (Brighton et al., 
1991; Tuncay et al., 1994; Matsuda et al., 1998; Utting et al., 2006). Brighton et. al. 
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(1991) and Tuncay et. al. (1994) demonstrated that rat-derived osteoblasts were able 
to proliferate to a greater number of population doublings under hypoxia compared 
with normoxia. However, the deposition of bone matrix molecules and alkaline 
phosphatase activity was only expressed under normoxia and when osteoblasts, 
expanded under hypoxia, were subsequently cultured under high oxygen. Recent 
investigations have concurred with these results and showed that the osteogenic genes, 
osteocalcin and alkaline phosphatase were inhibited under hypoxic culture, thereby 
contributing to the reduced bone formation (Utting et al., 2006). However, expression 
of type I collagen was comparable in both cultures, although structural analysis 
revealed  a weaker and disorganised collagen matrix created under anoxia compared 
with the structure formed under normoxic culture conditions.  
 
The metabolism of osteoblasts has been shown to involve a substantially greater 
oxygen consumption, when compared to chondrocytes (Smith et al., 1973; Komarova 
et al., 2000). However, these cells upon culture in vitro have been shown to produce 
lactate upon consumption of glucose, therefore demonstrating the Warburg effect 
(Borle et al., 1960a; Borle et al., 1960b; Cohn and Forscher, 1962; Felix et al., 1978). 
These studies demonstrate that osteoblasts have a mixed metabolism utilising both 
glycolysis and oxidative phosphorylation. However, Komarova et. al. (2000) and 
Chen et. al. (2008) measured the mitochondrial potential of osteoblasts and showed 
that these cells utilised the majority of their total cellular oxidative capacity, indicating 
a greater proportion of ATP production via oxidative phosphorylation compared with 
freshly isolated chondrocytes (Heywood and Lee, 2008).  The increased oxygen 
consumption induces the production of ROS and studies have described that their 
production is required for development of extracellular matrix, although anti-oxidant 
enzymes within the cells control the level of ROS (Chae et al., 1999; Chae et al., 
2000; Chen et al., 2008). 
 
Hypoxic culture conditions have been shown to stimulate osteoclast or bone-resorbing 
cells (Arnett et al., 2003). The hypoxic culture conditions stimulate the secretion of 
VEGF and induce vascularisation through angiogenesis (Gerber et al., 1999; Nilsson 
et al., 2004). The incoming vascularisation enables oxygen levels in the resorbed area 
to increase and thereby support new bone reformation from osteoblasts.  
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Brighton et. al. (1991) described a model for bone healing, whereby hypoxia 
stimulates proliferation of osteoblasts and as oxygen tension rises, the osteoblasts 
begin to synthesize matrix. During the early stages of bone healing, osteoclasts are 
present in an area of damage prior to bone regeneration (Arnett et al., 2003). Thus, 
these osteoclast studies provide experimental evidence for the validity of the described 
model.  However, the studies show that the process of bone remodelling is partially 
controlled by the oxygen tension and in particular, the behaviour of osteoblasts and 
osteoclasts. 
 
1.6.3 Telomeres, telomerase and oxidative damage 
Recent developments in tissue engineering often involve systems that require a 
substantial number of cells for tissue repair/regeneration. These are often obtained 
through expansion of cells through cell proliferation in vitro. However, expansion of 
cells is limited by their lifespan, which is partially dependent upon the length of sub-
units on the ends of chromosomes, known as telomeres. Telomeres prevent the ends of 
chromosomes from combining together or degrading (Zimmermann et al., 2003). 
During cell proliferation, these telomeres begin to degrade with each successive 
population doubling and then upon reaching a critical length, the cells begin to 
undergo cell-cycle arrest, resulting in premature cellular senescence (Harley et al., 
1990; Harley et al., 1992). The length of the telomeres has been postulated as a 
marker of cellular aging and is linked to their population doubling limit (Hayflick, 
1974; Campisi, 2001). The teleomere length for MSCs was approximated to be 11.4 + 
2.5 kb, shorter than the length of chondrocytes (13.4 + 2.2 kb) but the telomere length 
was not linked to the age of the donor (Parsch et al., 2004). 
 
The loss of telomere length may be accelerated through the production of ROS via 
oxidative phosphorylation or various oxygen consumption pathways, resulting in the 
formation of an oxidative stress (Busuttil et al., 2003; Parrinello et al., 2003; Saretzki 
et al., 2004). The oxidative stress causes DNA damage within the cells and thereby 
directly or indirectly accelerates the process of teleomere shortening, affecting the 
replicative lifespan of the cells. Parinello et. al. (2003) and Bahta et. al. (2008) 
showed that induction of premature senescence was related to the expression of p16, 
suggesting that the environmental conditions induced premature senescence amongst 
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the cell population. However, culture of the cells under low oxygen conditions 
resulted in reduced ROS generation and a lack of p16 expression, thereby extending 
the lifespan of the cells. The process of cellular aging has also been shown to be 
accelerated in the presence of high levels of glucose, particularly for MSCs (Blazer et 
al., 2002; Stolzing et al., 2006; Li et al., 2007). 
 
The process of senescence is often detected through the use of -galactosidase and 
p53 expression (Dimri et al., 1995a; Itahana et al., 2001). Dimri et. al. (1995) showed 
that -galactosidase was present in fibroblasts and keratinocytes that were undergoing 
senescence and it is thought to be associated with lysomal activities that are detected 
at pH 6, and due to changes in cell function. Studies utilising MSCs show that cellular 
senescence increases with time in culture and therefore an increasing number of cells 
stained for -galactosidase at later time points (DiGirolamo et al., 1999; Stenderup et 
al., 2003). The gene, p16, is associated with environmental induced senescence, but 
the key gene marker for cellular senescence is p53. As the telomeres shorten with each 
passing population doubling, p53 senses the shortened telomeres and may induce 
replicative senescence. Indeed, p53 may protect against lethal mutation via 
programmed cell death that leads to apoptosis (Itahana et al., 2001; Busuttil et al., 
2003).  
 
The aging of MSCs through telomere shortening during culture causes both a slowing 
in the proliferation capacity and a reduction in the multipotency of the cells 
(DiGirolamo et al., 1999; Banfi et al., 2002; Stenderup et al., 2003; Liu et al., 2004). 
Di Girolamo et. al. (1999) showed that the ability of MSCs to differentiate towards the 
adipogenic lineage was lost in late passage cultures, whereas the cells were able to 
spontaneously differentiate towards the osteogenic lineage. However, recent studies 
have also shown the osteogenic potential of the cells is lost with time in culture and 
telomere erosion (Alves et al., 2008).    
 
However, there is an enzyme, telomerase, that enables reformation of the telomeres, 
through re-synthesis of the sub-unit (Greider and Blackburn, 1985; Greider, 1998). 
Telomerase is not typically present in MSCs and so these cells undergo the process of 
senescence after a finite number of population doublings (Zimmermann et al., 2003; 
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Parsch et al., 2004). However, there are sub-populations of MSCs isolated in vitro  
that have been shown to possess telomerase, thereby enabling these cells to undergo 
extensive proliferation without loss in differentiation potential  (Jiang et al., 2002; 
Rubin, 2002; d'Ippolito et al., 2004).  ESCs possess telomerase and thus are assumed 
to undergo unlimited population doublings with no loss in cell pluripotency (Thomson 
et al., 1998; Amit et al., 2000). The activity of telomerase reduces as the cells 
differentiate to a mature cell phenotype and is eventually lost, through proliferation 
(Ravindranath et al., 1997; Campisi, 2001; Forsyth et al., 2002; Sethe et al., 2006).  
 
MSCs can be induced with telomerase through transfection of the sub-unit, human 
reverse telomerase reverse transcriptase (hTERT), on to the cell. The ectopic 
expression extends their proliferation and maintains the multipotency of MSCs 
beyond the normal population doubling limit (Simonsen et al., 2002; Shi et al., 2002; 
Yamamoto et al., 2006). However, ectopic expression of telomerase within MSCs 
does not prevent premature senescence under normoxic conditions but proliferation is 
extended under hypoxia (Moussavi-Harami et al., 2004).  
 
1.6.4 Effect of oxygen levels on proliferation of stem cells 
Tissue engineering applications require a substantial number of cells for regeneration 
of tissues and thereby a large number of population doublings (section 1.1).  However, 
the number of cell population doublings is often limited before senescence occurs 
(Hayflick and Moorhead, 1961; Hayflick, 1965; Hayflick, 1974).  Hayflick et. al. 
(1965) cultured human diploid cell strains or human embryo fibroblasts for 
approximately 50 + 10 population doublings before senescence is initiated. Thus, 
studies have utilised the “Hayflick limit” to define the proliferation potential of cells, 
before senescence occurs. Alterations in oxygen tension have been utilised to extend 
the lifetime of the cells in culture. In the case of MSCs, their normally limited number 
of population doublings are extended before the process of cellular senescence occurs 
(DiGirolamo et al., 1999; Moussavi-Harami et al., 2004).  
 
Bradley et. al. (1978) described the isolation of hematopoietic progenitor cells, 
granulocyte-macrophage colony (GM-C), under hypoxic (5% oxygen) culture 
conditions. The number, size and cell density of the GM-C colonies formed under low 
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oxygen was greater compared with normoxic culture conditions and was not enhanced 
in the presence of hematopoietic growth factors. Thus, it was the oxygen tension 
rather than the presence of growth factors that increased the colony formation of these 
hematopoietic progenitor cells. Maeda et. al. (1986) examined colony growth of 
erythroid progenitors, GM-C and multipotent stromal cells (CFU-Fs) from whole bone 
marrow samples cultured under 10% oxygen conditions. The lowered oxygen 
conditions resulted in the increased colony formation of each of the cell types with 
erythroid progenitors exhibiting a greater number of colonies compared with 
granulocyte-macrophage progenitors. It was postulated that a reduction in ROS 
enabled hematopoietic progenitor cells to produce more colonies (Frank and Massaro, 
1980; Rich and Kubanek, 1982). 
 
The isolation of hematopoietic stem cells from whole bone marrow samples yielded 
further evidence of the effect of hypoxic culture conditions on the proliferation 
potential of these cells after formation of colonies (Koller et al., 1992; Cipolleschi et 
al., 1993). Studies showed that the clonal expansion of hematopoietic progenitor cells 
removed from the bone marrow stroma under 5% oxygen conditions, had enhanced 
proliferation under hypoxia compared with cells expanded under 20% oxygen 
conditions (Koller et al., 1992). Cipolleschi et. al. (1992) showed that there are sub-
populations of hematopoietic stem cells and progenitors within the bone marrow that 
corresponded to the cultured oxygen tension and their mitochondrial activity. 
Undifferentiated hematopoietic stem cells have a low mitochondrial activity, whilst 
progenitors increase their mitochondrial activity. Greater colony formation was 
observed for cells cultured between 1-3% oxygen. Greater numbers of uncommitted 
hematopoietic stem cells were obtained  under anoxic conditions, whereas committed 
progenitor cells proliferated under normoxic conditions corresponding to their 
mitochondrial activity and differentiation commitment (Cipolleschi et al., 1993). 
 
Neuronal stem cells have been shown to be affected by changes in oxygen tension in 
vivo, specifically gene products associated with metabolism, erythropoesis and 
angiogenesis (Studer et al., 2000; Wenger, 2002; Zhu et al., 2005; Milosevic et al., 
2005). Expansion of neuronal stem cells under hypoxia resulted in greater cell 
proliferation, low cell apoptotic rates and preservation of stem cell primitiveness or 
uncommitted features (Studer et al., 2000). The hypoxic culture enabled isolation of 
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subsets of uncommitted neuronal stem cells such as those associated with the mid-
brain (mescencephalic precursor cells). Recent studies reported that the telomeres, 
were maintained under low oxygen culture conditions, whereas the telomere length 
shortened at later population doublings under 20% oxygen conditions, due to ROS 
production and the subsequent formation of an oxidative stress (Milosevic et al., 
2005).        
 
The earlier study by Maeda et. al. (1986) provided evidence that low oxygen enabled 
greater colony formation of bone marrow stromal cells or CFU-Fs, thus providing 
evidence that MSCs are affected by oxygen level. The ability to form colonies is of 
primary importance for the isolation of MSCs, as the greater the number of colonies, 
the greater the potential number of stem cells. Recent studies have also shown that 
greater numbers of colonies are formed under low oxygen conditions, indicating the 
presence of a primitive MSC population (Grayson et al., 2006).  Fehrer et. al. (2007) 
revealed that cells isolated from trabecular bone and cultured under hypoxic culture 
conditions (3% oxygen) formed greater numbers of CFU-Fs compared with normoxic 
culture conditions. Studies using rat bone marrow derived MSCs correlated with these 
results and showed that isolation and culture under hypoxic (5% oxygen) culture 
conditions produced greater numbers of cells compared to normoxic culture (Lennon 
et al., 2001). The culture of ESCs derived from human sources also yielded a 
significant increase in the number of embryoid bodies during the initial culture under 
hypoxia (Ezashi et al., 2005; Forsyth et al., 2006).  
 
Studies culturing MSCs under hypoxic culture conditions showed that short-term 
culture caused limited cell apoptosis, although studies using adipose-derived MSCs 
and serum deprived human MSCs demonstrated increased apoptosis (Follmar et al., 
2006; Potier et al., 2007a; Potier et al., 2007b). Long-term culture revealed that 
greater numbers of cells could be obtained under hypoxia but there were no significant 
differences in the doubling rates between the culture conditions (Grayson et al., 2006; 
Fehrer et al., 2007; Grayson et al., 2007). However, these studies showed that 
hypoxic-cultured cells had a longer proliferative phase compared with normoxic 
culture and thus are presumed to undergoing greater population doublings with 
reduced apoptosis or senescence (Csete, 2005). Expansion of adipose-derived MSCs 
has revealed similar population growth patterns under hypoxia and in some cases, a 
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greater population of cells obtained during the initial growth phases (Wang et al., 
2005; Xu et al., 2007). 
 
The initial finding that greater numbers of colonies are formed under hypoxia suggests 
the presence of MSC sub-populations. D’Ippolito et. al. (2004) described the existence 
of MIAMI cells that were isolated through a combination of colony isolation and 
expansion under a low oxygen tension (3% oxygen), clonal expansion and cell sorting 
via flow cytometry. These cells were telomerase positive and thus assumed to undergo 
an extended number of population doublings with the ability for self-renewal 
(Zimmermann et al., 2003; d'Ippolito et al., 2006c).   
 
1.6.5 The effect of oxygen on the differentiation of stem cells 
The multipotential ability of MSCs makes these cells an attractive cell source for 
tissue engineering and regenerative medicine therapies (Caplan and Bruder, 2001; 
Muschler et al., 2004). However, these cells lose their multipotency characteristics 
with time in culture and due to the heterogeneous nature of the MSC population, have 
limited potential to differentiate to all three lineages from the outset (section 1.4.3 and 
section 1.6.3). The mechanisms through which stem cells are isolated from the bone 
marrow are thought to hold the key to generate multipotent MSCs with limited loss in 
their differentiation potential with time in culture. 
 
MAPC and MIAMI cells are sub-populations of MSCs that have been isolated under 
low oxygen conditions (Jiang et al., 2002; d'Ippolito et al., 2004). These cells 
expressed markers, OCT-4, SSEA-4, REX-1, NANOG and SOX-2 that are associated 
with stem cell pluripotency and have been expressed by ESCs (Thomson et al., 1998; 
Amit et al., 2000; Kolf et al., 2007). D’Ippolito et. al. (2004) showed that MIAMI 
cells, due to their expression of these pluripotency markers, had the ability to 
differentiate to cells of the endodermal and ectodermal lineages. The long-term culture 
and expansion of these cells under hypoxia resulted in the maintenance of the 
differentiation potential through control of these pluripotency genes (d'Ippolito et al., 
2004; Ezashi et al., 2005; Grayson et al., 2006; Grayson et al., 2007). 
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Lennon et. al. (2001) differentiated rat bone marrow-derived MSCs under hypoxia 
and normoxia. Hypoxic culture conditions revealed enhanced osteogenesis compared 
with normoxic culture, through analysis of bone nodule formation and calcium 
content. A previous investigation showed that the osteoblast marker, alkaline 
phosphatase, had increased activity under 5% oxygen compared with normoxic and 
anoxic cultures of periosteal derived cells (Deren et al., 1990). However, recent 
studies have shown that osteogenesis is inhibited by hypoxia (Malladi et al., 2006; 
d'Ippolito et al., 2006a; Potier et al., 2007a).  
 
Salim et. al. (2004) cultured and differentiated pre-osteoblastic cells, MC3T3-E1 cells 
and MSCs towards the osteoblastic lineage under normoxia, hypoxia (2% oxygen) and 
anoxia (0.2% oxygen). The anoxic conditions resulted in inhibited bone nodule 
formation and an associated decrease in the expression of Runx-2, resulting in 
inhibition of osteogenic matrix genes, osteocalcin, osteonection and osteopontin. 
Collagen type I and III were expressed but formation of an organised matrix was 
prevented with continuous hypoxic culture (Warren et al., 2001).  
 
In many of these studies, greater VEGF expression was apparent under hypoxia 
compared with normoxia (Warren et al., 2001; Arnett et al., 2003; Nilsson et al., 
2004; Potier et al., 2007a). The expression of VEGF indicates that blood vessel 
formation would be facilitated in vivo and thus enable increases in oxygen tension 
within the site of bone remodelling to enable bone formation (Arnett et al., 2003). 
 
The literature relating to the effect of hypoxia on the induction of adipogenesis and 
formation of lipid droplets also provides conflicting results. Ren et. al. (2006) showed 
induction of adipogenesis, through greater lipid droplet formation, under 8% oxygen 
conditions compared with normoxia. However, an earlier study showed that the 
accumulation of lipid droplets was reduced under hypoxia, with inhibited expression 
of the adipogenic marker, PPAR-2 and other subsequent adipogenic genes (Fink et 
al., 2004). 
 
Csete et. al. (2001) cultured MSCs in adipogenic medium under either hypoxia or 
normoxia. PPAR-2 expression was greater under normoxia, with subsequent 
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accumulation of lipids in culture. However, culture under hypoxia resulted in the 
formation of skeletal muscle cells, through myogenic differentiation. Previous 
investigations have shown that PPAR-2 represses the myogenesis gene marker, 
MyoD, and therefore the induction of myogenesis may have been induced under 
hypoxia due to suppression of PPAR-2 expression and expression of MyoD (Csete, 
2005).  
 
As described in section 1.6.2, hypoxia has been utilised in the redifferentiation of 
chondrocytes to generate cartilage-specific extracellular matrix (Grimshaw and 
Mason, 2000; Murphy and Sambanis, 2001a; Domm et al., 2004; Malda et al., 2004b). 
SOX-9 expression has been demonstrated to be enhanced under hypoxic culture 
conditions (Robins et al., 2005). Analysis of the role of hypoxia in the chondrogenic 
differentiation of MSCs in 3D cell culture have confirmed these observations (Lennon 
et al., 2001; Wang et al., 2005; Malladi et al., 2006). Lennon et. al. (2001) showed 
that the central regions of ceramic cubes removed from the subcutaneous muscle of 
rats demonstrated the formation of cartilage, in the same manner as investigations 
utilising diffusion chambers (section 1.4.1). In both cases, the central regions of the 
samples are under low oxygen, which leads to the expression of hypoxia inducible 
factor-1HIF-1that has been demonstrated to stimulate expression of SOX-9, 
resulting in cartilage formation (Robins et al., 2005; Malladi et al., 2007; Kanichai et 
al., 2008).  
 
Wang et. al. (2005) differentiated adipose-derived MSCs towards the chondrogenic 
lineage under hypoxia and showed greater collagen production, although there was no 
alteration in sulphated GAG synthesis compared with normoxia. However, the 
conditions inhibited cell proliferation, and it was hypothesized that these effects may 
be related to the cellular metabolism, as the cells utilised glycolysis under hypoxia. 
Recent studies have shown that hypoxia prevents cells from maturing to hypertrophic 
chondrocytes under standard chondrogenic differentiation culture medium, due to 
HIF-1-associated inhibition of collagen X and suppression of Runx-2 (Hirao et al., 
2006). 
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Nonetheless, Malladi et. al. (2006) showed that chondrogenic differentiation of 
adipose-derived MSCs was inhibited under hypoxia. The micromass cultures had 
decreased proliferation during differentiation but increased cell survival under 
hypoxia compared with normoxia. The accumulation of extracellular matrix molecules 
was greatest at normoxia and it was hypothesized in the investigation that the oxygen 
gradients formed under hypoxic conditions resulted in severe anoxia within the centre 
of the micromass. However, recent studies using similar conditions reported enhanced 
chondrogenesis under hypoxia (Xu et al., 2007; Pilgaard et al., 2009a).  Further to 
these investigations, it has been shown that stem cells pre-expanded under hypoxia 
may have an enhanced ability to differentiate towards the chondrogenic phenotype 
(Xu et al., 2007; Koay and Athanasiou, 2008).  Recent studies have utilised hypoxic 
culture conditions combined with mechanical loading to enhance the stimulation of 
MSCs towards the chondrogenic phenotype (Scherer et al., 2004; Wernike et al., 
2008). 
 
The results of these investigations show that the effect of hypoxia on adipogenic, 
osteogenic and chondrogenic differentiation are contradictory. The limitations within 
these investigations are the different hypoxia levels used within each study and the 
fact that controlled and continuous oxygen tension was not utilised in the 
differentiation of these cells.  
 
1.6.6 Metabolism of MSCs 
Section 1.6.2 describes the metabolic differences between chondrocytes and 
osteoblasts cultured under normoxia. The distinct differences in their metabolism may 
influence their ability to produce extracellular matrix for the development of tissues 
and may be related to their habitual in vivo oxygen tension (Brighton et al., 1991; 
Tuncay et al., 1994; Rajpurohit et al., 1996; Malda et al., 2004b). Studies culturing 
hematopoietic progenitors under hypoxia suggest that the cellular metabolism 
influences the number of colonies formed (Frank and Massaro, 1980; Rich and 
Kubanek, 1982). The reduction in ROS under hypoxia is thought to influence the 
number of colonies, in addition to their cellular metabolism.  The conditions enabled 
the cells to utilise glycolysis rather than oxidative phosphorylation for their cell 
survival (Zwartouw and Westwood, 1958).  
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Moussavi-Harami et. al. (2004) cultured hTERT-transfected human MSCs under 
hypoxia and found that the population doubling limit increased to 22 population 
doublings whilst normoxia cultured cells had a limit of 11 population doublings. The 
study did not measure the consumption of oxygen under these conditions but 
measurements of the ROS product, hydrogen peroxide, demonstrated increased ROS 
production under normoxia, which could lead to oxidative stress and results in 
premature senescence. The consumption of oxygen and therefore the utilisation of 
oxidative phosphorylation may be casually related to the increased production of ROS 
and could induce spontaneous stem cell differentiation (section 1.5.3) (Ezashi et al., 
2005). However, studies have only measured the glucose consumption and lactate 
production for MSCs during their expansion phase (Grayson et al., 2006; Markusen et 
al., 2006; Follmar et al., 2006; Mischen et al., 2008). The results of the studies show 
that there was lactate production on consumption of glucose, in the presence of high 
oxygen levels. This behaviour is indicative of the Warburg Effect. The measured ratio 
between glucose and lactate for hypoxia-cultured cells during time in culture was 
calculated to be 1:2, which is the stoichiometric ratio for glycolysis (Grayson et al., 
2006).  
 
Cell proliferation was shown to be inhibited in the absence of glucose and exogenous 
lactate (Follmar et al., 2006). However, culture of MSCs in a high glucose medium 
(25 mM) increased the induction of premature senescence compared with MSCs 
cultured in low glucose medium (5.6 mM) or caused no enhancement in cell 
proliferation (Blazer et al., 2002; Stolzing et al., 2006; Follmar et al., 2006; Li et al., 
2007). Mischen et. al. (2008) showed that MSCs had a significant increase in lactate 
production upon culture under hypoxia compared with normoxia, thereby 
demonstrating the Pasteur Effect.  
 
A further metabolite measured in previous investigations was glutamine and the 
subsequent production of ammonia (section 1.1) (Follmar et al., 2006; Schop et al., 
2008; Schop et al., 2009). The studies show that glutamine was utilised by cells but 
the subsequent production of ammonia resulted in inhibited growth of the cell 
population, which subsequently led to cell death. However, the absence of glutamine 
results in the cells having low rates of glucose consumption and lactate production, 
thereby inferring that the cells are quiescent (Follmar et al., 2006). The utilisation of 
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oxygen was not measured in these studies but it may be hypothesized that the 
mitochondrial capacity may not be fully utilised and that they are preferentially 
glycolytic, as these cells produce lactate under high levels of oxygen (Chen et al., 
2008). 
 
In terms of the differentiation of these cells towards the chondrogenic or osteogenic 
lineages, there are limited data. Wang et. al. (2005) measured lactate production 
during stages of chondrogenic differentiation for adipose-derived MSCs cultured 
under hypoxic and normoxic conditions. There was a significant increase in lactate 
production for hypoxia-differentiated MSCs but there were significant levels of lactate 
produced for MSCs differentiated under normoxia for each of the time points 
measured. A recent study measured the oxygen consumption of MSCs differentiated 
towards the osteogenic lineage and found an increase in oxygen consumption and 
mitochondrial activity after two weeks in culture (Chen et al., 2008) However, there 
were no direct measurements of the oxygen consumption and no indications of 
changes in the metabolism during differentiation. Nonetheless, these studies show the 
differences in cellular metabolism during chondrogenic and osteogenic differentiation 
of MSCs.    
  
Accordingly, there is a need to study the metabolism of MSCs and how this may be 
altered during expansion, differentiation and in response to altered environmental 
oxygen conditions. Data on the metabolism of MSCs during expansion and 
differentiation are ultimately valuable for the development of tissue engineered 
applications utilising these cells. Understanding changes in the rates of consumption 
of key metabolites under different conditions would help to provide optimised 
conditions for bioreactor culture and help to indicate the state of MSCs during the 
process of differentiation.    
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1.7 Aims and Objectives 
The literature has shown that control of oxygen levels leads to changes in both the 
proliferation and differentiation of MSCs that may be related to the metabolism of the 
cells. Hypoxia has been shown to be beneficial for long-term culture of these cells and 
for maintenance of their differentiation capacity. However, the control of oxygen in 
these studies has not been continuous and therefore changes in oxygen levels may 
have contributed to the variation in results between studies (section 1.6.4 and 1.6.5). 
Therefore, the aim of the thesis is to characterise the metabolism of MSCs during 
proliferation and differentiation, in addition to examining the effects of continuous 
oxygen tension on the proliferation and differentiation of MSCs. Based upon the 
previous literature, the hypotheses for the thesis are: - 
 
 MSCs maintain a high level glycolysis on expansion under normoxic culture 
conditions 
 
 Differentiation of MSCs towards a mature cell phenotype changes the 
metabolism of the cells 
 
 Hypoxia enables MSCs to undergo greater population doublings without 
concomitant senescence or loss in differentiation potential 
 
 Chondrogenic differentiation is enhanced under hypoxia, whilst osteogenesis 
is inhibited under the same conditions. 
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2 THE UTILISATION OF OXYGEN AND GLUCOSE 
METABOLIC PATHWAYS IN HUMAN MSCs 
2.1 Introduction 
The physiological or in vivo oxygen tension within human bone marrow has been 
measured to be between 4-7% oxygen (Grant and Smith, 1963). The oxygen tension 
surrounding MSCs or bone marrow stromal cells has been shown to affect both their 
proliferation (Moussavi-Harami et al., 2004; Grayson et al., 2006; Ren et al., 2006; 
d'Ippolito et al., 2006a) and differentiation (Lennon et al., 2001; Fink et al., 2004; 
Wang et al., 2005; Ren et al., 2006; d'Ippolito et al., 2006a; Potier et al., 2007a). 
Studies that have cultured MSCs under normoxic (20% oxygen) and hypoxic (5% 
oxygen) environments show that premature senescence is reduced upon culture under 
hypoxia (Lennon et al., 2001; Parrinello et al., 2003; Zimmermann et al., 2003; 
Moussavi-Harami et al., 2004). This phenomenon may be associated with oxidative 
damage linked to their energy metabolism. 
 
Studies analysing the oxygen and glucose consumption and lactate production of 
tumour cells and chondrocytes that originate from hypoxic conditions in vivo have 
shown a preferentially glycolytic metabolism upon culture under normoxic in vitro 
culture conditions, a phenomenon known as the Warburg effect (Bywaters, 1937; 
Krebs, 1972; Rajpurohit et al., 1996; Heywood et al., 2006). However, under limiting 
glucose, an increase in oxygen consumption and oxidative phosphorylation is apparent 
(Heywood et al., 2006). This process has been described as the Crabtree effect (Krebs, 
1972). Studies have measured the lactate production of MSCs cultured under 
normoxic and hypoxic conditions. MSCs cultured under hypoxia increased lactate 
production, reflecting a shift towards a glycolytic metabolism, indicative of the 
Pasteur effect (Krebs, 1972; Wang et al., 2005; Grayson et al., 2006; Mischen et al., 
2008).  
 
These studies suggest that the metabolism of MSCs changes in response to alterations 
in the surrounding environment. However, MSC studies have not measured the 
oxygen consumption of these cells. Tissue engineering solutions require cells to create 
tissues within 3D environments. The viability of the cells is partially dependent upon 
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oxygen and glucose metabolism. In 3D environments, it has been shown that oxygen 
gradients are formed, due to a combination of diffusion within the construct and 
cellular metabolite consumption (Malda et al., 2004a; Heywood, 2005). In addition, 
MSCs are required to be undego successive passages to enable them to be utilised for 
tissue engineering applications. However, culture of these cells under normoxia has 
led to premature senescence and therefore resulted in inadequate numbers of cells for 
use in tissue engineering therapies. The reasons for this phenomena have been 
discussed previously (section 1.6). 
 
The aims of the current chapter are to analyse the glucose and oxygen consumption by 
human MSCs cultured under normoxia to test the hypothesis that human MSCs 
maintain a high level of glycolysis upon expansion under normoxic conditions. 
Oxygen consumption is measured using an oxygen biosensor plate, whilst glucose and 
lactate measurements were analysed using standard biochemical assays. In 
conjunction with this study, assessments of MSC population growth and 
differentiation were examined (Pittenger et al., 1999).  
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2.2 Methodology 
2.2.1 Preparation of proliferation medium 
The proliferation medium used for the current investigations was Alpha Minimal 
Essential Medium + 8.5% (v/v) foetal bovine serum (-MEM + 8.5% FBS). The 
medium was prepared under asceptic conditions within a laminar flow hood. The 
proliferation medium was prepared through addition of the following reagents to 500 
ml Alpha Minimal Essential medium (-MEM, Invitrogen, Paisley, UK) (Table 2.1).  
 
Table 2.1. Volume and final concentration of reagents for -MEM + 8.5% FBS. 
Reagents  
(stock solution concentration) 
Volume Final concentration Supplier 
-MEM 500 ml  Invitrogen, Paisley, UK 
Foetal Bovine serum 50 ml 8.5% Sigma-Aldrich, Poole, UK 
L-Glutamine (200 mM) 5 ml 1.7 mM Sigma-Aldrich, Poole, UK 
Penicillin (10000 U/ml) 
/streptomycin (10 mg/ml) 
5 ml 
85.5 U/ml penicillin; 
0.085 mg/ml 
streptomycin 
Sigma-Aldrich, Poole, UK 
Basic fibroblastic growth factor   
(100 ng/ml) 
5 ml 0.9 ng/ml Serotec, Oxford, UK 
L-ascorbic acid-2-phosphate  
(20 mM) 
5 ml 0.17 mM Sigma-Aldrich, Poole, UK 
HEPES buffer  (1 M) 15 ml 25 mM Sigma-Aldrich, Poole, UK 

The reagents were filtered through a 0.22 m pore size filter (Millipore, Consett, UK) 
into the -MEM and mixed prior to use. Basic fibroblast growth factor has been shown 
to enhance the proliferation of the cells without compromising their differentiation 
capacity (Walsh et al., 2000; Both et al., 2007; Stewart et al., 2007). In addition, 
studies have shown that basal media, -MEM, enhances the proliferation of MSCs 
compared with Dulbecco’s Modified Eagle media (DMEM), although there are no 
differences with to regards to MSC differentiation (Majumdar et al., 2000; Both et al., 
2007).  
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2.2.2 LonzaTM characterised human MSCs 
The human MSC populations used in the current studies were procured from a 
commercial source (Lonza, Wokingham, UK). The donor used in the present studies 
was aged 19. The cells were expanded to passage two and cryopreserved in media + 
10% dimethyl sulphoxide (DMSO) prior to delivery to the host laboratory. On receipt 
of the vial, the cells were stored in a liquid nitrogen cryobank prior to use. In 
compliance with manufacturers’ procedure and quality control, the cells were 
characterised for MSC markers (positive expression: CD29, CD44, CD166; negative 
expression: CD14, CD34, CD45) and differentiation towards adipogenic (Oil-red-O 
staining), chondrogenic (safranin-O staining) and osteogenic (calcium deposition assay) 
lineages. Replicates used within these studies were derived from the same donor. To 
minimise the effect of serial cryopreservation on cellular metabolism, a bank of cells 
was created from initial resuscitation and were cryopreserved according to protocol 
described in 2.2.5. Results described in the investigation and future studies within this 
thesis (Chapter 3 and 4) are derived from cells beginning at passage 2 and undergoing 
only two resuscitations, inclusive of initial cell culture phase upon procurement of 
cells. 
 
Cell culture was initiated through placement of the cryovial in a 370C water bath to 
resuscitate the cells. Once the cell suspension mixture was thawed, it was added 
dropwise to 10 ml warm -MEM + 8.5% FBS. A cell count was performed, using a 
Neubauer haemacytometer (Improved Neubauer, VWR, Lutterworth, UK), and a trypan 
blue viability assay (section 2.2.4). Cells were introduced into cell culture flasks at a 
seeding density of 2 x 103 cells/cm2 and cultured in a 370C/5% CO2 incubator. 
 
2.2.3 Trypsinisation of adherent cells 
The cells were sub-cultured by trypsinisation on reaching 80-90% confluence. The 
medium from the culture flask was removed and replaced with 5 ml phosphate buffered 
saline (PBS, Sigma-Aldrich, Poole, UK). The PBS was gently washed over the cells for 
approximately 2-3 minutes. The PBS was removed from the flask and replaced with 
5ml 0.5 g/l Tryspin-0.2 g/l EDTA in Hanks balanced salt solution with phenol red 
(Sigma-Aldrich, Poole, UK). The culture flask was placed in an incubator (370C/5% 
CO2) for 5-10 minutes and was checked at appropriate intervals using a bench-top 
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inverted microscope (Leica Microsystems, Wetzlar, Germany) for cell detachment from 
the culture flask surface.  
 
Once the cells were rounded and detached from the culture flask, 10 ml of fresh -
MEM + 8.5% FBS was added to inactivate the trypsin and the cell suspension was 
transferred to a centrifuge tube (Corning Life Sciences, Acton, USA). A 20 l sample 
of the cell suspension was removed and mixed with an equal volume of trypan blue 
solution and transferred to a Neubauer haemacytometer for assessment of the number 
of viable cells in the cell suspension. The cell suspension was centrifuged at 500 x g for 
five minutes and led to the creation of a cell pellet. The supernatant was removed and 
the cells were resuspended in an appropriate volume of -MEM + 8.5% FBS. A 
syringe and 20G needle was used to create a single cell suspension and the cells were 
placed into appropriately sized cell culture flasks at a seeding density of 2 x 103 
cells/cm2 with further supplementation of -MEM + 8.5%. The flasks were placed into 
a 370C/5% CO2 incubator to enable cell attachment and division of cells. The medium 
was replaced every 2-3 days. 
 
2.2.4 Cell counting and viability – Trypan blue exclusion assay 
The number of cells after each trypsinisation or cell resuscitation was calculated using a 
Neubauer haemocytometer and 0.4% trypan blue staining solution prepared in saline 
solution (Sigma-Aldrich, Poole, UK). A 20 l aliquot of the cell suspension was added 
to an equal volume of trypan blue solution and mixed using a pipette. A coverslip was 
placed on the counting chambers of the haemacytometer until secure and a sample of 
the cell suspension-trypan blue solution was pipetted into each counting chamber 
underneath the coverslip. Cells within the defined grid area were counted, with cells 
stained dark blue counted as dead cells. The number of cells in the suspension was 
calculated using equation 2.1. The volume of cell suspension was adjusted accordingly, 
for further experimentation and passage. 
 
         volumesuspensioncellgridincellsofNoNumberCell  4102.                (2.1) 
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2.2.5 Cryopreservation of cells 
Cells were cryopreserved in liquid nitrogen at -1970C for future use. Cells were sub-
cultured from a culture flask and a cell count was performed using the protocol outlined 
in section 2.2.4. The cell suspension was centrifuged at 500 x g for five minutes to form 
a cell pellet. The supernatant was removed from the centrifuge tube and replaced with 
0.5 ml -MEM + 10% FBS and the cell suspension was pipetted into a cryovial and 
placed on ice. A 0.5 ml solution of -MEM + 10% FBS + 20% DMSO was then added 
slowly to the cell suspension, resulting in a cell suspension containing 10% DMSO. 
The cryovial was labelled and placed in a Nalgene freezing container (Nalgene, 
Hereford, UK) and stored in a -800C freezer for 24 hours. The vial was subsequently 
placed in a liquid nitrogen cryobank for long-term storage. 
 
To resuscitate the cells from cryopreservation, the vial was removed from the cryobank 
and opened briefly within a laminar flow hood. The vial was placed in a 370C water 
bath for 2-3 minutes until the medium was thawed. The thawed cell suspension was 
removed from the vial and added to an appropriate volume of -MEM + 8.5% FBS. 
The cells were resuspended in -MEM + 8.5% FBS and the number of viable cells was 
counted (section 2.2.4). The cells were centrifuged and the supernatant was removed to 
ensure that there was no DMSO present within the cultures. The cells were resuspended 
in -MEM + 8.5% FBS and were distributed into culture flasks at a seeding density of 
2 x 103 cells/cm2. The flasks were placed into a 370C/5% CO2 incubator for culture and 
were fed every 2-3 days until sub-culture at 80-90% confluence. 
 
2.2.6 Analysis of cell population growth 
MSCs were passaged upon reaching 90% confluence and the number of viable cells 
was recorded before being split into new flasks for the next passage (section 2.2.4). At 
each passage, a multiplication factor was calculated using equation 2.2. 
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L
TM                     (2.2) 
 
M = Multiplication factor 
T = Total number of live cells at end of passage 
L = Cell seeded at start of passage 
 
A growth curve was generated for each of the samples through the calculation of a 
cumulative cell number. The cumulative cell number was calculated through successive 
multiplication of the potential number of live cells at the end of each passage with the 
multiplication factor of the next passage (equation 2.3). 
 
xxx MNcNc  1                  (2.3) 
Nc = Cumulative cell number 
M = Multiplication factor 
x = Passage number 
 
The rate at which the cell population increases is dependent upon on the duration of the 
cell cycle and the proportion of proliferating cells within the cell population. Cell 
growth dynamics are assumed to consist of the following components: lag phase, log 
growth and plateau phases (Figure 2.1a). The population growth rate may be analysed 
through calculation of cell doubling time. The doubling time may be calculated through 
fitting a logarithmic linear model to the exponential growth phase of the cell population 
and using equation 2.4 (Figure 2.1b).  
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D = Doubling time (hours)  
Nx = Cell number after x cell doublings 
Ni = Cell number at intercept  
m = Gradient of line of best fit (Figure 2.1b) 
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Figure 2.1. (a) A representative curve showing the distinctive phases involved during cell growth,  
and (b) a logarithmic representation of the growth curve in (a). The dotted line shows a best fit line 
through the linear portion of the curve. 
 
2.2.7 Differentiation of MSCs 
2.2.7.1 Osteogenic differentiation 
 
Table 2.2. The components and final concentrations for osteogenic medium. 
Reagents 
(stock solution concentration) 
Volume Final concentration Supplier 
-MEM 425 ml - Invitrogen, Paisley, UK 
Foetal Bovine serum 50 ml 10 % Sigma-Aldrich, Poole, UK 
L-Glutamine (200 mM) 5 ml 2 mM Sigma-Aldrich, Poole, UK 
Penicillin (10000 U/ml) 
/streptomycin (10 mg/ml) 
5 ml 
85.5 U/ml penicillin; 
0.085 mg/ml 
streptomycin 
Sigma-Aldrich, Poole, UK 
L-ascorbic acid-2-phosphate 
(5 mM) 
5 ml 0.05 mM Sigma-Aldrich, Poole, UK 
-glycerophosphate (1 M) 5 ml 10 mM Sigma-Aldrich, Poole, UK 
Dexamethasone (10 M) 5 ml 0.1 M Sigma-Aldrich, Poole, UK 
 
MSCs were cultured until 80-90% confluence and trypsinised using the protocol 
described in section 2.2.3. The cells were seeded at 2 x 103 cells/cm2 into 6-well culture 
plates (Corning Life Sciences, Acton, USA) and placed into a 370C/5% CO2 incubator 
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for 24 hours to enable cell attachment. Osteogenic medium was prepared as outlined in 
Table 2.2. The control medium for the osteogenic study was cells cultured in -MEM + 
8.5% FBS (Table 2.1). The cells were cultured for 21 days and the appropriate medium 
was replaced every 2-3 days. 
 
Alizarin red staining for calcium deposition 
A 2% (w/v) alizarin red solution (Sigma-Aldrich, Poole, UK) was prepared in distilled 
water. The pH was adjusted to 4.2 through addition of ammonium hydroxide (BDH, 
Poole, UK) and the solution was filtered prior to use. Procedures were performed in a 
chemical fume cupboard. Osteogenic cultures were removed on days 7, 14 and 21 for 
analysis of calcium deposition. Medium was removed from each well and the cells 
were washed using PBS, prior to fixation in 70% (v/v) ethanol for one hour at room 
temperature. The fixative was aspirated and the cells were washed twice using distilled 
water. The cultures were bathed in 0.5 ml 2% alizarin red solution and incubated at 
room temperature for 30 minutes. The alizarin red solution was removed and the cells 
were washed several times with distilled water. The cells were mounted using 70% 
(v/v) glycerol solution and visualised using a light microscope. 
 
2.2.7.2 Adipogenic differentiation 
 
Table 2.3. The components and final concentrations for adipogenic induction medium. 
Reagents 
(stock solution concentration) 
Volume Final concentration Supplier 
DMEM 438.4 ml - Sigma-Aldrich, Poole, UK 
Foetal Bovine serum 50 ml 10% Sigma-Aldrich, Poole, UK 
Penicillin (10000 U/ml) 
/streptomycin (10 mg/ml) 
5 ml 
85.5 U/ml penicillin; 
0.085 mg/ml 
streptomycin 
Sigma-Aldrich, Poole, UK 
Isobutyl-methylxanthine (83 mM) 3.1 ml 0.5 mM Sigma-Aldrich, Poole, UK 
Indomethacin  (40 mM) 2.5 ml 0.05 mM Sigma-Aldrich, Poole, UK 
Insulin (10 mM) 0.5 ml 10 mM Sigma-Aldrich, Poole, UK 
Dexamethasone (1 mM) 0.5 ml 1 M Sigma-Aldrich, Poole, UK 
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MSCs were seeded at 2 x 103 cells/cm2 into 6-well culture plates (Corning Life 
Science, Acton, USA). The cells were maintained in -MEM + 8.5% FBS until 
confluence. Selected samples were incubated with adipogenic induction medium (Table 
2.3) with further samples incubated with adipogenic maintenance medium (DMEM + 
10% FBS + 10 M insulin; Sigma-Aldrich, Poole, UK). The medium was replaced 
after three days with adipogenic maintenance medium in each of the samples. The 
samples induced towards the adipogenic lineage underwent three cycles of adipogenic 
induction and adipogenic maintenance medium, whilst control cultures were 
continually fed with adipogenic maintenance medium for the duration of culture (21 
days). 
 
Oil-red-O staining for lipid droplets 
A 0.3% (w/v) stock solution of Oil-red-O solution (Sigma-Aldrich, Poole, UK) was 
prepared in isopropanol (BDH, Poole, UK). Prior to staining, 3 volumes Oil-red-O 
stock solution was mixed with 2 volumes distilled water and filtered prior to use. 
Procedures were performed within a chemical fume cupboard. 
 
Adipogenic culture was assessed for lipid droplet formation on days 7, 14 and 21 of 
culture. The medium was aspirated and the cells were washed using PBS. The cultures 
were fixed using 3.7% (v/v) formaldehyde in PBS for 30 minutes at 370C. The fixative 
was aspirated and the cultures were rinsed in sterile distilled water. The water was 
replaced with 60% (v/v) Isopropanol (BDH, Poole, UK) in water and the cells were 
incubated at room temperature for five minutes. The isopropanol was aspirated and 
replaced with Oil-red-O solution and the cells were incubated for a further five 
minutes. The cells were rinsed with distilled water and mounted using 70% (v/v) 
glycerol solution and visualised using a light microscope.  
 
2.2.7.3 Chondrogenic differentiation 
Confluent cells were trypsinised and counted using the protocols described in sections 
2.2.3 and 2.2.4. The medium used for chondrogenic differentiation is outlined in Table 
2.4. Control chondrogenic medium contains the same components without TGF-3. 
Aliquots of 1 ml cell suspensions containing 2 x 105 cells, were transferred into 15 ml 
polypropylene tubes (Corning Life Science, Acton, USA). The cell suspensions were 
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centrifugated at 500 x g for five minutes. Once centrifugation was completed, the 
supernatant was removed and replaced with 1 ml control chondrogenic medium and 
resuspended to wash the cells. The cells were centrifugated at 500 x g for five minutes. 
Cell pellets were placed in a 370C/5% CO2 incubator for culture.  
 
To initiate cell pellets for chondrogenesis, control chondrogenic medium was aspirated 
after washing and replaced with 1 ml chondrogenic medium. A cell suspension was 
created in each of the tubes and the suspensions were re-centrifugated at 500 x g for 
five minutes. Once centrifugation was completed, the cell pellets were placed into a 
370C/5% CO2 incubator for culture.  
 
Table 2.4. Components and final concentrations for chondrogenic medium. 
Reagents 
(stock solution concentration) 
Volume Final concentration Supplier 
DMEM-High glucose (25 mM)  479.75 ml - Sigma-Aldrich, Poole, UK 
ITS + Premix  5 ml 1 % BD Biosciences, Oxford, UK 
Penicillin (10000 U/ml) 
/streptomycin (10 mg/ml) 
5 ml 
85.5 U/ml penicillin; 
0.085 mg/ml 
streptomycin 
Sigma-Aldrich, Poole, UK 
Sodium pyruvate(100 mM) 5 ml 1 mM Sigma-Aldrich, Poole, UK 
L-Proline(35 mM) 5 ml 0.35 mM Sigma-Aldrich, Poole, UK 
L-ascorbic acid-2-phosphate  
(17 mM) 
0.5 ml 0.17 mM Sigma-Aldrich, Poole, UK 
Dexamethasone (10 M) 0.5 ml 0.1 M Sigma-Aldrich, Poole, UK 
Transforming growth factor-3  
(2 g/ml) 
0.25 ml 10 nM Peprotech, London, UK 
 
Once pellets had formed, after 24 hours, individual pellets were transferred into fresh 
15 ml polypropylene tubes and fresh control chondrogenic or chondrogenic medium 
was added (0.5 ml per tube). The cells were cultured for 21 days and the appropriate 
medium was replaced every 2-3 days. 
 
Toluidine blue staining for glycosaminoglycans 
MSC pellets cultured for 21 days were washed using PBS. The pellets were fixed with 
3.7% (v/v) formaldehyde in PBS and incubated at 370C for 30 minutes. The fixative 
was removed and the pellets were stored in PBS at 40C prior to embedding and 
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sectioning. The embedding and staining procedures were performed by the Pathology 
core facility, Institute of Cell and Molecular Science, Queen Mary University of 
London. The pellet samples were secured in histology cassettes, dehydrated, cleared 
and embedded in molten wax using standard procedures. The schedule for processing 
the samples is outlined in Table 2.5. The paraffin blocks were sectioned using a 
microtome saw and cut to create 5 m thick sections. The sections were stretched on 
the surface of distilled water at 450C for a few minutes, before being floated on to glass 
slides and allowed to adhere. The sections were allowed to dry before commencement 
of staining procedure 
 
Table 2.5. Sequence of reagents for tissue embedding, re-hydration and dehydration for tissue 
staining of chondrogenic pellets. 
Tissue embedding 
Tissue re-hydration for staining 
(reverse sequence for dehydration and 
mounting) 
Step Reagent Time Step Reagent Time 
1 50% Ethanol 45 mins. 1 Xylene 5 mins. 
2 70% Ethanol 45 mins. 2 Xylene 5 mins. 
3 90% Ethanol  45 mins. 3 Ethanol 3 mins. 
4 100% Ethanol 45 mins. 4 Ethanol 3 mins. 
5 50% Ethanol/50% Toluene 45 mins. 5 Ethanol 3 mins. 
6 100% Toluene 45 mins. 6 Distilled water 5 mins. 
7 Molten wax (580C) 30 mins.    
8 Molten wax (580C) 1 hr.    
 
A 1% (w/v) toluidine blue stock solution (Sigma-Aldrich, Poole, UK) was prepared in 
70% (v/v) ethanol. A 1% (w/v) sodium chloride solution was prepared and 5 ml 
toluidine blue stock solution was added to 45 ml of 1% sodium chloride solution to 
formulate the staining solution. The pH of the staining solution was adjusted to 2.3. The 
sections were cleared of wax and rehydrated using distilled water, following the 
sequence detailed in Table 2.5. Slides were then submerged in the staining solution for 
3 minutes. The sections were then washed to remove excess staining solution with 
distilled water before dehydrating and mounting in DePeX under a coverslip.      
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2.2.8 Oxygen biosensor plate 
 
Figure 2.2. Schematic diagram describing the operation of a well in a 384-well oxygen biosensor 
plate (BD Biosciences, Oxford, UK). (a) Experimental setup with cells in suspension and (b) 
measurement of oxygen within a well. 
 
The oxygen consumption of MSCs was measured using an oxygen biosensor system, 
developed by BD Biosciences, Oxford, UK (Figure 2.2). The system has been used in 
previous studies to measure the oxygen consumption of various cell types (Sinaasappel 
and Ince, 1996; Heywood, 2005; Dike et al., 2006). The oxygen biosensor used in this 
study was the 384-well plate design. The bottom of each well in the plate contains an 
oxygen sensitive fluorescent dye or fluorophore (tris-1,7-diphenyl-1,10 phenanthroline 
ruthenium (II) chloride) within a gas permeable silicon matrix (Figure 2.2). The 
fluorescence of the fluorophore is quenched by molecular oxygen within the well in a 
concentration dependent manner. Thus, as oxygen is consumed by the cells in the 
media over time, the concentration of oxygen decreases and the fluorescence increases. 
Therefore, the fluorescence intensity is inversely proportional to the oxygen 
concentration within the wells of the biosensor. The relationship obeys the 
mathematical model known as the Stern-Volmer equation (equation 2.5) 
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SV                  (2.5) 
 
Equation 2.5 states that the oxygen concentration [O2] is related to the fluorescence 
intensity at zero oxygen concentration (I0) and the sample oxygen concentration (I). 
KSV is the quenching constant or Stern-Volmer constant for the fluorophore in the 
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plates. The fluorescence intensity of each well of the oxygen biosensor plate was read 
using a fluorometer (Fluostar Galaxy, BMG technologies, Aylesbury, UK), set to read 
for fluorescence intensity at the base of the wells using an excitation filter at 485nm 
and an emission filter at 590nm.  
 
2.2.9 Oxygen consumption of MSCs – sealed biosensor plate 
Cells were sub-cultured using the protocol described in described in section 2.2.3, cell 
suspension samples were aspirated and resuspended at selected concentrations in 
oxygen and temperature equilibrated -MEM without phenol red (Invitrogen, Paisley, 
UK) + 8.5% FBS medium. The medium was placed in a 370C/5% CO2 incubator for 
equilibration for 24 hours. The cell concentrations ranged from 4.16 x 105 – 1.66 x 106 
cells/ml, that when aliquoted into the biosensor wells at a volume of 130 l correspond 
to 0.5 x 105, 1 x 105, 1.5 x 105 and 2 x 105 cells per well. 
 
The oxygen biosensor plate was placed in a fluorometer and the basal fluorescent 
intensities were read before addition of the samples into the wells. The oxygen 
biosensor plate was opened within a laminar flow hood and three 130 l aliquots of 
each cell concentration were placed into selected wells of the biosensor plate. Three 
130 l aliquots of cell-free temperature and oxygen equilibrated culture medium were 
added to further wells of the biosensor plate. The cell-free culture medium control 
represents the fluorescence intensity at ambient oxygen conditions (IA), whilst 0.1 M 
sodium sulphite (Sigma-Aldrich, Poole, UK) samples signify the fluorescence at zero 
oxygen or anoxic concentration (I0). The plate was sealed with a sterile plate sealer 
before it was placed in the fluorometer. The fluorometer was set to read the 
fluorescence intensity of the wells under incubator conditions (370C) with excitation 
wavelength, 485nm and emission wavelength, 590nm. Fluorescence intensity was 
measured over a two hour period with measurements taken every ten minutes. 
 
2.2.10 Calculation of oxygen concentration 
The fluorescence intensity measurements underwent a series of normalisation processes 
to calculate the oxygen concentration at each time point measured. Initially, readings 
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taken for the samples for each time point were normalised against the reading of the 
well from a blank biosensor plate, to reduce the variability between each well.  
 
The oxygen concentration for each time point was calculated using the fluorescence 
intensities of the cell suspension samples (I) and the mean fluorescence intensity of the 
cell-free medium or ambient control samples (IA). The relationship between 
fluorescence intensity and oxygen concentration obeys the Stern-Volmer equation 
described by equation 2.5. The sample readings were normalised by dividing the 
fluorescence intensities over the mean ambient control sample readings (I/IA) to 
calculate the normalised relative fluorescence (NRF). Substitution of the NRF into 
equation 2.5 means that at ambient oxygen conditions (370C/5% CO2), equation 2.5 
becomes  
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The zero oxygen/anoxic condition is given by the fluorescence intensity readings for 
0.1 M sodium sulphite that demonstrate the maximum fluorescence signals, whilst the 
intensities provided by the medium samples provide the fluorescence signals for 
ambient oxygen concentration. The ratio between the fluorescence in zero oxygen, I0 
and at ambient oxygen, IA, is known as the dynamic range. The calculation of the 
dynamic range (DR) enables calculation of the quenching constant (KSV) (equation 
2.7),   
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The expression [O2]A  is the ambient oxygen concentration. Under the conditions used 
in the experiment, the ambient oxygen concentration was calculated as 200 M 
(Heywood et al., 2006). The ratio between the normalised relative fluorescence (NRF) 
and the dynamic range (DR) gives I0 / I. Thus, the Stern-Volmer equation may be 
rearranged to determine the oxygen concentration within each of the wells during the 
experiment at various time points (equation 2.8). 
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Oxygen consumption curves were generated from the data. The MSCs consumption 
rate was measured from the linear region of the curves using a line of best fit after 
converting the oxygen data from micromolar to nanomoles (O2) through multiplying 
medium volume (V) by the measured oxygen concentration [O2] at each time point 
(equation 2.9; Figure 2.3). The gradient of the line was calculated as the cellular 
consumption rate. The per cell consumption rate was calculated through normalisation 
of the consumption rate with the number of cells within the well. 
 
    VOO  22                   (2.9) 
 
 
Figure 2.3. Representative graph of MSC oxygen consumption from a replicate sample. The line of 
best fit is used to calculate MSC oxygen consumption rate, e.g. 16.38 nmoles/hr. 
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2.2.11 Measurement of glucose and lactate in sample medium 
Cells sub-cultured for the oxygen biosensor protocol were also aliquoted into separate 
384-well plates (BD Biosciences, Oxford, UK). The well plate setup replicated the 
procedure outlined in section 2.2.9, minus the fluorophore in each well. The well plates 
were sealed using a sterile plate sealer and then placed in an incubator. A plate was 
removed at 0.5, 1, 2, 4 and 6 hours and the plate was centrifuged at 500g for five 
minutes to pellet the cells. The medium was aspirated from the wells and subsequently 
pipetted into sterile microcentrifuge tubes. The samples were frozen and stored at -200C 
prior to assay for glucose and lactate. Cell-free medium samples used in the experiment 
were also  stored frozen to provide basal glucose and lactate readings. 
 
Glucose assay 
A 100 mM glucose stock solution (Sigma-Aldrich, Poole, UK) was prepared in distilled 
water and filtered for sterility. The stock solution was aliquoted into microcentrifuge 
tubes and frozen until use. Prior to the assay, the glucose stock solution was diluted 
using distilled water to form a 10 mM glucose solution and then further diluted to 
standard concentrations ranging from 0-10 mM. The assay reagent used for this assay 
was the InfinityTM Glucose hexokinase reagent (Thermotrace, Pittsburgh, USA). The 
constituents of the reagent are detailed in Table 2.6. 
 
Table 2.6. Reagent composition of InfinityTM glucose hexokinase assay. 
Reagents Concentration 
Buffer 37.6 mmol/l 
ATP 2.1 mmol/l 
NAD 2.5 mmol/l 
Hexokinase (recombinant yeast) > 1500 U/l 
Glucose-6-phosphate dehydrogenase > 2500 U/l 
pH 7.7 + 0.1 (200C)  
  
The assay uses the substrate specificity of the enzymes, hexokinase and glucose-6-
phosphate dehydrogenase, combined with the quantitative detection of NADH through 
spectrophotometer absorbance at 340nm. The enzymes catalyse the reactions described 
in equations 2.10 and 2.11. Glucose within the samples is converted into glucose-6-
phosphate (G-6-P) by the hexokinase (HK) enzyme through consumption of ATP 
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(equation 2.10). The glucose-6-phosphate is then the substrate for the glucose-6-
phosphate dehydrogenase (G-6-PDH) enzyme and catalyses the oxidation of the 
substrate to 6-phosphogluconate via reduction of NAD+ from the reagent mixture to 
NADH + H+ (equation 2.11). 
 
ADPPGATPeGlu HK  6cos              (2.9) 
 
        HNADHconatephosphogluNADPG PDHG 66 6                  (2.10) 
 
Using a Gilson pipette, 6 l aliquots of the glucose standards (0-10 mM), cell-free 
medium control and medium samples were added to a NuncTM Immunosorp 96-well 
plate. In a chemical fume cupboard, 200 l InfinityTM glucose reagent was added to 
each well. The plate was incubated at 370C for one hour and then placed into a 
spectrophotometer. The absorbance at 340nm was measured and recorded for 3 minutes 
at 370C after a 15 second orbital mixing stage. The concentration of glucose within 
each of the samples was calculated against known glucose concentration standards 
(Figure 2.4). The amount of glucose consumed at each time point was calculated with 
respect to the basal cell-free medium samples. Glucose consumption curves were 
generated from the data and then consumption rates were calculated as described for 
MSC oxygen consumption rate (section 2.2.10 and Figure 2.3). 
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Figure 2.4. Representative standard curve for determination of glucose concentrations in sample 
medium (n = 4; y = 0.0977x + 0.2906; R2 = 0.9978). 
 
Lactate assay 
A 100 mM stock lactate solution (Sigma-Aldrich, Poole, UK) was prepared in distilled 
water and sterile filtered. The stock lactate solution was aliquoted into microcentrifuge 
tubes and frozen prior to use. The assay reagent is composed of the ingredients detailed 
in Table 2.6. The pre-weighed 20 mg -NAD+ phials (Sigma-Aldrich, Poole, UK) were 
allowed to defrost at room temperature before reconstitution. The -NAD+ was 
reconstituted within a chemical fume cupboard with the addition of 8 ml distilled water, 
4 ml glycine buffer (Sigma-Aldrich, Poole, UK), 0.2 ml lactate dehydrogenase 
suspension (Sigma-Aldrich, Poole, UK).  
 
Table 2.7. The constituents for lactate assay reagent. 
Reagents Details Supplier 
-NAD+ 20 mg/phial Sigma-Aldrich, Poole, UK 
Lactate dehydrogenase suspension 1000 U/ml Sigma-Aldrich, Poole, UK 
Lactate stock solution 100 mM Sigma-Aldrich, Poole, UK 
Glycine buffer pH 9.2 (250C) Sigma-Aldrich, Poole, UK 
Distilled water   
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The assay uses the substrate specificity of the enzyme, lactate dehydrogenase (LDH) 
that catalyses the oxidation of the lactate within the sample to pyruvate and the 
additional product, NADH from reduction of NAD+ (equation 2.12). The reaction is 
reversible and is driven from left to right by supply of excess NAD+ in the reaction 
mixture. 
 
         HNADHPyruvateNADLactate LDH                   (2.12) 
 
An aliquot of the stock lactate solution was diluted using distilled water and further 
diluted to form standard concentrations ranging from 0-10 mM. Using a Gilson pipette, 
6 l of lactate standards, cell-free medium control and medium samples were added to 
individual wells of a NuncTM Immunosorp 96-well plate. In a chemical fume cupboard, 
174 l lactate assay reagent was added to each well. The plate was incubated for one 
hour at 370C. The spectrophotometer was set to measure and record the absorbance at 
340nm. The plate was placed into the spectrophotometer and measured for 3 minutes at 
370C after a 15 second orbital mixing stage. The concentration of lactate was calculated 
against known lactate standard concentrations (Figure 2.5). The amount of lactate 
produced at each time point was calculated with respect to the basal cell-free medium 
samples. Lactate production curves were generated from the data and then production 
rates were calculated as described for MSC oxygen consumption rate (section 2.2.10 
and Figure 2.3). 
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Figure 2.5. Representative standard curve for determination of lactate concentrations in sample 
medium (n = 4; y = 0.0708x + 0.3296; R2 = 0.9935). 
 
2.2.12 Statistical analysis 
The per cell oxygen and glucose consumption and lactate production rates were 
compared between cell densities and passage number for each parameter using a 2-
factor ANOVA (= 0.05). If differences were significant (p < 0.05) between samples 
then post-hoc Student t-test with Bonferroni correction was applied. Comparisons were 
made between cell densities and passages. A single-factor ANOVA ( = 0.05) was 
used to compare doubling time between passages and if found to be significant (p < 
0.05), the same post-hoc test was used.   
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2.3 Results 
2.3.1 Cell growth and differentiation of MSCs 
Human MSCs attached to the tissue culture flask within 24 hours of seeding. These 
cells developed a typical spindle-shaped and fibroblastic morphology, as described in 
previous investigations (Pittenger et al., 1999; Colter et al., 2001). The cells were 
cultured until confluence with typical examples of day 1 and sub-confluent MSCs 
described in Figure 2.6. The morphology of the cells did not change markedly between 
passages 2-4.  
 
 
Figure 2.6. Representative photomicrographs of human MSCs (LonzaTM, Wokingham, UK) on (a) 
day 3 and (b) day 7 of culture at passage 4. 
 
An analysis of the cell proliferation for the human MSC sample was assessed through 
passaging of the cells on six separate occasions. Proliferation growth curves, 
represented as cumulative fold increase in cell number against time were generated 
from the raw data with time zero assumed to be passage 2, the point of receipt of the 
cells from the commercial source (Figure 2.7). The cumulative growth curves for a 
batch of cells followed the typical cell growth curve indicated in Figure 2.1.         
(a) (b) 
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Figure 2.7. Cumulative population growth curve with respect to cumulative fold increase in cell 
population for human MSCs cultured between passage 2 to passage 4: MSC replicate 10/10/06 
( ), MSC replicate 31/10/06 ( ), MSC replicate 7/11/06 ( ), MSC replicate 4/1/07 ( ) ,MSC 
replicate 9/1/07 ( ) MSC replicate 1/2/07 ( ). Doubling rates are presented in Table 2.8. 
 
The cell doubling time for the MSCs during culture was calculated between each 
passage on assumption that passage two is the first data point on the growth curve. 
Table 2.8 shows the cell doubling time for the cells cultured between passages 2-4. 
There was found to be no significant difference in cell doubling time between passage 
2 and passage 3 (Student t-test; p > 0.05), however, there was a significant increase in 
doubling time between passages 3 and 4 (Student t-test; p < 0.05).     
 
Table 2.8. Cell doubling times derived from Figure 2.7 (mean + S.D.; n= 6. Bonferroni corrected 
Student t-test, p < 0.05 [*P4 doubling time significant with respect to P2 and P3 doubling time]) for 
MSCs cultured between passage 2-4.   
Passage number Population doubling time (hours) 
P2 59.4 + 8.5 
P3 65.8 + 11.7 
P4 88.8 + 24..8* 
                                                                     Chapter 2: MSC oxygen and glucose utilisation  
 - 84 -  
Human MSCs were assessed for their multipotency through differentiation towards the 
chondrogenic, osteogenic and adipogenic lineages at passage 3 of cell culture. 
Histological analysis was utilised to assess the differentiation of these cells towards 
their respective lineages (Figure 2.8).  Human MSCs were cultured in pellets in the 
presence of chondrogenic medium and cultured for 21 days to assess chondrogenic 
differentiation.  Pellets were stained with toluidine blue staining after 21 days in culture 
for assessment of the presence of GAGs within control and chondrogenic pellets. 
Assessment of the chondrogenic pellet (Figure 2.8b) shows the presence of GAGs due 
to the strong staining across the pellet and compaction of cells within the central region 
of the pellet. Pellets cultured in control chondrogenic medium (Figure 2.8a) showed 
weaker GAG staining compared with chondrogenic cultures, especially towards the 
periphery of the pellet with cells less compacted.  
 
Osteogenic differentiation of human MSCs was assessed by culturing cells in the 
presence of osteogenic medium for 21 days. During the course of culture, cells cultured 
in osteogenic medium developed into multi-layered colonies and individual cells 
developed a rounded polygonal morphology, compared with control cultures which 
maintained their spindle-shaped fibroblastic morphology (Figure 2.8c, d). Histological 
analysis of osteogenic cultures after 21 days showed the presence of calcium deposits 
in osteogenic cultures when stained with alizarin red (Figure 2.8d), whereas control 
cultures contained no calcium deposition (Figure 2.8c). 
 
A similar observation was made for adipogenic differentiation of MSCs (Figure 2.8e, 
f). Cells changed morphology on application of adipogenic induction medium from a 
spindle-shaped fibroblastic morphology to a rounded polygonal morphology with lipid 
droplets visible after 14 days in culture (Figure 2.8e, f). Cells cultured for 21 days in 
adipogenic induction medium exhibited large lipid droplets, which could be visualised 
upon staining with Oil-red-O (Figure 2.8f). No lipid droplet formation was observed for 
cells maintained in adipogenic maintenance medium (Figure 2.8e).           
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Figure 2.8. Representative photomicrographs of MSCs differentiated towards (b) chondrogenic, 
(d) osteogenic and (f) adipogenic lineages after 21 days in culture using histological staining.  The 
control cultures for these samples are represented in a (chondrogenic), c (osteogenic) and e 
(adipogenic). 
200 m 200 m 
(a) (b) 
(c) (d) 
200 m 200 m 
(e) (f) 
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2.3.2 Measurements of oxygen consumption for human MSCs 
At the highest cell densities, the oxygen was consumed during the initial two hour 
period for initial experiments measuring oxygen consumption over a 6 hour period 
(Figure 2.9). The protocol was adjusted to a two hour experimental period and 
measurements were taken every ten minutes (section 2.2.9). The oxygen consumption 
rate was measured at passages 2, 3 and 4 on resuscitation of cells from cryopreservation 
(section 2.2.5). 
 
 
 
Figure 2.9. Representative graph showing the oxygen consumption of human MSCs during six 
hour period of experimentation. Each time point represents mean + S.D. of n = 3:  0.5 x 105 ( ), 1 
x 105 ( ), 1.5 x 105 cells ( ) and 2 x 105 cells ( ).   
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Figure 2.10. Oxygen consumption of MSCs at (a) P2, (b) P3, (c) P4 during culture. Data represent 
the mean + S.D. of n = 9: 0.5 x 105 ( ), 1 x 105 ( ), 1.5 x 105 cells ( ) and 2 x 105 cells ( ). Refer 
to Table 2.9 for consumption rates and statistical analysis. 
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The data shown in Figure 2.10 indicate a relationship between cell density and oxygen 
consumption with greatest oxygen depletion within the wells containing 2 x 105 cells at 
each passage. This relationship was retained in the per cell oxygen consumption rate 
data with the greatest consumption rate at 2 x 105 cells and lowest rate at 0.5 x 105 cells 
(Table 2.9). However, there was no statistically significant difference in the per cell 
oxygen consumption rate between passages 2-4 when comparing data from the same 
cell density (2-factor ANOVA; p > 0.05). Table 2.9 shows the per cell oxygen 
consumption rate without the correction for oxygen ingress into the plate. Table A.1 
(Appendix A.3) shows oxygen consumption data corrected for ingress into the plate 
and shows that similar to Table 2.9, there was no significant difference in per cell 
consumption rate between passages 2-4 for the same cell density. However, there was 
also found to be no significant difference in the per cell consumption rate between cell 
densities at each passage (2-factor ANOVA; p < 0.05). 
 
Table 2.9. Oxygen consumption rate and per cell consumption rate derived from Figure 2.10 for 
human MSCs between P2-P4. Data represent the mean + S.D. of n = 9. Significant differences in 
per cell consumption rates within a passage (p < 0.05) were tested using Bonferroni corrected 
Student t-test (see N.B. for significant data and relative groups).  Corrected data are presented in 
Appendix A.3, Table A.1. 
 Oxygen consumption rate (nmol/hr) Oxygen consumption rate/cell (fmol/hr/cell) 
Cell 
number 
(x105) 
P2 P3 P4 P2 P3 P4 
2 16.2 + 2.9 18.6 + 2.42 17.9 + 1.97 81.03 + 14.36a 92.83 + 12.87a 89.8 + 9.85a 
1.5  6.8 + 1.1 7.63 + 1.3 7.66 + 1.02 45.32 + 7.34 52.56 + 4.8b 51.08 + 6.76b 
1  3.96 + 0.51 4.15 + 0.48 3.98 + 0.66 39.64 + 5.14 41.48 + 4.78 39.77 + 6.58 
0.5  1.84 + 0.34 1.87 + 0.5 1.72 + 0.39 36.76 + 6.74 37.38 + 9.97 34.31+ 7.77 
N.B.:  a – significant with respect to 1.5 x 105 and 1 x 105 and 0.5 x 105 per cell consumption rates 
           b – significant with respect to 2 x 105, 1x 105 and 0.5 x 105 per cell consumption rates 
 
2.3.3 Glucose consumption lactate production of human MSCs 
The glucose consumption and lactate production of human MSCs was measured in the 
medium recovered from cells at 0.5, 1, 2, 4 and 6 hour time points. Glucose was 
consumed continuously during the period of experimentation beyond the two hour 
period for the measurement of oxygen consumption (Figure 2.11). The rate of glucose 
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consumption was calculated by finding the gradient of the line of best fit for curves 
described in Figure 2.11, whilst the per cell consumption rate was calculated through 
normalising the consumption rate to the number of cells within the well. There were no 
statistically significant differences in per cell glucose consumption rate between 
passages 2-4 when comparing data from the same cell density (Table 2.10, 2-factor 
ANOVA; p > 0.05). A comparison between between cell densities within a passage 
shows that there were no significant differences in per cell consumption rates at 
passage 4 (2-factor ANOVA; p < 0.05). At passages 2 and 3, 1 x 105 cells had 
significantly reduced per cell glucose consumption compared with 2 x 105 and 1.5. x 
105 cells at both passages, whilst 0.5 x 105 cells demonstrated significant differences 
compared to other cell numbers at passage 3 (Student t-test; p < 0.05). 
 
Table 2.10. Glucose consumption and per cell consumption rate derived from Figure 2.11 for 
human MSCs between P2-P4. Data represent the mean + S.D. of n = 9. Significant differences in 
per cell consumption rates within a passage (p < 0.05) were tested using Bonferroni corrected 
Student t-test (see N.B. for significant data and relative groups). 
 Glucose consumption rate (nmol/hr) Glucose consumption rate/cell (fmol/hr/cell) 
Cell 
number 
(x 105) 
P2 P3 P4 P2 P3 P4 
2 75.5 + 7.9 67.96 + 6.31 70.92 + 11.43 377.6 + 39.41 339.8 + 31.5 354.6 + 57.5 
1.5 51 + 5.88 51.31 + 5.03 45.12 + 8.93 340 + 39.21 342.1 + 33.5 300.8 + 59.5 
1  27.49 + 4.52 28.67 + 0.97 25.68 + 5.87 274.9 + 45.18a 286.7 + 9.7b 256.8 + 58.7 
0.5  18.79 + 4.47 21.73 + 1.67 16.21 + 9.62 375.8 + 89.41 434.7 + 33.5c 324.2 + 192.4 
N.B.:  a – significant with respect to 2 x 105 and 1.5 x 105 per cell consumption rates 
           b – significant with respect to 2 x 105, 1.5 x 105 and 0.5 x105 per cell consumption rates 
           c – significant with respect to 2 x 105, 1.5 x 105 and 1 x105 per cell consumption rates 
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Figure 2.11. The consumption of glucose by MSCs at (a) P2, (b) P3 and (c) P4 during culture. Data 
represent mean + S.D. of n = 9: 0.5 x 105 ( ), 1 x 105 ( ), 1.5 x 105 cells ( ) and 2 x 105 cells ( ). 
Refer to Table 2.10 for consumption rates and statistical analysis. 
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The measurement of lactate production occurred at the same points. Lactate was 
produced steadily during the period of experimentation (Figure 2.12). The lactate 
production and per cell lactate production rate of human MSCs was calculated in a 
similar manner to that used for glucose and oxygen consumption rates. The general 
trends shown in Table 2.11, indicates that the highest lactate production and per cell 
lactate production rates were obtained for the highest cell number. Analysis of the per 
cell lactate production rate within  a passage, showed that at each passage, 1 x 105 cells, 
had significant differences in production rate compared with higher cell numbers and 
0.5 x 105 cells at passages 2 and 4 (Student t-test; p < 0.05). However, there was no 
statistically significant difference in the per cell lactate production rate for human 
MSCs between passages 2-4 for the same cell density (2-factor ANOVA; p > 0.05).  
 
Table 2.11. Lactate production rate and per cell production rate derived from Figure 2.12 for 
human MSCs between P2-P4. Data represent mean + S.D. of n = 9. Significant differences in per 
cell production rates within a passage (*p < 0.05) were tested using Bonferroni corrected Student t-
test (see N.B. for significant data and relative groups).    
 Lactate production rate (nmol/hr) Lactate production rate/cell (fmol/hr/cell) 
Cell 
number 
(x105) 
P2 P3 P4 P2 P3 P4 
2 200.3 + 34.8 179.5 + 17.7 176.1 + 28.1 1047.8 + 173.9 928.3 + 88.6 904.1 + 140.7 
1.5  121.8 + 12.4 125.9 + 11.9 125.3 + 17.8 812.2 + 82.9 839.6 + 79.3 835.4 + 118.9 
1  60.21 + 10 68.01 + 13.9 63 + 12.6 602.1 + 100.3a 680.1 + 139b 630.3 + 125.5a 
0.5 36.17 + 19 43.73 + 12.5 31.4 + 10.3 723.3 + 380.4 874.7 + 249.3 627.8 + 205.1 
N.B.:  a – significant with respect to 2 x 105, 1.5 x 105 and 0.5 x105 per cell production rates 
           b – significant with respect to 2 x 105 per cell production rates 
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Figure 2.12. The production of lactate by MSCs at (a) P2, (b) P3 and (c) P4 during culture. Data 
represent the mean + S.D. of n = 9: 0.5 x 105 ( ), 1 x 105 ( ), 1.5 x 105 cells ( ) and 2 x 105 cells 
( ). Refer to Table 2.11 for production rates and statistical analysis. 
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An analysis of the ratio between glucose consumption and lactate production showed a 
gradual increase in the ratio which either approached, or was greater than, 1 glucose 
molecule: 2 lactate molecules, the stoichiometric ratio for glycolysis, by later time 
points (Table 2.12). 
 
Table 2.12. Ratio between glucose: lactate at each cell number between passages at time points 
measured (Figures 2.11 and 2.12) for human MSCs. 
 2 x 105 1.5 x 105 1 x 105 0.5 x 105 
Time P2 P3 P4 P2 P3 P4 P2 P3 P4 P2 P3 P4 
0.5 1:0.8 1:1 1:0.6 1:0.5 1:1.2 1:0.6 1:0.1 1:0.9 1:0.2 1:0 1:0.6 1:0.3 
1 1:1.8 1:1.8 1:0.7 1:1.5 1:1.7 1:0.6 1:1.1 1:1.3 1:0.4 1:1.1 1:0.9 1:0.2 
2 1:2 1:2.2 1:1.9 1:1.7 1:1.3 1:1.3 1:1.7 1:1.3 1:1.7 1:2.2 1:1.3 1:0.7 
4 1:2.2 1:2.1 1:2 1:1.8 1:1.5 1:1.3 1:1.6 1:1.8 1:1.4 1:1.7 1:1.4 1:1 
6 1:2.7 1:2.5 1:2.4 1:2.3 1:2.5 1:2.8 1:1.9 1:2.1 1:1.9 1:1.7 1:1.7 1:1.5 
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2.4 Discussion 
The aim of this chapter was to analyse the consumption of oxygen and glucose by 
MSCs, in order to develop an understanding of their metabolism. Previous 
investigations have shown that MSCs are influenced by their cultured oxygen tension 
in terms of their proliferation (Moussavi-Harami et al., 2004; Grayson et al., 2006; 
Ren et al., 2006; d'Ippolito et al., 2006a) and differentiation (Lennon et al., 2001; Fink 
et al., 2004; Wang et al., 2005; Grayson et al., 2006; Ren et al., 2006; d'Ippolito et al., 
2006a). These studies have shown that MSCs have enhanced expansion under hypoxia 
compared with normoxia. The reason for the enhanced expansion has been associated 
with the reduction in premature senescence occurring under hypoxic culture due to 
reduced oxidative damage that may result from oxidative phosphorylation (Moussavi-
Harami et al., 2004). Accordingly, analysis of the glucose and oxygen utilisation of 
MSCs would help to explain the premature senescence of these cells under normoxia. 
 
In conjunction with the study, an assessment of the population growth and 
multipotency of these MSCs was conducted. The cell morphology showed the 
characteristic spindle-shaped or fibroblastic morphology that has been described in 
various investigations (Pittenger et al., 1999; Colter et al., 2001). The morphology 
appeared homogeneous during the period of MSC culture (Figure 2.6). However, 
some cells within the cell population gradually became flattened and had a circular 
morphology that has been previously described for senescent cells (DiGirolamo et al., 
1999; Colter et al., 2000), although markers for cellular senescence such as -
galactosidase were not utilised in the present investigation. However, Table 2.8 shows 
a significant increase in cell doubling time between passages 3 and 4. Previous 
investigations have shown that the population doubling limit for MSCs, or the point at 
which cellular senescence begins, is approximately 11 population doublings 
(Moussavi-Harami et al., 2004). The present investigation has only cultured the cells 
for approximately 7 population doublings from cryopreservation until passage 4, 
which is below the population doubling limit described in earlier studies. However, it 
should be noted that the cells had undergone doublings prior to transfer to the host 
laboratory.  
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The histological assessment of MSC multipotency shows that these cells had the 
ability to differentiate into cells of the chondrogenic, osteogenic and adipogenic 
lineages, as reported in many previous studies (Figure 2.8) (Pittenger et al., 1999). 
The morphology of the MSCs changed upon differentiation towards the osteogenic 
and adipogenic lineages. Initially, the cells had a spindle-shaped fibroblastic 
morphology and then as differentiation towards the osteogenic lineage progresses, 
they changed to a rounded polygonal shape, whilst during adipogenesis, cells 
developed lipid vacuoles upon differentiation (Figure 2.8d, f). Previous studies have 
confirmed the change in morphology upon differentiation of these cells, although 
staining techniques are required to confirm that the cells have differentiated towards 
their specific lineages (Haynesworth et al., 1992b; Jaiswal et al., 1997; Peter et al., 
1998). In terms of adipogenic differentiation, lipid droplets formed within seven days 
of culture. Oil-red-O staining confirmed the presence of lipid droplets within the 
culture, while calcium deposition was noted under osteogenic conditions via alizarin 
red staining.       
 
The results of the investigations show that oxygen was consumed by the cells during a 
two hour period of experimentation with concomitant consumption of glucose (Figure 
2.10 and Figure 2.11). This suggests that the cells may be utilising oxidative 
phosphorylation for ATP generation due to their consumption of oxygen. However, 
oxygen is required for other cellular processes and further investigation is needed to 
determine whether the oxygen consumption is associated with oxidative 
phosphorylation. However, Figure 2.9 shows that MSC oxygen consumption did not 
occur after two hours despite the presence of high oxygen levels within the wells, 
particularly at the lower cell densities. This indicates that the measurement of oxygen 
consumption could have been affected by oxygen leakage into the plate, despite the 
plate being sealed to prevent oxygen replenishment. Thus, in the present investigation, 
oxygen consumption was measured during the linear region of consumption from the 
initial optimisation experiments, which was estimated to be 2 hours. The rates of 
consumption may be an under-estimate of the actual per cell oxygen consumption rate 
dependant upon the diffusional rate of oxygen into the plate with respect to cellular 
oxygen consumption (Table 2.6) (Arain et al., 2005). 
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This was confirmed through analysis of oxygen ingress into cell-free oxygen depleted 
medium as depicted in Appendix A.3; Figure A.10. The curve was used to calculate 
the rate of ingress into the plate and then applied to experimental data to calculate the 
per cell consumption rate. Table A.1 (Appendix A.3) shows that there were no 
significant differences in per cell oxygen consumption rate between cell numbers 
within a passage or between passages at the same cell number. The table indicates that 
the greatest effect on consumption rate was at the lowest cell numbers compared with 
the higher cell numbers, correlating with the previously stated discussion point. The 
fact that there was no significant difference in oxygen consumption between cell 
densities means that any cell density may be used in future studies, despite differences 
in glucose consumption and lactate production for some cell numbers (Table 2.10 and 
Table 2.11). 
 
During the early time points and in the presence of high levels of oxygen within the 
wells, there was significant lactate production by the cells (Figure 2.12). Indeed, 
Figure 2.12, with respect to Figure 2.10, shows that for low cell densities and in the 
presence of high levels of oxygen, lactate is produced. An analysis of the ratio 
between and glucose consumption and lactate production, shows a gradual increase 
leading to an equal or greater than glycolytic ratio of 1 glucose molecule to 2 lactate 
molecules at later time points. Thus, these data suggest that the cells also utilise 
glycolysis for their ATP production and suggest that the cells have a mixed 
metabolism, utilising both oxidative phosphorylation and glycolysis. 
 
The stoichiometric ratio for glycolysis assumes that lactate production was solely 
derived from glucose consumption. However, studies have shown that lactate 
production may also be derived from the consumption of L-glutamine. Ardawi et. al. 
(1983) and Newsholme et. al. (1985) demonstrated that upon consumption of 
glutamine within rat lymphocytes, lactate was produced alongside ammonia 
production. The production of lactate from glutamine was through partial oxidation of 
glutamine and is similar to the glycolysis pathway that is used to produce lactate from 
glucose. It was postulated that glutamine is initially converted into glutamate and via 
the enzyme, aspirate aminotransferase, is converted into 2-oxoglutarate (Newsholme 
et al., 1985). This molecule may then enter the Krebs’ cycle, whereby it goes through 
the cycle and upon formation of oxaloacetate, may be converted into pyruvate, thereby 
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leading to the creation of lactate (Newsholme et al., 1985). This process has been 
demonstrated for various cell types including hepatocytes and macrophages and has 
been described as ‘glutaminolysis’ (Newsholme et al., 1987; Newsholme and 
Newsholme, 1989; Newsholme et al., 2003a; Newsholme et al., 2003b). Previous 
investigations assessing glutamine consumption for MSCs have shown that it is an 
important metabolite, as its absence reduced glucose consumption and lactate 
production that resulted in inhibited cell growth, whilst the production of ammonia 
derived from glutamine has been shown to inhibit MSC proliferation above certain 
concentrations (Follmar et al., 2006; Schop et al., 2008; Mischen et al., 2008; Schop 
et al., 2009). However, in the case of the present investigation, the consumption of 
glutamine was not ascertained and therefore the production of lactate derived from 
this metabolite could not be analysed. Therefore, it should be noted that lactate 
production was not solely derived from glucose and that glutamine consumption may 
have contributed to its production, which means that the glucose to lactate ratio may 
be lower than that described in Table 2.12. Future investigations may assess glutamine 
consumption and its contribution to lactate production using the experimental systems 
used within this chapter, thereby enabling accurate measures for the ratio between 
glucose and lactate or glutamine and lactate. 
 
Previous investigations have analysed the glucose consumption and lactate production 
of MSCs, although culture conditions vary from the current study (Wang et al., 2005; 
Grayson et al., 2006). Grayson et. al. (2006) measured glucose consumption and 
lactate production for human MSCs cultured on polyethylene terephthalate (PET) 
fibrous scaffolds. Analysis of glucose to lactate ratios showed that under normoxia, 
lactate is produced by the cells and approaches a glycolytic ratio, although it did not 
reach a 1:2 ratio during culture (Grayson et al., 2006). Wang et. al. (2005) cultured 
adipose-derived MSCs within alginate beads, although the cells were in suspension 
similar to this study. The study measured lactate production and showed that under 
both normal proliferation and chondrogenic differentiation conditions, lactate was 
being produced by the cells. However, neither study measured the oxygen 
consumption and therefore provided no evidence of ATP production through oxidative 
phosphorylation. Both investigations compared normoxia cultured MSCs with those 
cultured under hypoxia and showed an increase in their lactate production under 
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hypoxia and therefore, a hypothetical increase in the utilisation of glycolysis for ATP 
production. 
 
The sealed culture environment for the experiment resulted in the creation of hypoxic 
and anoxic environments within the wells of the plate through cellular oxygen 
consumption, specifically at higher cell densities. Conversely, at early time points and 
lower cell densities, there was plentiful oxygen within the wells and high levels of 
glycolysis (Table 2.12). The production of lactate in the presence of high levels of 
oxygen has been described as aerobic glycolysis or the Warburg effect (Krebs, 1972).  
 
The rates of glucose and oxygen consumption and lactate production are described in 
Table 2.9 (corrected oxygen consumption data, Appendix A.3; Table A.1) - Table 
2.11. There was found to be no statistically significant difference in the oxygen and 
glucose consumption and lactate production rate between passages at each cell 
density. The importance of this finding is that measurements of these parameters can 
be conducted between passages 2-4 and pooled for MSC replicates, although the per 
cell oxygen consumption rate, as depicted in Table A.1 (Appendix A.3) shows that 
oxygen leakage affected the final per cell consumption rates shown in Table 2.9. The 
384-well plate design provides a non-invasive technique for measurement of cellular 
oxygen consumption compared with methods such as a Clark electrode (von 
Heimburg et al., 2005; Chen et al., 2008). In techniques such as the Clark electrode, 
oxygen is consumed by the electrode and thus measurements can be overestimated 
compared to the actual cellular oxygen consumption. 
 
Table 2.13 shows that human bone marrow-derived MSCs have a similar oxygen 
consumption rate when compared with adipose-derived MSCs, although significantly 
lower compared with adipocytes and porcine-derived hepatocytes (Balis et al., 1999; 
Johnson et al., 2000; von Heimburg et al., 2005). The overall behaviour of MSCs 
cultured under normoxia is similar to cell types that reside in low oxygen conditions in 
vivo such as tumour cells and chondrocytes that have been shown to undergo both the 
Warburg and Crabtree effects (Krebs, 1972; Rajpurohit et al., 1996).  
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Table 2.13. A comparison table describing the oxygen consumption rates of different cell types 
compared with human MSCs from the present study (data shown for human MSCs in the present 
study were taken from Table A.1 in Appendix A.3). 
Cell type Detection method 
Oxygen  consumption 
rate/cell (fmol/hr/cell) 
Author 
Human bone 
marrow MSCs 
384-well oxygen 
biosensor plate (BD 
Biosciences, Oxford 
UK) 
117.7 Present study 
Human 
chondrocytes 
(monolayer) 
Clark electrode (Rank 
Brothers, Cambridge 
UK) 
36 Johnson et al., 2000 
Porcine 
hepatocytes 
Polargraphic oxygen 
electrode 
324 Balis et al., 1999 
Bovine 
chondrocytes 
96-well oxygen 
biosensor plate (BD 
Biosciences, Oxford 
UK) 
0.96 Heywood et al., 2006 
Human adipose 
MSCs  
88.7 
Adipocytes 
Clark electrode 
429.8 
von Heimburg et al., 2005 
 
It should be noted within the present investigation that only one donor was utilised for 
the assessment of oxygen and glucose consumption and lactate production within this 
study. Prior to assessment with this donor, pilot investigations assessing these 
parameters showed similar consumption patterns and no significant difference in 
absolute values between each of these donors (data not shown). The donor used in the 
present investigation was from a young patient. Studies comparing hepatocytes or 
skeletal muscle cells from different age groups showed that oxygen consumption and 
oxidative phosphorylation-derived ATP production were reduced with donor age 
(Boffoli et al., 1994; Harper et al., 1998). In both studies, it was shown that this was 
associated with mitochondrial activity and particularly reduced activity of complex I, 
II and IV of the electron transport chain from cells derived from older patients. These 
findings may be related to ROS production and its associated damage to the 
mitochondria within the cell, which subsequently leads to less efficient ATP 
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generation via oxidative phosphorylation (Valko et al., 2007; Wei et al., 2009). The 
present donor and those used in the pilot studies were derived from a young age group 
and therefore future investigations may require analysis of MSC metabolic parameters 
from a range of age groups and assess whether there are changes with age similar to 
previous investigations for other cell types. 
 
The present investigation minimised the cryopreservation and resuscitation cycles 
during these studies to minimise the damaging effects of the process. Studies 
assessing the effect of cryopreservation on oxygen consumption for hepatocytes have 
demonstrated that oxygen consumption is reduced with serial freeze-defrost cycles, 
due to damage to complex I and ATP synthase (complex V) of the electron transport 
chain resulting from ROS generation within the mitochondria (Sammut et al., 1998). 
However, the effects of cryopreservation on oxygen consumption have been also 
shown to be cell-dependant (Fuller et al., 1989; Bravo et al., 2000). It has been 
described in a study comparing mitochondrial activity of endothelial and smooth 
muscle cells of the aorta, that mitochondria within smooth muscle cells were intact 
upon resuscitation after cryopreservation, whereas endothelial cells were damaged 
from the process (Arnaud, 2000). In order to reduce these effects for the present 
investigation, freeze-defrost cycles were kept to a minimum, although assessment of 
the groups showed no significant difference in oxygen consumption between each set 
of grouped data (data not shown). Future investigations may require assessment of 
these metabolic parameters after serial freeze-defrost cycles to observe whether there 
are changes in the described metabolic parameters. 
 
In conclusion, the data from these studies suggest that human MSCs have a mixed 
metabolism utilising both glycolysis and oxidative phosphorylation for their ATP 
generation. There are no significant differences in terms of per cell oxygen and 
glucose consumption and lactate production between passages 2-4. The production of 
lactate in the presence of high levels of oxygen demonstrates a high level of 
glycolysis, a phenomenon known as the Warburg effect. However, the oxygen 
consumed by the MSCs may not necessarily be utilised for oxidative phosphorylation 
and could be used for either non-mitochondrial (e.g. pentose phosphate pathway) or 
other mitochondrial (e.g. ROS generation) processes. The use of metabolic modulators 
may help to demonstrate the proportions of ATP production generated from glycolysis 
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and oxidative phosphorylation, and observe whether MSCs fully utilise their 
mitochondrial oxidative capacity for the latter process. These studies form the basis of 
chapter 3 of this thesis. 
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3 INHIBITION OF METABOLIC PATHWAYS FOR 
METABOLIC CHARACTERISATION 
3.1 Introduction 
In chapter 2, it was demonstrated that human MSCs produce lactate on consumption 
of glucose, even under normoxic conditions and is in agreement with previous studies 
(Wang et al., 2005; Grayson et al., 2006; Schop et al., 2008). The previous chapter 
also showed that MSCs consume oxygen at rates equivalent to adipose-derived MSCs 
and monolayer passaged chondrocytes, although it was substantially higher than 
freshly isolated bovine chondrocytes, suggesting that the cells have a mixed 
metabolism utilising both oxidative phosphorylation and glycolysis for their ATP 
production. Previous studies did not measure the oxygen consumption of MSCs and 
assumed that MSCs only utilise glycolysis for their ATP production (Wang et al., 
2005). Therefore, the present investigation aims to analyse the utilisation of oxidative 
phosphorylation and glycolysis for human MSC ATP production.  
 
Oxidative phosphorylation produces 30 ATP molecules per glucose compared with 
only 2 ATP molcules per glucose produced via glycolysis. Oxidative phosphorylation 
is therefore, the more efficient pathway for ATP production. However, in vitro studies 
have shown that this metabolic pathway produces ROS, which includes molecules 
such as hydrogen peroxide, superoxide anion and hydroxyl radicals (Newsholme and 
Leech, 1991; Henrotin et al., 2005). These by-products have been implicated in the 
premature senescence of various cells including chondrocytes, ESCs and bone 
marrow-derived MSCs, with several in vitro studies describing enhanced ROS 
production upon culture under normoxia (Zwartouw and Westwood, 1958; Bradley et 
al., 1978; Moussavi-Harami et al., 2004; Martin et al., 2004; Ezashi et al., 2005; 
Henrotin et al., 2005; Grayson et al., 2006; Fehrer et al., 2007). In some of the studies, 
culture of cells under hypoxic culture conditions reduces premature senescence due to 
a reduction in the production of ROS (Moussavi-Harami et al., 2004; Heywood and 
Lee, 2008). This, in turn, may be attributed to the reduction in the use of oxidative 
phosphorylation under hypoxic conditions. In order to critically investigate the 
utilisation of glycolysis and oxidative phosphorylation for MSCs cultured under 
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different oxygen tensions, an understanding of their basal mechanisms of utilisation 
needs to be analysed.   
 
In order, to assess the contribution of glycolysis and oxidative phosphorylation 
towards ATP production, metabolic modulators may be used. Metabolic modulators 
are chemicals that can either inhibit or enhance consumption of specific metabolites 
such as glucose or oxygen via action at specific points in the metabolic pathway. The 
metabolic modulators used in the present studies are (1) 2-Deoxy-D-glucose, (2) 
sodium azide and (3) carbonyl cyanide-m-chlorophenylhydrazone (CCCP). The 
modulators act either on enzymes or electron carriers along the glucose-oxygen 
metabolic pathway (Newsholme and Leech, 1991). 
 
 
Figure 3.1. The mode of action for 2-Deoxy-D-glucose. Normally, (a) glucose-6-phosphate is 
catalysed by phosphoglucose isomerase to fructose-6-phosphate, although entry of  (b) 2-Deoxy-
D-glucose into the glycolysis pathway blocks this conversion and prevents cellular glucose 
consumption (adapted from Newsholme and Leech, 1991). 
 
The metabolic modulator, 2-Deoxy-D-glucose, is a substrate that acts upon the 
glycolysis pathway of the glucose-oxygen metabolic pathway. The substrate 
specifically inhibits the consumption of glucose, as it mimics the substrate specific 
affinity of glucose to the enzyme, phosphoglucose or glucose-6-phosphate isomerase 
(Newsholme and Leech, 1991; Alberts et al., 2002; Malda, 2003). 2-Deoxy-D-glucose 
works as a competitive inhibitor, thereby competing for the enzyme active site with 
glucose and inhibiting its breakdown upon attachment to the active site. As a result of 
this property, the inhibition of glucose consumption through 2-Deoxy-D-glucose is 
concentration-dependent (Figure 3.1). Previous investigations using 2-Deoxy-D-
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glucose for cells residing under hypoxic conditions in vivo, show that glucose is the 
limiting factor for their survival and that glycolysis is their primary source for ATP 
production (Nirenberg and Hogg, 1958; Barban and Schulze, 1961; Lee and Urban, 
1997; Ishihara and Urban, 1999). However, inhibition of glucose resulted in increased 
utilisation of oxidative phosphorylation to compensate for the inhibited glycolysis 
pathway. The use of this modulator may show whether MSCs have the ability to 
utilise oxidative phosphorylation upon inhibition of glycolysis. 
 
 
Figure 3.2.  The mode of action of sodium azide that prevents cellular oxygen consumption at 
complex IV within the electron transport chain (adapted from Newsholme and Leech, 1991 and 
Voet, 2004). 
 
Sodium azide is a chemical that acts upon complex IV of the electron transport chain 
prior to the process of oxidative phosphorylation. Complex IV or cytochrome oxidase 
is the point at which electrons from cytochrome c are catalysed to reduce oxygen and 
form water (Figure 3.2). The water is released into the cell and enables the production 
of more ATP molecules. However, sodium azide prevents oxygen consumption at 
complex IV through its presence at this point of the electron transport chain. 
Investigations have shown that sodium azide prevents oxygen consumption and 
therefore ATP production through oxidative phosphorylation (Barban and Schulze, 
1961; Lee and Urban, 1997; Ishihara and Urban, 1999). However, there is typically an 
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increase in the rate of glycolysis due to inhibited oxygen consumption. As such, 
glycolysis may be used as a survival mechanism to compensate for reduced ATP 
production via oxidative phosphorylation. Oxygen can also be consumed by the cells 
for non-mitochondrial pathways such as the pentose-phosphate pathway or in the case 
of chondrocytes, the production of chondroitin sulphate. These processes would not be 
inhibited by sodium azide. 
 
 
Figure 3.3. The mode of action for CCCP, that enables separation of the processes of oxidative 
phosphorylation and ATP synthesis through opening of the mitochondrial memebrane channels 
and creating a temporary proton pump (adapted from Newsholme and Leech, 1991 and Voet, 
2004). 
 
The final modulator to be used in the investigation was CCCP. It has been described 
as a mitochondrial uncoupler, whereby the substance enables the separation of the 
processes of oxidative phosphorylation and electron transport chain, without an effect 
on subsequent ATP synthesis (Figure 3.3). Normally, the processes of oxidative 
phosphorylation and electron transport chain are tightly coupled through an 
electrochemical gradient that drives ATP synthesis. However, if the electrochemical 
gradient at rest reaches a level across the inner mitochondrial membrane that does not 
permit further proton pumping, then ATP synthesis via oxidative phosphorylation is 
inhibited. The presence of a mitochondrial uncoupler enables the inner mitochondrial 
membrane to open its channels and allow protons emanating from the electron 
transport chain to pass across the membrane for oxidative phosphorylation and 
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therefore ATP synthesis to proceed. Thus, the uncoupler enables ATP synthesis 
without the requirement of an electrochemical proton gradient to drive the process. 
The free energy from the proton gradient, not utilised for ATP synthesis, is released 
into surroundings in the form of heat (Newsholme and Leech, 1991). 
  
Examples of mitochondrial uncouplers are 2,4-dinitrophenol, carbonyl-cyanide-p-
trifluoromethoxyphenylhydrazone (FCCP) and CCCP (Terada, 1990; Lee and Urban, 
1997). These uncouplers help to disperse the protons across the mitochondrial 
membrane, through binding to the protons on the low or acidic side of the membrane 
and transferring the gradient or protons across the membrane through diffusion, then 
releasing the protons on the high pH or alkali side of the membrane. The process 
mimics the electrochemical gradient that enables ATP synthesis to occur. CCCP was 
chosen as the modulator within this investigation due to its sensitivity and site 
specificity within the mitochondria (Heytler and Prichard, 1962; Heytler, 1980; 
Terada, 1981). 
 
Mitochondrial uncouplers are utilised to assess the oxidative capacity and integrity of 
the mitochondria. Culturing of certain cell types in vitro has been shown to cause 
damage to the cell mitochondria, resulting in reduced oxygen consumption and an 
inability to fully utilise their oxidative capacity (Mignotte et al., 1991). The use of the 
mitochondrial uncoupler would help demonstrate whether the mitochondria within the 
cells are undamaged and if so, the total oxidative capacity of the cells through 
measurement of cellular oxygen consumption. The presence of the uncoupler should 
increase oxygen consumption of the cells to its maximum rate and provide an 
indication of the proportion of oxygen utilised for oxidative phosphorylation and other 
mitochondrial processes. 
 
The present investigation assesses the glucose and oxygen consumption and lactate 
production rates of MSCs in the presence of these metabolic modulators. As detailed, 
each modulator will inhibit or enhance specific metabolites along the glucose-oxygen 
metabolic pathway. It may be hypothesized for the study that upon glucose inhibition 
through 2-Deoxy-D-glucose, the cells increase oxygen consumption and therefore 
increase their utilisation of oxidative phosphorylation. Sodium azide via inhibition of 
oxygen consumption should increase MSC glycolysis utilisation, whilst CCCP would 
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provide an indication of the total oxidative capacity for the cell and the integrity of the 
mitochondria. Using the oxygen consumption and lactate production data for the 
control MSC samples and the oxygen consumption data for the sodium azide treated 
MSC samples, the proportion of glycolysis and oxidative phosphorylation for ATP 
generation may be estimated. The oxygen consumption data obtained for the control, 
sodium azide and CCCP-treated MSC samples may be used to estimate the 
proportions of the total mitochondrial capacity used for the various mitochondrial-
dependent processes, e.g. oxidative phosphorylation. 
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3.2 Methodology 
3.2.1 Optimisation of modulator concentration 
The modulator concentrations used in this investigation were optimised according to 
the cellular oxygen consumption rate and cross-referencing previous studies. In terms 
of 2-Deoxy-D-glucose and CCCP, the concentration at which the greatest cellular 
oxygen consumption rate occurs was chosen, whilst the sodium azide concentration 
that attained the lowest cellular oxygen consumption rate was used in the final study.  
 
Sodium azide (BDH, Poole, UK) and 2-Deoxy-D-glucose (Sigma-Aldrich, Poole, UK) 
were dissolved in distilled water to create 1 M stock solutions. CCCP (Sigma-Aldrich, 
Poole, UK) was dissolved in DMSO (Sigma-Aldrich, Poole, UK) to create a 100 mM 
stock solution. The solutions were aliquoted into 1.5 ml microcentrifuge tubes and 
stored at -200C until use. 
 
The modulators were added to temperature and oxygen equilibrated medium at 
various concentrations before the medium was used to resuspend cells after 
trypsinisation (section 2.2.3). Aliquots containing human MSCs were added to wells 
of the 384-well oxygen biosensor plate (BD Biosciences, Oxford, UK) and the oxygen 
consumption was measured over a two hour period in a sealed plate using the 
protocols described in section 3.2.3. The concentrations examined for 2-Deoxy-D-
glucose were 25 mM, 50 mM and 100 mM, whilst medium concentrations assessed 
for sodium azide were 5 mM, 10 mM and 50 mM. The control for the experiments 
was cells in temperature and oxygen-equilibrated medium without the presence of the 
modulator. CCCP was diluted to medium concentrations, 0.01 M, 0.1 M and 1 M 
for examination of MSC oxygen consumption. In the case of the latter modulator, 
control samples were resuspended in medium containing 0.01% DMSO due to the 
presence of the solvent in the modulator sample. 
 
3.2.2 MSC viability in the presence of modulator – Calcein AM assay 
MSC viability in the presence of each metabolic modulator was assessed through the 
use of Calcein AM (Molecular Probes, Invitrogen, Paisley, UK). The probe is a non-
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fluorescent molecule that is hydrolysed upon entry into the cell. The fluorescent 
component, calcein, remains within the cell cytoplasm and emits green fluorescence 
upon excitation. The assay is based upon the integrity of the cell membrane; an intact 
cell membrane is associated with a viable cell.  
 
Human MSCs were trypsinised (section 2.2.3) and resuspended in medium in the 
presence or absence of the modulators at the optimised concentration and 130 l 
aliquots each containing 1.5 x 105 cells were added to individual wells of a 384-well 
plate (BD Bioscience, Oxford, UK). Plates were sealed and placed in a 370C/5% CO2 
incubator for culture. The assay commences when the plate was removed and 
centrifugated at 500 x g. Medium was aspirated from each well, leaving the cells 
within the well and then replaced with 100 l Calcein AM (2 M) in PBS. The plate 
was sealed and placed in an incubator for 30 minutes, away from light sources. The 
plate was then placed in a fluorometer with the excitation wavelength set at 485nm 
and emission wavelength at 530nm. The fluorescence measurements were recorded 
and their fluorescence analysed with respect to control samples to calculate relative 
fluorescence. Plates were measured at 0, 2 and 6 hour time points.  
 
3.2.3 Oxygen consumption of human MSCs in the presence of metabolic 
modulators 
Human MSCs (Lonza, Wokingham, UK) were cultured to passages 3 or 4, trypsinised 
and counted using protocols outlined in section 2.2.3 and 2.2.4. The cells were 
resuspended in medium in the presence or absence of the selected modulators and 130 
l aliquots were added to individual wells of a 384-well oxygen biosensor plate, 
corresponding to 1.5 x 105 cells/well.  
 
Prior to measurement of the oxygen consumption rate, a blank reading was taken at an 
excitation wavelength, 485nm, and emission wavelength, 590nm. In addition to the 
cell suspension samples, a zero oxygen or anoxic control (0.1 M sodium sulphite) and 
cell-free medium controls were added to the plate. The plate was sealed using a sterile 
plate sealer and placed in a fluorometer set to read the fluorescence under incubator 
(370C) conditions using the protocols described in sections 2.2.9 and 2.2.10. 
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3.2.4 Measurement of glucose and lactate in sample medium 
Cell suspensions with or without the metabolic modulators were placed into separate 
384-well plates (BD Biosciences, Oxford, UK) without the fluorophore that 
represented time points from which medim was aspirated from the wells. Medium was 
aspirated at 0.5, 1, 2, 4 and 6 hour time points. The time point for 2 hours was medium 
removed from the 384-well oxygen biosensor plate. A plate was removed at each of 
the time intervals described and centrifuged at 500 x g for five minutes. The medium 
was aspirated from the wells and placed into sterile microcentrifuge tubes. Cell-free 
medium control and medium samples were stored at -200C prior to assay. The glucose 
and lactate assay procedures, outlined in section 2.2.11, were used to measure the 
concentration of glucose and lactate in the medium. Furthermore, the rates of glucose 
consumption and lactate production were calculated using the procedures outlined in 
the stated section. 
 
3.2.5 Statistical analysis 
Initial comparisons for optimisation of modulator concentration used a single-factor 
ANOVA (= 0.05) and if found significant (p < 0.05), a Student t-test with 
Bonferroni correction was applied. Assessments of the modulator data were compared 
with their respective control sample.  Data was presented in two parts as control 
sample for CCCP contained DMSO and therefore required separate analysis, whilst 
parameters for 2-Deoxy-D-glucose and sodium azide were compared with standard 
control.  Comparison with 2-Deoxy-D-glucose and sodium azide for per cell oxygen 
and glucose consumption and lactate production rates were compared using a single-
factor ANOVA (= 0.05). If differences were significant (p < 0.05) between samples 
then post-hoc Student t-test with Bonferroni correction was applied. Statistical 
comparisons for CCCP and its respective control used a Student t-test; p < 0.05 was 
considered significant. The viability of MSCs in the presence of their modulator were 
tested using a 2-factor ANOVA (= 0.05) between time points and modulator 
conditions. A post-hoc Student t-test with Bonferroni correction was applied, if groups 
were significant (p < 0.05). 
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3.3 Results 
3.3.1 Optimisation of modulator concentration 
The oxygen consumption was the parameter used to analyse the effect of modulator 
concentration on MSCs. The optimised concentration for 2-Deoxy-D-glucose was 
shown to be 50 mM, as this concentration induced the greatest oxygen consumption 
rate compared with 100 mM and 25 mM 2-Deoxy-D-glucose (Figure 3.4). There was 
no significant increase in oxygen consumption between control and MSCs treated 
with 100 mM 2-Deoxy-D-glucose (Student t-test; p > 0.05), whereas there was a 
significant increase in oxygen consumption for MSCs treated with 50 mM and 25 mM 
2-Deoxy-D-glucose samples (Student t-test; p < 0.05). Analysis of the glucose 
consumption showed that it was inhibited at each concentration (data not shown).  
 
 
Figure 3.4. The effect of varying 2-Deoxy-D-glucose (2-D-G) concentration on oxygen 
consumption of human MSCs. Data represent the mean + S.D. of n = 3: Control ( ), 25 mM 2-D-
G ( ), 50 mM 2-D-G ( ) and 100 mM 2-D-G ( ).  
 
The application of sodium azide to the cells resulted in inhibited oxygen consumption 
at each concentration (Figure 3.5). The sodium azide concentrations with the greatest 
inhibition of oxygen consumption were cells treated with 50 mM and 10 mM sodium 
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azide (Student t-test; p < 0.05).  The inhibitory effects induced at 10 mM and 50 mM 
sodium azide were virtually identical and indistinguishable using statistical analysis 
techniques. The chosen sodium azide concentration for the final study was 10 mM, as 
previous investigations used this specific concentration (Ohshima and Urban, 1992; 
Lee and Urban, 1997). Analysis of glucose consumption and lactate production at 2 
hours only showed that cells increased their rate of glycolysis to compensate for 
inhibited oxidative phosphorylation (data not shown). 
. 
 
Figure 3.5. The effect of varying sodium azide (SA) concentration on oxygen consumption of 
human MSCs. Data represent mean + S.D.  of n = 3:  Control ( ), 5 mM SA ( ), 10 mM SA ( ) 
and 50  mM SA ( ). 
 
The mitochondrial uncoupler, CCCP, resulted in a significant increase in cellular 
oxygen consumption (Figure 3.6). The increase in cellular oxygen consumption was 
dose dependent, with the greatest increase in oxygen consumption recorded for 1 M 
CCCP. There were subsequent increases in glucose consumption and lactate 
production comparative to the control at the 2 hour time point (data not shown).  
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Figure 3.6.  The effect of varying CCCP concentration on oxygen consumption of human MSCs. 
Data represent mean + S.D. of n = 3: Control ( ), 1 M CCCP ( ), 0.1 M CCCP ( ) and 0.01 
M CCCP ( ). 
 
At each optimised modulator concentration, MSC viability was assessed and based 
upon the relative fluorescence that was calculated using the modulator fluorescence 
readings relative to control sample fluorescence (Table 3.1). There was found to be no 
significant difference in relative fluorescence for modulators between the 0 hour and 2 
hour time points (2-factor ANOVA; p > 0.05). However, at 6 hours there was a 
significant reduction in relative fluorescence for MSCs cultured in the presence of 
CCCP compared with other modulators at this time point (Student t-test; p < 0.05).  
 
Table 3.1.  Relative fluorescence (%) of MSCs in the presence of modulators compared with 
control sample.  Data represent mean + S.D. of n = 6. Significant differences in viability at a time 
point between treatments (*p < 0.05) were tested using Bonferroni corrected Student t-test.   
% relative fluorescence 
Inhibitor 
0 hours 2 hours  6 hours 
0.01% DMSO 90.9 + 10 84.5 + 9 89.4 + 8 
50 mM 2-Deoxy-D-glucose 97.4 + 9.8 95.8 + 4 89.2 + 7 
10 mM sodium azide 94.7 + 11 89.7 + 6 83.8 + 8 
1 M CCCP 94.2 + 14 106.5 + 10 71.7 + 5* 
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3.3.2 Oxygen and glucose consumption and lactate production in the 
presence of 2-Deoxy-D-glucose and sodium azide 
 
 
Figure 3.7.  Oxygen consumption of human MSCs in the presence of inhibitors of glycolysis (2-
Deoxy-D-glucose) and oxidative phosphorylation (sodium azide). Data represent mean + S.D. of n 
= 9: Control ( ), 50 mM 2-Deoxy-D-glucose ( ), 10 mM sodium azide ( ). Refer to Table 3.2 
for consumption rates and statistical analysis. 
 
Oxygen consumption by MSCs was significantly inhibited in the presence of sodium 
azide (Student t-test; p < 0.05) compared with control sample (Figure 3.7 and Table 
3.2). However, there was a significant increase in oxygen consumption when cells 
were incubated in the presence of 2-Deoxy-D-glucose (Student t-test; p < 0.05). 
Corrected data for oxygen ingress demonstrated significant increases in oxygen 
consumption, although there were no changes in terms of the statistical analysis of the 
data presented (Appendix A.3; Table A.2). Analysis of glucose concentration suggests 
a complete inhibition of glucose consumption in the presence of 2-Deoxy-D-glucose, 
confirming its effect as an inhibitor of glucose consumption (Figure 3.8 and Table 
3.3). There was no significant difference in the glucose consumption rate between the 
sodium azide-treated and control MSC samples (Student t-test; p > 0.05).  
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Table 3.2.  Oxygen consumption and per cell consumption rate derived from Figure 3.7 for 
human MSCs in the presence of metabolic modulators: 2-Deoxy-D-glucose and sodium azide. 
Data represent the mean + S.D. of n = 9.  Significant differences in consumption rates upon 
modulator treament (*p < 0.05) relative to control were tested using Bonferroni corrected 
Student t-test.  Corrected data presented in Appendix A.3, Table A.2. 
Inhibitor 
Oxygen consumption rate 
(nmol/hr) 
Oxygen consumption rate/cell 
(fmol/hr/cell) 
Control 6.95 + 1.09 46.4 + 7.2 
50 mM 2-Deoxy-D-glucose 15.44 +  4.16* 103 + 27.8* 
10 mM sodium azide 2.49 + 0.92* 16.6 + 6.2* 
 
 
Figure 3.8. Glucose consumption of human MSCs in the presence of inhibitors of glycolysis (2-
Deoxy-D-glucose) and oxidative phosphorylation (sodium azide). Data represent mean + S.D. of n 
= 9: Control ( ), 50 mM 2-Deoxy-D-glucose ( ), 10 mM sodium azide ( ). Refer to Table 3.3 
for consumption rates and statistical analysis. 
 
MSCs produced lactate in the presence of both modulators and the control sample 
(Figure 3.9 and Table 3.3). Cellular lactate production in the presence of sodium azide 
was significantly increased compared with control (Student t-test; p < 0.05). MSCs 
incubated in the presence of the inhibitor, 2-Deoxy-D-glucose, had a significantly 
reduced rate of production compared with control values (Student t-test; p < 0.05). 
Lactate production was inhibited almost completely in the presence of 2-Deoxy-D-
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glucose after the 1 hour time point, in contrast to control and sodium azide samples 
where significant lactate production was maintained throughout the 6-hour culture 
period.  
 
 
Figure 3.9. Lactate production of human MSCs in the presence of inhibitors of glycolysis (2-
Deoxy-D-glucose) and oxidative phosphorylation (sodium azide). Data represent the mean + S.D. 
of n = 9: Control ( ), 50 mM 2-Deoxy-D-glucose ( ), 10 mM sodium azide ( ). Refer to Table 
3.3 for production rates and statistical analysis. 
 
Table 3.3. Glucose consumption and lactate production rate and per cell rates derived from 
Figure 3.8 and Figure 3.9 for human MSCs in the presence of metabolic modulators: 2-Deoxy-D-
glucose and sodium azide. Data represent the mean + S.D. of n = 9. Significant differences in 
consumption/production rates upon modulator treament (*p < 0.05) relative to control were 
tested using Bonferroni corrected Student t-test.   
Inhibitor 
Glucose 
consumption 
rate (nmol/hr) 
Glucose 
consumption 
rate/cell 
(fmol/hr/cell) 
Lactate 
production rate 
(nmol/hr) 
Lactate 
production 
rate/cell 
(fmol/hr/cell) 
Control 51.31 + 5.03 342.1 + 33.5 125.9 + 11.9 839.6 + 79.3 
50 mM 2-Deoxy-D-
glucose 
0 0* 36.88 + 2.49* 245.1 + 16.6* 
10 mM sodium azide 49.89 + 9.24 332.6 + 61.6 165 + 23.5* 1100 + 157* 
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Analysis of the glucose to lactate ratio (Table 3.4) indicates that with time in culture 
for control and sodium azide samples, the ratio approached or was greater than the 
stoichiometric glycolytic ratio (1 glucose: 2 lactate). These observations correlate with 
the results from chapter 2. A ratio could not be calculated for the 2-Deoxy-D-glucose 
samples due to the complete inhibition of glucose consumption.  
 
Table 3.4. Ratio between glucose:lactate in the presence of metabolic modulators: 2-Deoxy-D-
glucose and sodium azide. Data derived from Figures 3.8 and 3.9. 
Inhibitor 0.5 1 2 4 6 
Control 1:1.2 1:1.7 1:1.3 1:1.5 1:2.5 
50 mM 2-Deoxy-D-glucose N.D. N.D. N.D. N.D. N.D. 
10 mM sodium azide 1:0.6 1:1.4 1:1.9 1:2.4 1:2.7 
 N.D.: Not Determined, due to complete inhibition of glucosen consumption. 
3.3.3 Oxygen and glucose consumption and lactate production in the 
presence of the mitochondrial uncoupler, CCCP 
 
Figure 3.10. Oxygen consumption of human MSCs in the presence of the mitochondrial 
uncoupler, CCCP. Data represents mean + S.D. of n = 9: Control ( ), 1 M CCCP ( ). Refer 
to Table 3.5 for consumption rates and statistical analysis. 
 
                                                                           Chapter 3: MSC metabolic characterisation  
 - 118 -  
The mitochondrial uncoupler, CCCP, induced a significant increase in MSC oxygen 
consumption compared with control samples (Student t-test; p < 0.05, Table 3.5; 
corrected data, Appendix A.3; Table A.3). Figure 3.10 shows that oxygen within the 
wells was completely consumed after one hour. Analysis of the glucose consumption 
and lactate production for CCCP-treated MSCs showed that there was a two-phase 
profile: an initial phase representing the first hour in culture when oxygen 
consumption occurred (0-1 hour) and a second phase when no oxygen was present 
within the wells (1-6 hours).  
 
Table 3.5. Oxygen consumption and per cell consumption rate derived from Figure 3.10 for 
human MSCs in the presence of the mitochondrial uncoupler, CCCP. Data represent the mean + 
S.D. of n = 9. Significant differences in consumption rates upon modulator treament (*p < 0.05) 
relative to control were tested using Bonferroni corrected Student t-test. Corrected data 
presented in Appendix A.3, Table A.3. 
Inhibitor 
Oxygen consumption rate 
(nmol/hr) 
Oxygen consumption rate/cell 
(fmol/hr/cell) 
Control 9.67 + 0.58 64.47 + 3.85 
1 M CCCP 25.06 + 1.91* 167 + 12.7* 
 
 
Figure 3.11. Glucose consumption of human MSCs in the presence of the mitochondrial 
uncoupler, CCCP. Data represent mean + S.D. of n = 9: Control ( ), 1 M CCCP ( ). Refer to 
Table 3.6 for consumption rates and statistical analysis. 
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Glucose consumption and lactate production occurred throughout the period of 
experimentation (Figure 3.11 and Figure 3.12). During the period of oxygen 
consumption (0-1 hour), there was a significant increase in the glucose consumption 
rate for MSCs in the presence of the uncoupler compared with the control (Student t-
test; p < 0.05). However, during the period of zero oxygen consumption or anoxic 
conditions (1-6 hours) within the well, there was a significant decrease in glucose 
consumption rate for CCCP treated MSCs (Student t-test; p < 0.05). During this 
period, the glucose consumption was not significantly different from the control 
samples (Student t-test; p > 0.05).  
 
Table 3.6. Glucose consumption and per cell glucose consumption rate derived from Figure 3.11 
for human MSCs in the presence of the mitochondrial uncoupler, CCCP. Data represent mean + 
S.D. of n = 9. Significant differences in consumption rates upon modulator treament (*p < 0.05) 
relative to control at their respective time point were tested using Bonferroni corrected Student t-
test.   
Inhibitor 
Glucose 
consumption 
rate [0-1 hour] 
(nmol/hr) 
Glucose 
consumption 
rate/cell [0-1 hour] 
(fmol/hr/cell) 
Glucose 
consumption 
rate [1-6 hour]  
(nmol/hr) 
Glucose 
consumption 
rate/cell  
[1-6 hour] 
(fmol/hr/cell) 
Control 54.9 + 38.1 366.3 + 254.3 34.2 + 5.9 228.2 + 39.6 
1 M CCCP 181.2 + 26.32* 1212 + 175.4* 26.6 + 2.49 177.1 + 15.3 
 
Lactate production for MSCs treated in the presence of CCCP (Table 3.7), showed a 
significant increase in production rate compared with control during the period of 
oxygen consumption (0-1 hour, Student t-test; p < 0.05). Thereafter, the lactate 
production rate followed the pattern described for glucose consumption, with no 
significant difference between CCCP-treated and control MSC samples (Student t-
test; p > 0.05).  
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Figure 3.12. Lactate production of human MSCs in the presence of the mitochondrial uncoupler, 
CCCP. Data represent the mean + S.D. of n = 9: Control ( ), 1 M CCCP ( ). Refer to Table 
3.7 for production rates and statistical analysis. 
 
 
Table 3.7. Lactate production and per cell lactate production rate were derived from Figure 3.12 
for human MSCs in the presence of the mitochondrial uncoupler, CCCP. Data represents mean + 
S.D. of n = 9. Significant differences in production rates upon modulator treament (*p < 0.05) 
relative to control at their respective time point were tested using Bonferroni corrected Student t-
test.   
Inhibitor 
Lactate 
production rate 
[0-1 hour] 
(nmol/hr) 
Lactate production 
rate/cell [0-1 hour] 
(fmol/hr/cell) 
Lactate 
production rate 
[1-6 hour]  
(nmol/hr) 
Lactate 
production 
rate/cell  
[1-6 hour] 
(fmol/hr/cell) 
Control 59.2 + 39.7 394.5 + 264.4 122.5 + 27.4 816.6 + 182.5 
1 M CCCP 314.9 + 90.6* 2099 + 603.8* 95.4 + 4.8 636.3 + 32 
 
Analysis of the glucose to lactate ratio for MSCs in both control and CCCP-treated 
samples suggest that the cells are highly glycolytic, as the hypothesized ratio (1 
glucose: 2 lactate) is achieved at virtually all time points (Table 3.8). The values at the 
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early time points for both samples indicate that the cells produce lactate and achieve 
glycolytic ratios, despite the presence of high levels of oxygen within the well.  
 
Table 3.8. Ratio between glucose:lactate in the presence of metabolic modulator, CCCP. Data 
derived from Figures 3.11 and 3.12. 
 0.5 1 2 4 6 
Control 1:2.1 1:1.3 1:3.1 1:3.1 1:3.1 
1 M CCCP 1:2.4 1:1.7 1:2 1:2.4 1:2.5 
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3.4 Discussion 
The data presented in the previous chapter suggested that MSCs have a mixed 
metabolism utilising both glycolysis and oxidative phosphorylation for their ATP 
production. Previous studies have shown that MSCs utilising oxidative 
phosphorylation under normoxic conditions results in the formation of ROS and 
causes premature senescence (Moussavi-Harami et al., 2004; Martin et al., 2004; 
Heywood and Lee, 2008). However, studies have assumed that the majority of ATP 
production by MSCs upon culture in vitro is associated with oxidative 
phosphorylation (Wang et al., 2005). The present study has used metabolic 
modulators to provide a detailed assessment of the utilisation of various metabolic 
pathways within the cell. 
 
The metabolic modulator, 2-Deoxy-D-glucose, prevented the consumption of glucose 
within the glycolysis pathway (Figure 3.8). However, prior to assessment, an 
optimisation of the concentration to be used was undertaken. Figure 3.1 shows that 
there was no significant increase in oxygen consumption for MSCs treated with 100 
mM 2-Deoxy-D-glucose, whereas the consumption was enhanced at lower 
concentrations. The reasons for the difference in oxygen consumption are associated 
with the mode of action for the modulator. 2-Deoxy-D-glucose acts as a competitive 
inhibitor, whereby it competes with glucose for the enzyme active site and when 
present, prevents glucose consumption. At 100 mM 2-Deoxy-D-glucose, there was no 
effect on oxygen consumption, as glucose was able to enter the enzyme, glucose-6-
phosphate, and initiate metabolism of the substrate. However, low 2-Deoxy-D-glucose 
concentrations (50 mM and 25 mM) caused the modulator to enter and due to greater 
affinity towards the enzyme active site, inhibited glucose consumption, whilst 
significantly increasing oxygen consumption to compensate for inhibited glucose 
consumption. The cells treated with 50 mM 2-Deoxy-D-glucose had significantly 
increased oxygen consumption compared with 25 mM 2-Deoxy-D-glucose, as the 
glucose concentration was greater than the inhibitor concentration at the latter 
concentration and therefore its inhibition was reduced. The balance between substrate, 
enzyme and inhibitor concentration are controlled by Michaelis-Menten kinetics. 
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Michaelis-Menten kinetics describes the enzymatic rate of reaction with respect to 
substrate concentration (Figure 3.13). Initially, the rate of reaction (V) increases with 
increased substrate concentration ([S]) but then begins to remain constant, as substrate 
saturates the enzyme and results in no further increase in reaction rate. The maximal 
rate of reaction for an enzyme is described as Vmax, whilst a measure of the substrate 
concentration that does not influence the rate of reaction is defined as KM or 
Michealis-Menten constant. The constant, KM, is related to the dissociation constant or 
substrate affinity (Kd) for enzyme-substrate complex (Newsholme and Leech, 1991; 
Voet, 2004). In a reaction involving an inhibitor, the maximum rate of reaction 
remains unchanged. However, the affinity of the substrate towards the enzyme active 
site decreases, enabling inhibition of subsequent enzymatic processes. This may be 
overcome through increasing the substrate concentration or in the present study, 
reducing the inhibitor concentration, as shown by the differences in oxygen 
consumption rate between 50 mM and 25 mM 2-Deoxy-D-glucose.    
 
 
Figure 3.13.  A model describing Michaelis-Menten kinetics for enzyme reaction rate (v) with 
respect to substrate concentration ([S]) (adapted from Newsholme and Leech, 1991 and Voet, 
2004). 
 
The utilisation of oxidative phosphorylation through increased oxygen consumption, 
demonstrates a survival mechanism for MSCs when glucose becomes limited in the 
surrounding environment (Figure 3.7 and Table 3.2). This phenomena has been 
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described as the Crabtree effect. It has been shown experimentally, that cells cultured 
under limiting glucose concentrations, increase their oxygen consumption and have an 
associated reduction in glycolysis (Krebs, 1972; Heywood et al., 2006). However, an 
observation from the present investigation is that there was lactate production from the 
cells, despite inhibiting glucose consumption through 2-Deoxy-D-glucose. This 
phenomena may be due to a lag between inhibition of glucose consumption and 
lactate release associated with underlying metabolic pathways. The reduction in 
lactate release after the 1 hour time point would support this conclusion. Alternatively, 
the lactate produced from the cells may be associated with the release of glucose from 
glycogen stores inside the cell. The glycogen may be used for the production of lactate 
by the cells and enable subsequent activation of the Krebs’ cycle, leading to oxidative 
phosphorylation. This is a contributory factor to the increased oxygen consumption by 
MSCs in the presence of the described modulator. The modulator, 2-Deoxy-D-
glucose, has been used in studies where glucose is a possible limiting factor for their 
cell survival, e.g. tumour cells and chondrocytes (Nirenberg and Hogg, 1958; Barban 
and Schulze, 1961; Lee and Urban, 1997). These cell types reside under similar in 
vivo oxygen conditions to MSCs and show that the limiting factor for their survival is 
glucose rather than oxygen (Krebs, 1972; Lane et al., 1977; Heywood et al., 2006). 
Recent investigations have shown that MSCs had the ability to survive under severely 
depeleted glucose conditions and their possible survival mechanisms could be related 
to the increased utilisation of oxidative phosphorylation (Follmar et al., 2006; Mylotte 
et al., 2008). 
 
Sodium azide was shown to inhibit MSC oxygen consumption (Figure 3.7). The 
modulator acts on complex IV of the electron transport chain and prevents the 
reduction of oxygen into water. This leads to ATP production for MSCs, primarily via 
glycolysis. This inference is supported through analysis of the glucose consumption 
and lactate production rate, as the cells were producing lactate upon consumption of 
glucose (Figure 3.8 and Figure 3.9).  There was no significant difference in glucose 
consumption rate between control and azide-treated samples, although there was a 
significant increase in lactate production rate for the MSC samples treated with the 
modulator (Table 3.3). This latter observation shows that the glucose consumed is 
predominantly converted into lactate, with the glucose to lactate ratio meeting the 
requirements for the stoichiometric glycolytic ratio (Table 3.4). However, there was a 
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minimal amount of oxygen consumed by MSCs in the presence of the modulator, 
which indicates that oxygen may be utilised for non-mitochondrial or metabolic 
processes such as the pentose phosphate pathway.  
 
Table 3.9. The estimated proportion of ATP generated through glycolysis and oxidative 
phosphorylation for MSCs expanded under normoxia. Corrected estimations based on Table A.2 
in Appendix A.3. 
Metabolic process % ATP generation Corrected % ATP generation 
Oxidative Phosphorylation 14 30.1 
Glycolysis 86 69.9 
 
       ATPOHCOOOHC 30666 2226126               (3.1) 
 
ATPOHOHCPADPOHC 22222 22636126              (3.2) 
  
The oxygen consumption rate for MSCs both with or without the presence of sodium 
azide and control lactate production rate were used to estimate MSC ATP production 
from oxidative phosphorylation and glycolysis (Table 3.9). ATP production through 
oxidative phosphorylation produces 30 ATP molecules, whereby the P/O ratio is 2.5 
or 5 ATP molcules per oxygen molecule (O2) (Brand et al., 1993).  The respiratory 
equation for oxidative phosphorylation states that each cycle utilises six oxygen 
molecules (O2) for each glucose molecule (C6H12O6) consumed (equation 3.1). 
Glycolysis generates an ATP molecule for each lactate molecule (C3H6O2) produced, 
without the requirement for oxygen consumption (section 1.5 and equation 3.2). The 
difference between sodium azide and control sample oxygen consumption is assumed 
to be solely utilised for oxidative phosphorylation. The P/O ratio value is then used to 
estimate ATP produced through oxidative phosphorylation. The lactate production 
rate per cell in the control sample during the two hour period of oxygen consumption 
measurement is assumed to be solely derived from glycolysis and then using the 
lactate to ATP ratio, the ATP generated through glycolysis was estimated. Using these 
data, the proportion of ATP production from either oxidative phosphorylation or 
glycolysis was estimated. It was estimated that oxidative phosphorylation contributed 
to 14% of total ATP production, whilst the remaining 86% was derived from 
glycolysis. Utilising the corrected oxygen consumption data described in Table A.2 
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(Appendix A.3), it was estimated that ATP generation derived from oxidative 
phosphorylation was 30% of total ATP production, whilst the remaining 70% was 
generated from glycolysis. In both cases, the results show that the majority of MSC 
ATP production under normoxic conditions is through glycolysis, although they have 
a mixed metabolism.   
 
The use of oxidative phosphorylation by MSCs under these conditions shows that 
their mitochondria are being used for ATP production and therefore the cells possess 
fully functioning mitochondria. This was further demonstrated using the 
mitochondrial uncoupler, CCCP (Figure 3.10). The significant increase in oxygen 
consumption in the presence of the uncoupler shows that the mitochondria are intact 
within the cell and are undamaged (Mignotte et al., 1991). However, the full capacity 
of the mitochondria is not fully utilised in the process of cellular ATP production 
(Table 3.5).  
 
Table 3.10. The estimated proportions of the total oxidative capacity utilised for various 
mitochondrial processes during MSC expansion under normoxia. Corrected estimations based on 
Table A.3 in Appendix A.3. 
Oxidative process % Oxidative capacity 
Corrected % Oxidative 
capacity  
Oxidative Phosphorylation 18 34.4 
Respiratory reserve 72 54.2 
Other mitochondrial processes 10 11.4 
 
The proportions of oxidative capacity utilised for mitochondrial processes are based 
upon the oxygen consumption data for control MSC, azide and CCCP-treated-MSC 
samples. The total oxidative capacity or maximum oxygen consumption rate is 
equivalent to the oxygen consumption rate achieved for CCCP-treated MSC samples. 
The oxygen consumption solely utilised for oxidative phosphorylation was derived 
from the difference in control and azide-treated consumption data, whilst the 
difference in control and CCCP-treated oxygen consumption may be described as 
unused mitochondrial oxygen consumption associated with oxidative phosphorylation 
or respiratory reserve. The proportions for these calculated values were estimated with 
respect to the maximum oxygen consumption described by MSCs treated with the 
CCCP modulator. The remaining mitochondrial oxidative capacity may be utilised for 
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other mitochondrial processes that may be associated with ROS generation. Analysis 
of the control sample shows that only 18% of the total oxidative capacity is used for 
oxidative phosphorylation (Table 3.10). The majority of the cellular oxidative capacity 
is unused or in reserve (72%), whilst an estimated 10% of the oxidative capacity is 
used for other mitochondrial processes such as ROS production. However, correcting 
the CCCP data for oxygen ingress (Appendix A.3; Table A.3), the oxidative capacity 
utilised for oxidative phosphorylation increased (34.4%) and respiratory reserve 
decreased (54.2%). 
 
The observation that ROS production may be derived from MSC oxygen consumption 
could be influential during MSC expansion under normoxia. The generation of ROS 
has been shown to induce premature senescence amongst various cell types including 
MSCs and chondrocytes (Moussavi-Harami et al., 2004; Martin et al., 2004). 
However, ROS generation also influences cellular metabolic activity (Ramp et al., 
1987; LaCagnin et al., 1990; Liddell et al., 2009). ROS is produced primarily at 
complex I and III of the electron transport chain and induces damage to mitochondrial 
DNA that leads to inhibited mitochondrial function and subsequently cell apoptosis 
(Valko et al., 2007; Wei et al., 2009). ROS generation has also led to reductions in 
oxygen consumption and lactate production (Ramp et al., 1987; LaCagnin et al., 
1990). LaCagnin et. al. (1990) showed that in the presence of exogeneous hydrogen 
peroxide, lung alveolar cells have reduced ATP production and oxygen consumption, 
although it was found that ROS generation had a greater effect on ATP generation, as 
it inhibited conversion of ADP to ATP at ATP synthase. The study showed that 
despite reduced oxygen consumption in the presence of hydrogen peroxide, the 
electron transport chain was unaffected through analysis of the mitochondrial 
uncoupler, CCCP. Furthermore, previous investigations have shown reduced glucose 
consumption and lactate production in the presence of ROS may be associated with 
reduced ATP production and inhibited production of glycolysis intermediates from 
different metabolic pathways such as the pentose phosphate pathway (Liddell et al., 
2009). 
 
It should be noted that these calculations for ATP production and oxidative capacity 
are based upon the current data and modulators utilised. The use of sodium azide only 
inhibits oxygen consumption at complex IV of the electron transport chain and does 
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not inhibit ATP production via ATP synthase or heat production via proton leak 
(Newsholme and Leech, 1991). The proton leak involves protons re-entering the 
mitochondria, although they are not involved with ATP synthesis. In order to observe 
the effects of proton leak and ATP synthesis, studies have used oligomycin to measure 
the oxygen consumption utilised for other mitochondrial processes, due to the fact that 
it acts upon ATP synthase along the electron transport chain (Jekabsons and Nicholls, 
2004; Chen et al., 2008; Heywood and Lee, 2008). The use of sodium azide in further 
instances within the thesis should also take into account these limitations.      
 
It was further shown that the rates of glucose consumption and lactate production for 
human MSCs, in the presence of CCCP, change dependent upon the oxygen 
environment (Table 3.6 and Table 3.7). There was an increase in the glucose 
consumption and lactate production rate in the presence of CCCP, whilst MSCs were 
in the presence and during consumption of oxygen. Thereafter, it was observed that a 
reduction in glucose consumption and lactate production occurred during the period of 
zero oxygen or anoxic conditions. These observations correlate with results shown in 
chapter 2 that human MSCs have a mixed metabolism but once oxygen is depleted, 
the cells only utilise glycolysis for ATP production. This observation is further 
supported through analysis of the glucose to lactate ratio, which revealed a high level 
of glycolysis (Table 3.8). 
 
The implications of these results in terms of culture environments and bioreactors 
using MSCs suggest a requirement for optimising both oxygen and glucose 
concentration within the culture medium to ensure optimum expansion of the cells, in 
addition to alterations in the oxygen and glucose environment associated with 3D 
culture for tissue engineering. However, studies have shown that these cells undergo 
premature senescence and subsequently apoptosis under high glucose levels (25 mM 
glucose) in the same manner as normoxic cultures inducing the same processes 
(Stolzing et al., 2006; Sethe et al., 2006). Thus, a balance between glucose and 
oxygen levels are required to ensure high MSC yield that meets their metabolic 
requirements. Moreover, there may be significant alterations in the metabolic 
phenotype of the cells during differentiation, such as towards osteogenic and 
chondrogenic lineages. These effects have not been characterised previously and 
therefore form the basis of the next chapter of this thesis. 
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4 CHANGES IN THE OXYGEN CONSUMPTION OF 
HUMAN MSCs DURING CHONDROGENESIS AND 
OSTEOGENESIS 
4.1 Introduction 
The previous chapters within this thesis have described the metabolism of MSCs 
during expansion under normoxia (Chapters 1 and 2). Previous studies have shown 
that they have a predominantly glycolytic metabolism upon expansion but the present 
thesis has shown that MSCs also utilise oxidative phosphorylation for their ATP 
production (Wang et al., 2005; Grayson et al., 2006; Grayson et al., 2007; Mischen et 
al., 2008). However, a property of MSCs, is their ability to differentiate towards the 
osteogenic, chondrogenic and adipogenic lineages (Caplan, 1991; Pittenger et al., 
1999). Thus, the metabolism of MSCs may change during the differentiation process, 
potentially reflecting the metabolism of the mature cell type.    
 
Studies analysing the cellular metabolism of chondrocytes have shown that they have 
a highly glycolytic metabolism due to the utilisation of enzymes associated with 
glycolysis upon culture under low oxygen tension (Rajpurohit et al., 1996; Semenza, 
2000). This was further shown under normoxia through culture under variable glucose 
concentrations (Heywood et al., 2006). High glucose concentrations resulted in 
reduced cellular oxygen consumption, while oxygen consumption was increased in the 
presence of low glucose concentrations, indicative of the Crabtree effect. This 
demonstrates the ability of chondrocytes to compensate for inhibited glycolysis ATP 
production, through increasing their ATP production via oxidative phosphorylation, to 
enable them to meet their ATP requirements. These studies show that chondrocytes 
primarily utilise glucose for their survival.   
 
However, the creation of tissue engineered cartilage, typically involves expansion of 
cells in monolayer culture to achieve the required number of cells for implantation. 
Monolayer expansion of chondrocytes results in dedifferentiation, as the cells change 
their morphology from a rounded to a fibroblastic morphology and their collagen 
production alters from type II to type I (Domm et al., 2002; Malda et al., 2004b). 
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During monolayer expansion, chondrocyte oxygen consumption on day one is 
approximately 1 fmol/hr/cell and the cells utilise glycolysis for their ATP production 
(Heywood and Lee, 2008). Thereafter, chondrocytes increase their oxygen 
consumption to 83.2 fmol/hr/cell after a week in culture and a substantial proportion 
of their ATP production is generated through oxidative phosphorylation. However, 
previous investigations have shown that a by-product of the process is the generation 
of ROS that leads to cellular DNA damage (Moussavi-Harami et al., 2004; Martin et 
al., 2004; Heywood and Lee, 2008).  
  
The combination of hypoxia and 3D culture has been utilised to redifferentiate 
monolayer-passaged chondrocytes, enabling restoration of type II collagen synthesis, 
compared with cells cultured under normoxia (Domm et al., 2002; Malda et al., 
2004b). The conditions enabled the expression of chondrogenic genes and enzymes 
associated with the glycolysis pathway. 
 
Wang et. al. (2005) investigated the lactate production of adipose-derived MSCs 
during chondrogenic differentiation under normoxic and hypoxic culture conditions. 
The results demonstrated that at each time point measured, the lactate production rate 
during chondrogenic differentiation was significantly enhanced under hypoxia. 
However, there was no analysis of either oxygen or glucose consumption within the 
study.  
 
Investigations analysing the oxygen consumption of adipocytes revealed a 
substantially increased oxygen consumption compared with freshly isolated 
chondrocytes (Hepp et al., 1968; Klaus et al., 1998; von Heimburg et al., 2005). Hepp 
et. al. (1968) measured the oxygen consumption of adipocytes derived from rats and 
found that their per cell oxygen consumption rate was 589 fmol/hr/cell. A recent study 
clarified these measurements and showed that there was a substantial utilisation of the 
cellular mitochondrial capacity (~ 50-70%) for oxidative phosphorylation (Klaus et 
al., 1998). Von Heimburg et. al. (2005) differentiated human adipose derived MSCs 
towards the adipogenic lineage and found that from an initial oxygen consumption 
rate of 88.7 fmol/hr/cell, there was a significant increase in their consumption rate to 
429.8 fmol/hr/cell after 14 days in adipogenic differentiation medium.  
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By contrast, the metabolic behaviour of osteoblasts has been shown to be similar to 
the MSCs studied in earlier chapters within this thesis (Chapters 2 and 3). Studies 
isolating tissue samples from the metaphysis of bone showed that culture under 
normoxia resulted in both oxygen consumption and lactate production (Borle et al., 
1960a; Borle et al., 1960b; Cohn and Forscher, 1962; Felix et al., 1978). These studies 
demonstrated that osteoblasts undergo aerobic glycolysis or the Warburg effect, 
whereby lactate production occurs despite the presence of high levels of oxygen. The 
oxygen consumption of rat-derived osteoblasts was estimated to be 22.8 fmol/hr/cell 
(Smith et al., 1973).  
 
Komarova et. al. (2000) cultured rat calvaria osteoblasts under osteogenic 
differentiation conditions compared with medium without the differentiation 
components, -glycerophosphate and ascorbic acid. The differentiated osteoblasts had 
a cellular oxygen consumption rate after 14 days in culture of approximately 125 
fmol/hr/cell, whereas non-differentiated or immature osteoblasts had an oxygen 
consumption rate of 42 fmol/hr/cell. The increased oxygen consumption during 
differentiation resulted in increased mitochondrial membrane potential, which was 
assumed to be associated with greater utilisation of oxidative phosphorylation. 
However, the study showed that there was substantial lactate production during the 
culture period, specifically at later stages. The study estimated that after 14 days in 
culture, differentiated osteoblasts utilised both glycolysis and oxidative 
phosphorylation in approximately equal amounts for their ATP production.  
 
The differentiation of human MSCs towards the osteogenic lineage has been shown to 
induce a 3-fold increase in oxygen consumption compared with undifferentiated 
MSCs, although no absolute consumption values were stated in the study (Chen et al., 
2008). The resulting differentiation resulted in decreased expression of enzymes 
associated with glycolysis and lactate production. Osteogenic differentiation was 
found to be more dependent upon ATP generation through mitochondrial pathways, 
specifically oxidative phosphorylation. However, the presence of ROS and use of 
oxidative phosphorylation inhibitors, resulted in inhibited osteogenic differentiation, 
although it was demonstrated that there was an increase in the expression of anti-
oxidant enzymes during differentiation. Recent investigations differentiating MSCs 
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towards the osteogenic lineage under hypoxic conditions revealed an inhibition of 
osteogenic-specific genes and this may be associated with changes in metabolic 
requirements during differentiation (Tuncay et al., 1994; Warren et al., 2001; Salim et 
al., 2004; Malladi et al., 2006; d'Ippolito et al., 2006a; Potier et al., 2007a). 
 
The previous investigations show that differentiation towards the adipogenic, 
chondrogenic and osteogenic lineages induce alterations in both oxidative 
phosphorylation and glycolysis utilisation. However, a detailed analysis of the 
metabolism of human MSCs towards the osteogenic and chondrogenic lineages has 
not been undertaken. Therefore, the present investigation will measure the oxygen 
consumption, glucose consumption and lactate production of MSCs during 
chondrogenic and osteogenic differentiation. The hypothesis to be tested is that human 
MSCs maintain their glycolytic metabolism during chondrogenic differentiation but 
increase levels of oxidative phosphorylation during osteogenic differentiation. 
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4.2 Methodology 
4.2.1 MSC culture and chondrogenic pellet culture 
Cells procured from LonzaTM were resuscitated, passaged and cryopreserved 
according to methods described in sections 2.2.1 - 2.2.4. Cells at passage 3 were 
utilised for chondrogenic differentiation. Pellets were created and maintained using 
the protocol outlined in section 2.2.7.3. Pellets were transferred into fresh 15 ml 
polypropylene tubes containing either 0.5 ml control chondrogenic (-TGF-3) or 
chondrogenic (+TGF-3) medium after 24 hours in culture. Medium was refreshed 
every 2-3 days for 21 days, unless removed for metabolic analysis, GAG analysis or 
toluidine blue staining. 
 
4.2.2 Osteogenic culture of MSCs 
Cells were resuscitated and passaged using protocols described in sections 2.2.1 - 
2.2.4. The cells were seeded into 175 cm2 culture flasks at a seeding density of 2 x 103 
cells/cm2 and passaged at confluence. The cells were recovered at passage 3 and 
seeded into fresh culture flasks at 2 x 103 cells/cm2 and cultured in proliferation 
medium. The cells were allowed to attach for 24 hours in culture and then a set of 
flasks were supplied with osteogenic medium (section 2.2.7.1). This represented day 0 
for osteogenic differentiation of MSCs, with medium replacements every 2-3 days. 
Cells were cultured for 21 days unless required for experimentation or analysis at 
earlier time points.  Passage 3 MSCs were also seeded at a seeding density of 2 x 103 
cells/cm2 onto 6-well and 12-well culture plates and utilised for calcium deposition via 
alizarin red staining and analysis of alkaline phosphatase activity (section 4.2.5).  
 
4.2.3 Measurement of oxygen and glucose consumption and lactate 
production 
  
Chondrogenic differentiation 
Aliquots (130 l) of temperature and oxygen equilibrated control chondrogenic 
medium were added to wells of a 384-well oxygen biosensor plate (BD Biosciences, 
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Oxford, UK). Medium samples for chondrogenic pellets were required to be 
supplemented with 2 g/ml TGF-3 prior to aliquoting. Aliquots were added in 
triplicate into wells of the biosensor plate.  Control and chondrogenic pellets were 
placed into the appropriate wells of the biosensor plate. Each well contained two 
pellets and oxygen consumption was measured as described in section 2.2.9. The plate 
was sealed for the duration of the experiment and the oxygen consumption was 
calculated as described in section 2.2.10. Oxygen consumption measurements were 
taken on days 0, 1, 7, 14 and 21 during chondrogenic culture period. 
 
In conjunction with the oxygen measurements, pellets were placed in 384-well plates 
(BD Biosciences, Oxford, UK) containing 130 l aliquots of temperature and oxygen-
equilibrated control chondrogenic (-TGF-3) or chondrogenic (+TGF-3) medium. 
Two pellets were placed per well in triplicate format. Plates were sealed and incubated 
in a 370C/5% CO2 incubator. The medium was aspirated from the plates at 2, 4 and 6 
hour time points. Cell-free medium controls for both conditions and medium samples 
were frozen at -200C prior to assay analysis. Changes in glucose and lactate 
concentration in the medium, along with measuring the rates of glucose consumption 
and lactate production were assessed on days 0, 1, 7, 14 and 21 of culture using 
protocols detailed in section 2.2.11.  
 
In addition, control and chondrogenic medium was supplemented with 10 mM sodium 
azide for oxygen consumption measurements in the presence of the inhibitor for both 
sets of pellet cultures. Control and chondrogenic pellets on days 7 and 21 of culture 
were utilised. The data was used to estimate the proportion of ATP production 
generated from oxidative phosphorylation and glycolysis during chondrogenic 
differentiation. 
 
Osteogenic differentiation 
Proliferation and osteogenic medium were equilibrated in a 370C/5% CO2 incubator 
for 24 hours prior to experimentation. MSCs cultured in either proliferation or 
osteogenic medium were trypsinised using the protocol described in section 2.2.3. 
Cells were centrifuged at 500 x g for five minutes and the resultant supernatant was 
removed to leave a cell pellet. Cells were resuspended at a density of 1.15 x 106 
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cells/ml, with either proliferation or osteogenic medium and cell suspensions were 
aliquoted at a volume of 130 l (1.5 x 105 cells) into wells of a 384-well oxygen 
biosensor plate (BD Biosciences, Oxford, UK) for assessment of the oxygen 
consumption during a two hour period. Measurements and calculations of oxygen 
consumption followed protocols described in sections 2.2.9 and 2.2.10.  
 
Separate 384-well plates were prepared containing 130 l cell suspensions (1.5 x 105 
cells) of proliferating or osteogenic MSCs. Medium was aspirated at 2, 4 and 6 hour 
time points and samples were stored at -200C prior to analysis, along with cell-free 
medium controls for both conditions. Medium glucose and lactate concentrations were 
measured and rates calculated using protocols described in section 2.2.11. 
Measurements of oxygen and glucose consumption and lactate production were 
measured on days 0, 1, 7, 14 and 21 during culture. Osteogenic and control medium 
was supplemented with 10 mM sodium azide for assessment of oxygen consumption 
on days 7 and 21 for undifferentiated and osteogenic MSCs. The data was used to 
estimate the proportion of ATP production generated from glycolysis and oxidative 
phosphorylation at these time points during osteogenic differentiation. 
 
4.2.4 Deoxyribonucleic acid (DNA) and glycosaminoglycan (GAG) assay 
 
Table 4.1. Components of 500 ml Papain digest buffer solution adjusted to pH 6 using 1 M 
sodium hydroxide in 500 ml PBS. 
Reagents Concentration Supplier 
L-Cysteine hydrochloride  150 mM BDH, Poole, UK 
EDTA, disodium salt 55 mM Sigma-Aldrich, Poole, UK 
Sodium Chloride 5 mM BDH, Poole, UK 
Trisodium citrate 5 mM BDH, Poole, UK 
Papain enzyme 0.56 U/ml Sigma-Aldrich, Poole, UK 
 
Control and chondrogenic pellets were analysed for GAG and DNA content on days 0, 
1, 7, 14 and 21 of culture. The DNA content of the cells was normalised to the DNA 
content per MSC to calculate the number of cells within a pellet and utilised for the 
calculation of per cell oxygen and glucose consumption and lactate production rates. 
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Prior to DNA and GAG assays, the samples were digested with papain at 600C 
overnight and stored at -200C prior to analysis (Table 4.1). 
 
Hoechst 33258 assay for DNA quantification 
The Hoechst 33258 assay was used to quantify the amount of DNA within the cell 
pellet. The dye binds to the adenine-thymine base pair and fluoresces upon excitation 
at 390nm with emission at 460nm. The concentration of DNA within the samples was 
determined through assessment of fluorescence values obtained from DNA standards 
(Figure 4.1). 
 
 
Figure 4.1. Representative standard curve for determination of DNA concentrations in control 
and chondrogenic pellets (n = 4; y = 222.3x + 337.4; R2 = 0.99). 
 
A 1 mg/ml stock solution was created by dissolving DNA from calf thymus (Sigma-
Aldrich, Poole, UK) in distilled water. The stock solution was diluted to 20 g/ml and 
then further diluted to a series of standard concentrations ranging from 0-20 g/ml 
using the digest buffer. Standards and digested pellet samples were aliquoted at a 
volume of 100 l into wells of a white NuncTM Immunosorp 96-well plate. The stock 
Hoechst 33258 reagent was diluted to a working concentration of 1 mM using the 
digest buffer. An equivalent volume of working solution was added to the samples and 
standards.  
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The plate was read using a fluorometer (Fluostar Galaxy, BMG technologies, 
Aylesbury, UK) with the excitation wavelength set at 390nm, and emission 
wavelength at 460nm. The concentration within each sample was calculated against 
known DNA standards, as depicted in the standard curve (Figure 4.1). The mean 
amount of DNA per MSC, calculated from known cell numbers was 10.4 pg 
(Appendix A.2, Figure A.8). This value was used to calculate the number of MSCs 
within the cell pellet at each time point. 
       
DMB assay for sulphated glycosaminoglycams (GAG) 
The concentration of sulphated GAGs within the pellets was quantitatively determined 
using 1,9-dimethylmethylene blue (DMB) (Farndale et al., 1982; Farndale et al., 
1986). The principle of the assay involves the metachromatic shift in the absorbance 
maximum from 600nm to 535nm, when the dye complexes with the negatively 
charged GAGs. The reduction in absorbance at 595nm with increasing GAG 
concentration provides the basis for the assay. The concentration of sulphated GAGs 
within the samples was determined through assessment of the absorbance at 595nm, 
that was obtained using DMB solution, compared to that obtained from chondroitin-4-
sulphate standards (Sigma-Aldrich, Poole, UK) (Figure 4.2).. 
 
 
Figure 4.2. Representative standard curve for determination of GAG concentrations in control 
and chondrogenic pellets (n = 4; y = -0.024x + 1.1583; R2 = 0.989). 
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A 1 mg/ml chondroitin-4-sulphate solution was prepared by dissolving bovine 
chondroitin-4-sulphate (Sigma-Aldrich, Poole, UK) in distilled water. The stock 
solution was diluted to 100 g/ml and then further diluted to a series of standard 
concentrations ranging from 0-25 g/ml. DMB solution was prepared through 
addition of 16 mg 1,9-dimethylmethylene blue (Sigma-Aldrich, Poole, UK), 5 ml 
ethanol (BDH, Poole, UK) and 2 g sodium formate (Sigma-Aldrich, Poole, UK) in 
950 ml distilled water. The solution was adjusted to pH 3 with formic acid (BDH, 
Poole, UK) and made up to 1 litre with distilled waterAliquots of standards and 
digested samples at a volume of 40 l were added in duplicate, into a clear NuncTM 
Immunosorp 96-well plate with 250 l DMB solution added to the wells. The plate 
was placed into a Multiskan Ascent spectrophotometer (Thermolifesciences, 
Hampshire, UK), the absorbance at 595nm was recorded and the concentration of 
GAG within each of the samples was calculated against known GAG concentrations 
(Figure 4.2). 
 
4.2.5 Alkaline phosphatase activity and Picogreen dsDNA assay for human 
MSCs during osteogenesis 
 
Alkaline phosphatase activity for MSC osteogenic differentiation 
The assay measures the enzymatic activity of alkaline phosphatase. Control and 
osteogenic cultures were removed on days 1, 4, 7, 11, 14, 17, and 21 for alkaline 
phosphatase analysis. The medium was aspirated from the wells and the cells were 
washed using PBS (Sigma-Aldrich, Poole UK). A 500 l lysis solution containing 
PBS supplemented with 0.2% Triton X-100 (Sigma-Aldrich, Poole, UK) was used to 
lyse the cells present in the wells by incubation at room temperature for 30 minutes. 
The plate was stored at -800C and prior to analysis, the cells were further lysed 
through a series of freeze-thaw cycles to further lyse the cells. The resultant cell lysis 
solution was stored in a -800C freezer prior to analysis.  
 
The assay uses p-nitrophenylphosphate as a substrate for the alkaline phosphatase 
enzyme, thus enabling quantification of its enzymatic activity (Bessey et al., 1946; 
Sterling et al., 1964). The standards for the assay were formulated from a 10 mM p-
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nitrophenol stock solution (Sigma-Aldrich, Poole, UK), which was diluted to 2 mM p-
nitrophenol using PBS + 0.2% Triton X-100 and then further diluted to a series of 
concentrations ranging from 0-2 mM. An alkaline phosphatase kit (Randox 
Laboratories, County Amtrim, UK) was procured to perform the assay. The kit 
contained a buffer solution (1 M diethanolamine and 0.5 mM magnesium chloride) 
and the substrate, p-nitrophenylphosphate. The final concentration of the p-
nitrophenylphosphate upon addition of 10 ml buffer solution was 10 mM. This 
formulated solution acted as the reagent for the assay. 
 
 
Figure 4.3. Representative standard curve for determination of ALP enzyme activity in control 
and osteogenic samples (n = 4; y = 0.9881x + 0.0881; R2 = 0.99). 
 
Standards and cell lysate samples at a volume of 100 l were pipetted in duplicate into 
a clear NuncTM Immunosorp 96-well plate. An equivalent volume of the assay reagent 
was pipetted to both standards and cell lysate, followed by incubation at 370C for 2 
hours that enables the enzymatic reaction to occur. The plate was transferred to a 
spectrophotometer (Fluostar Galaxy, BMG technologies, Aylesbury, UK) and 
absorbance was recorded at 450nm. The enzymatic activity of alkaline phosphatase 
was measured against known concentrations of p-nitrophenol (Figure 4.3).  
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Quant-it Picogreen dsDNA assay for DNA quantifcation 
To calculate the relative activity of alkaline phosphatase, the data were normalised to 
the amount of DNA within the sample, which was measured using a commercial kit, 
Quant-it Picogreen dsDNA reagent (Invitrogen, Paisley, UK). The kit contains 
Picogreen dsDNA reagent, TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) and -
DNA standard. A 2 g/ml -DNA stock solution was formulated using TE buffer and 
then further diluted to produce a range of concentrations between 0–2 g/ml. The 
stock Picogreen dsDNA reagent was diluted 200-fold using TE buffer to the required 
assay reagent concentration.  
 
 
Figure 4.4. Representative standard curve for determination of DNA concentration in control and 
osteogenic samples using Picogreen assay (n = 4; y = 63582x + 745.2; R2 = 0.99). 
 
A 100 l sample of the cell lysate was added to 400 l TE buffer using an Eppendorf 
tube (VWR, Lutterworth, UK). An equivalent volume of Picogreen assay reagent, 500 
l, was added to the cell lysate-TE buffer solution and vortexed prior to assay. The 
formulated standards were made to 500 l solutions and an equivalent volume of 
Picogreen reagent was added. The standards and cell lysate solutions (100 l) were 
pipetted in duplicate into a white NuncTM Immunosorp 96-well plate. The plate was 
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placed into a fluorometer (Fluostar Galaxy, BMG technologies, Aylesbury, UK) set at 
an excitation wavelength of 480nm, and emission wavelength of 520nm. The samples 
and standards were mixed within the plate reader and the fluorescence measurements 
were recorded. The concentration of DNA within the sample was calculated using the 
standard curve generated from known DNA standards (Figure 4.4).  
 
Hoescht 33258 was utilised for the chondrogenic pellets, as these samples contain a 
high number of MSCs within the pellet. The number of MSCs utilised for osteogenic 
differentiation is significantly reduced compared with chondrogenic samples. Hoescht 
33258 can detect and quantify DNA concentrations from 10 ng/ml, whereas Picogreen 
dsDNA assay has the ability to detect concentrations from 0.5 ng/ml, according to the 
manufacturer’s instructions. Investigations analysing osteogenic or chondrogenic 
differentiation of MSCs have utilised the Picogreen assay for their studies to quantify 
cell number within 3D constructs or cultured on tissue culture plates (McGowan et al., 
2002; Wang et al., 2005; Jager et al., 2005; Malladi et al., 2006; Mauck et al., 2006; 
Nair et al., 2009). As a result of the increased sensitivity of the assay, Picogreen was 
used to quantify MSC populations within cell culture plates during osteogenic 
differentiation. The amount of DNA per MSC using the assay was calculated through 
measurement of lysed cell samples ranging from 5 x 104 – 2 x 105 cells utilising the 
protocol described. Analysis of the cell lysate samples showed that the amount of 
DNA per MSC was 10.9 pg, similar to that detemined using Hoescht 33258 
(Appendix A.2, Figure A.9). This value was used to calculate the number of MSCs 
within the well plates used for osteogenic differentiation and measurement of alkaline 
phosphatase activity.            
    
4.2.6 Toluidine blue staining for chondrogenic pellets and alizarin red 
staining of osteogenic samples 
The embedding and staining procedures for the analysis of chondrogenic pellets was 
performed as outlined in section 2.2.7.3. Briefly, pellets were fixed after 21 days of 
culture and analysed for the presence of GAG within the pellets. The pellets were 
fixed in PBS containing 3.7% (v/v) formaldehyde, and embedding and staining 
procedures were performed at the Pathology core facility, Institute of Cell and 
Molecular Science, Queen Mary University of London. Osteogenic samples were 
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assessed for calcium deposition after 21 days in culture using protocol described in 
section 2.2.7.1.  
 
4.2.7 Statistical analysis 
The per cell oxygen and glucose consumption and lactate production rates were 
compared between chondrogenic and osteogenic samples with their respective 
controls and between time points for each parameter using a 2-factor ANOVA (= 
0.05). If differences were significant (p < 0.05) between samples then post-hoc 
Student t-test with Bonferroni correction was applied. Comparison between 
chondrogenic and osteogenic samples were compared at each time point for these 
metabolic parameters using a Student t-test with p < 0.05 considered significant. DNA 
or cell number, alkaline phosphatase activity and GAG deposition were compared 
between cultures at each time point using a Student t-test (p < 0.05).  
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4.3 Results 
4.3.1 Oxygen consumption of chondrogenic pellets and osteogenic MSCs 
The oxygen consumption rate for the control and chondrogenic pellets was measured 
with two pellets placed into each well and measured over a two hour period (section 
4.2.3). Figure 4.5 shows the change in per cell oxygen consumption rate for control 
and chondrogenic pellets on days 0, 1, 7, 14 and 21 during culture.  Day 0 represents 
MSC cell suspension in either control chondrogenic or chondrogenic medium. 
 
 
Figure 4.5. The change in per cell oxygen consumption rate for cultured control (-TGF-3) and 
chondrogenic (+TGF-3) MSC pellets. Data represent mean + S.D. of n = 6: Control ( ) and 
Chondrogenic ( ).  Corrected data presented in Appendix A.3, Figure A.13. 
 
The per cell oxygen consumption rate was significantly reduced, by approximately 4-
fold, after 24 hours in both control and chondrogenic medium (Student t-test; p < 
0.05) and there was a further significant decrease between days 1 and 7 for both 
culture conditions (Student t-test; p < 0.05). However, between days 7-21 of culture, 
there were no further changes in the per cell oxygen consumption rate (Student t-test; 
p > 0.05), nor were there any significant differences between MSC pellets cultured in 
either control or chondrogenic medium during the course of the experiment. 
Correcting the data for oxygen ingress into the plate (Appendix A.3; Figure A.13), 
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demonstrated a similar pattern in per cell consumption rate within control and 
chondrogenic pellet cultures, although absolute values were higher than that displayed 
in Figure 4.5.   
 
 
Figure 4.6. The change in per cell oxygen consumption rate for cultured control and osteogenic 
MSC cultures. Data represents mean + S.D. of n = 6: Control ( ) and osteogenic ( ). Corrected 
data presented in Appendix A.3, Figure A.14. 
    
The oxygen consumption rates for MSCs differentiating towards the osteogenic 
lineage were assessed at the same time points as the chondrogenic pellets (Figure 4.6). 
However, the cells were in an unattached state and the number of cells within each 
well was 1.5 x 105 cells. Figure 4.6 shows the change in per cell oxygen consumption 
rate for control or proliferating MSCs and osteogenic MSCs. There was no significant 
difference in the per cell oxygen consumption rates on day 0 or day 1 when comparing 
osteogenic and control samples (Student t-test; p > 0.05). Thereafter, a significant 
increase in oxygen consumption for the control samples was observed, compared with 
osteogenic samples (Student t-test; p < 0.05). There was no significant difference in 
the per cell oxygen consumption for the control samples between day 7-21 (Student t-
test; p > 0.05), whereas there was a decrease in the per cell consumption rate on day 
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21 for samples cultured in osteogenic medium (Student t-test; p < 0.05). However, 
correction for oxygen ingress showed that there was a significant increase in both 
control and osteogenic MSC, per cell oxygen consumption rate (Appendix A.3; Figure 
A.14). In contrast to Figure 4.6, corrected oxygen consumption for osteogenic cultures 
had a greater per cell oxygen consumption rate compared with control, although there 
was found to be no significant differences between control and osteogenic cultures at 
each time point or between time points within each condition (2-factor ANOVA; p > 
0.05).   
 
A comparison of the per cell oxygen consumption rate between chondrogenic and 
osteogenic samples, indicates a significantly greater per cell consumption rate for 
MSCs cultured under osteogenic conditions, compared to chondrogenic conditions at 
each time point, apart from day 0 (Student t-test; p < 0.05). Furthermore, comparison 
of the corrected oxygen consumption for both chondrogenic (Appendix A.3; Figure 
A.13) and osteogenic (Appendix A.3; Figure A.14) cultures demonstrated the same 
pattern, although at day 0, there was found to be no significant difference between 
these cultures (Student t-test; p < 0.05). 
 
4.3.2 Glucose consumption and lactate production of chondrogenic pellets 
and osteogenic MSCs 
 
Figure 4.7 shows the per cell glucose consumption during chondrogenic 
differentiation of MSCs. There was no significant difference in the glucose 
consumption between control and chondrogenic MSC pellet samples (2-factor 
ANOVA; p > 0.05) bar cultures at day 0. There was a reduction in per cell glucose 
consumption rate after day 0 in culture. However, there was no overall significant 
difference between days 1 and 14 for both cultures (2-factor ANOVA; p > 0.05), but a 
significant increase in consumption rate was noted between days 14 and 21 for the 
chondrogenic cultures (Student t-test; p < 0.05).  
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Figure 4.7. The change in per cell glucose consumption rate of human MSC pellets during 
chondrogenesis. Data represent mean + S.D. of n = 6: Control ( ) and Chondrogenic ( ); 
Bonferroni corrected student t-test: * p< 0.05. 
 
Figure 4.8 describes the per cell lactate production rate in both control and 
chondrogenic MSC pellet cultures. There was no significant difference in the per cell 
lactate production rate between control and chondrogenic pellets on days 1, 7, 14 and 
21 in culture (2-factor ANOVA; p > 0.05) but there was a significant difference 
between samples on day 0 of culture (Student t-test; p < 0.05). In terms of the lactate 
production under each condition, there was no overall significant difference in the per 
cell production for both the control and chondrogenic samples (2-factor ANOVA; p > 
0.05), except for samples on day 0 (Student t-test; p < 0.05).    
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Figure 4.8. The change in per cell lactate production rate of human MSC pellets during 
chondrogenesis. Data represent mean + S.D. of n = 6: Control ( ) and Chondrogenic ( ); 
Bonferroni corrected student t-test: * p< 0.05. 
 
The per cell glucose consumption rate for MSCs cultured under osteogenic conditions, 
shows that there was a significantly reduced consumption rate compared with control 
samples at all time points except at day 0 (Figure 4.9, Student t-test; p < 0.05). There 
was no significant difference in terms of the per cell glucose consumption rate on days 
0-7 for the control (2-factor ANOVA; p > 0.05), but thereafter, a significant increase 
in the per cell glucose consumption rate was recorded (Student t-test; p < 0.05). A 
similar phenomenon occurred for osteogenic MSC samples between days 7 and 14, 
but there was also a significant decrease in per cell consumption rate between day 0 
and day 1 samples (Student t-test; p < 0.05).  
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Figure 4.9. The change in per cell glucose consumption rate of human MSCs during osteogenesis. 
Data represent mean + S.D. of n = 6: Control ( ) and Osteogenic ( ); Bonferroni corrected 
student t-test: * p< 0.05. 
 
In terms of the lactate production rate (Figure 4.10), there was a significant reduction 
in per cell lactate production rate for osteogenic samples compared with the control 
(Student t-test; p < 0.05). There was no significant difference in the production rate for 
control samples between all the time points and for osteogenic samples between days 
7-21 in culture (2-factor ANOVA; p > 0.05). However, there was a significant 
reduction in the production rate between osteogenic samples on days 0 and 1 
compared with the later time points (Student t-test; p < 0.05).  
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Figure 4.10. The change in per cell lactate production rate of human MSCs during osteogenesis. 
Data represent mean + S.D. of n = 6: Control ( ) and Osteogenic ( ); Bonferroni corrected 
student t-test: * p< 0.05. 
 
Assessments of ATP production derived from glycolysis and oxidative 
phosphorylation were conducted on chondrogenic and osteogenic MSCs on days 7 
and 21 (Figure 4.11). These data were calculated using oxygen consumption data 
obtained for samples in the presence of sodium azide, to determine oxygen 
consumption, solely utilised for oxidative phosphorylation as described in section 3.4 
(Table 4.2). The per cell lactate production rate was used to determine ATP generation 
via glycolysis. In each case, the presence of sodium azide within the medium, 
significantly decreased the oxygen consumption of the cells (Student t-test; p < 0.05).  
The cellular glucose consumption rate in the presence of sodium azide was not 
measured due to the fact that the previous chapter showed that there was no significant 
difference in the MSC glucose consumption rate between proliferating MSCs and 
MSCs treated with sodium azide (Chapter 3). 
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Table 4.2. MSC oxygen consumption rate during differentiation towards the chondrogenic and 
osteogenic lineages on day 7 and 21 of culture either with or without the treatment of 10 mM 
sodium azide. Data represent mean + S.D. of n = 6. Corrected data are presented in Appendix 
A.3, Table. A.4. 
 
A mixed metabolism was maintained for MSCs differentiated towards the osteogenic 
lineage under each of the conditions for both time points but chondrogenic pellets 
displayed a predominantly glycolytic metabolism at the time points investigated 
(Figure 4.11). On day 7 during culture, ATP production through oxidative 
phosphorylation was 1% for chondrogenic pellets and 16% for osteogenic MSCs. 
However, after 21 days in culture, the utilisation of oxidative phosphorylation 
remained at a similar level for chondrogenic pellet and osteogenic cultures compared 
with day 7, although there was a significant increase in oxidative phosphorylation 
utilisation for their respective control cultures (Student t-test; p < 0.05). There was no 
significant difference in terms of oxidative phosphorylation employment between the 
osteogenic cultures for both time points (Student t-test; p > 0.05), although for 
chondrogenic cultures there was found to be a significant difference on day 21 
(Student t-test; p < 0.05). In terms of the chondrogenic pellet and osteogenic cultures, 
there was a significant difference in the proportion of oxidative phosphorylation at 
each time point (Student t-test; p < 0.05).     
 
The estimated ATP production data presented in Figure 4.11 are based upon 
uncorrected oxygen consumption data (Table 4.2). The corrected oxygen ingress data 
are described in Table A.4 (Appendix A.3). Based on these data, corrected estimations 
were calculated and described in Figure A.15 (Appendix A.3). There are increases in 
oxidative phosphorylation utilisation for all conditions compared to Figure 4.11. 
However, on both day 7 and 21, osteogenic cultures had a significant increase in 
oxidative phosphorylation ATP generation (45% and 43%) compared to its control 
Oxygen consumption rate/cell (fmol/hr/cell) 
Conditions Day 7 
Untreated 
Day 7  10 mM 
sodium azide 
Day 21 
Untreated 
Day 21  10 mM 
sodium azide 
Control osteogenic 59.89 + 4.80 28.9 + 3.47 55.76 + 6.39 10.59 + 4.43 
Osteogenic  41.92 + 1.89 18.18 + 0.88 31.73 + 7.36 13.78 + 3.56 
Control pellet 9.18 + 1.51 5.99 + 1.49 13.35 + 1.14 7.47 + 1.86 
Chondrogenic pellet 9.93 + 2.56 9.12 + 3.51 13.47 + 5.94 10.63 + 4.08 
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(28% and 26%) (Student t-test; p < 0.05). In comparison to chondrogenic pellet 
cultures (8% and 12%), the pattern from the uncorrected estimates remained the same, 
with a substantial increase in oxidative phosphorylation ATP production for 
osteogenic cultures (Student t-test; p < 0.05).      
     
 
Figure 4.11. Representative graphs showing the estimated proportions  of ATP production 
generated from oxdiative phosphorylation ( ) and glycolysis ( ) by human MSCs differentiated 
towards osteogenic and chondrogenic lineages on (a) day 7 and (b) day 21 during culture under 
normoxia. Estimations based on corrected data presented in Appendix A.3, Figure A.15. 
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4.3.3 DNA and GAG analysis for chondrogenic differentiation 
 
Figure 4.12. The number of cells within MSC pellets during chondrogenic differentiation of 
human MSCs. Data represents mean + S.D. of n = 6: Control ( ) and Chondrogenic ( ). 
 
The DNA content of MSCs represented as cell number, within control or 
chondrogenic pellet cultures is illustrated in Figure 4.12. There was a reduction in cell 
number within both control and chondrogenic pellet cultures during the culture. There 
was no significant difference in cell number between the samples cultured in either 
control or chondrogenic medium at each time point (Student t-test; p > 0.05). A 
marker for chondrogenic differentiation is the presence of sulphated GAGs. This was 
analysed through staining using toluidine blue and quantitatively through using a 
DMB assay. In both conditions, GAG content increased with time in culture, although 
on day 14 and 21, there was a significantly greater GAG content within chondrogenic 
cell pellets compared with control pellets at these time points (Figure 4.13, Student t-
test; p < 0.05).  
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Figure 4.13. The GAG production per DNA during chondrogenic differentiation of MSC pellets. 
Data represents mean + S.D. of n = 6; Bonferroni corrected student t-test: * p< 0.05. Control [-
TGF-3] ( ) and chondrogenic MSC pellets [+TGF-3] ( ). 
 
Toluidine blue staining was utilised to observe the presence of sulphated GAGs within 
chondrogenic and control pellets samples using microscopy (section 2.2.7.3). The 
samples were assessed after 21 days in culture. Chondrogenic samples showed greater 
amounts of GAG deposition within the extracellular matrix compared with control 
samples (Figure 4.14).  
 
 
Figure 4.14. Representative photomicrographs of (a) control (-TGF-3) and (b) chondrogenic 
MSC pellets (+TGF-3) stained for GAG deposition using Toluidine blue staining after 21 days in 
culture. 
(b) (a) 
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4.3.4 Alkaline phosphatase activity and calcium deposition analysis for 
osteogenic differentiation 
 
Figure 4.15. Cell growth curves for human MSCs during osteogenic differentiation. Data 
represents mean + S.D. of n = 6. Control ( ) and osteogenic ( ). 
 
Figure 4.15 illustrates the cell growth of MSCs during osteogenic differentiation. The 
cell number in MSC cultures differentiated towards the osteogenic lineage was 
significantly reduced compared with control cultures at all time points (Student t-test; 
p < 0.05). The differentiation of MSCs towards the osteogenic lineage was assessed 
by analysis of the enzymatic activity of alkaline phosphatase. Figure 4.16 shows that 
in both control and osteogenic samples, there was a rise in the alkaline phosphatase 
activity from day 7, although the activity in osteogenic samples was significantly 
greater (Student t-test; p < 0.05). Cells cultured in osteogenic medium showed regions 
of alizarin red staining, indicating the presence of calcium deposits within the 
extracellular matrix of these samples (Figure 4.17b). Control samples did not stain for 
alizarin red, suggesting maintainance of their proliferative phenotype (Figure 4.17a). 
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Figure 4.16. Alkaline phosphatase activity during osteogenic differenntiation of human MSCs. 
Data represents mean + S.D. of n = 6. Control ( ) and osteogenic ( ). 
 
 
 
 
 
Figure 4.17. Representative photomicrographs of alizarin red stained (a) control and (b) 
osteogenic samples after 21 days in culture for the detection of calcium deposits within the 
extracellular matrix.  
200 m 
(a) (b) 
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4.4 Discussion 
Investigations analysing the metabolism of mature chondrocytes and osteoblasts 
shows that these cells demonstrate differences in oxygen consumption (Smith et al., 
1973; Komarova et al., 2000; Chen et al., 2008; Heywood and Lee, 2008). These 
studies suggest that MSC differentiation towards these specific lineages could result in 
alterations in their metabolism dependent upon the culture conditions and the eventual 
mature cell phenotype. The present chapter has studied the metabolism of MSCs 
during the process of osteogenic and chondrogenic differentiation, observing the 
changes in oxygen and glucose consumption and lactate production rate with time in 
culture (Figure 4.5 - Figure 4.10). 
 
Figure 4.5 illustrates the oxygen consumption rate for MSCs differentiated towards 
the chondrogenic lineage. There was a rapid reduction in cellular oxygen consumption 
for chondrogenic and control pellets from day 0 till day 7, although there was found to 
be no significant differences in the consumption rate after day 7. The reduction in 
oxygen consumption until day 7 in culture may be attributed to the culture 
environment for chondrogenic differentiation. MSCs are cultured in a pellet, enabling 
interactions between the cells to initiate the differentiation process. This pattern 
remained upon correction of per cell oxygen consumption for oxygen ingress 
(Appendix A.3; Figure A.13). In addition, MSC chondrogenesis after initial pellet 
formation (day 0) did not result in significant differences in glucose consumption and 
lactate production rate between culture points and pellet cultures (Figure 4.7 - Figure 
4.8). The fact that there was no significant difference in the consumption rates of 
oxygen and glucose and lactate production rate between chondrogenic and control 
pellets, shows that the culture system was the key to the altered metabolic phenotype 
rather than differentiation per se. The fact that the culture medium contained the anti-
oxidant, selenium, that may have contributed to the chondrogenic process, through 
reducing the amount of ROS generation within the culture medium (Ebert et al., 
2006).  
 
Analysis of the utilisation of glycolysis and oxidative phosphorylation showed that on 
both days 7 and 21, chondrogenic MSCs had a predominantly glycolytic metabolism 
with minimal oxidative phosphorylation (Figure 4.11/Appendix A.3; Figure A.15). 
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The reduction in oxygen consumption for MSCs cultured within the pellet system 
contributed to this effect, which means that the majority of the oxygen consumed may 
not be associated with oxidative phosphorylation (Table 4.2/Appendix A.3; Table 
A.4). The high levels of glycolysis may also be due to the high glucose concentration 
in the chondrogenic medium and potentially, the generation of hypoxia within the 
pellet culture system (Malladi et al., 2006). Semenza et. al. (1994) and Rajpuorhit et. 
al. (1996) showed that hypoxic environments stimulate the expression of glycolytic 
enzymes, initiating chondrogenesis and maintaining the survival of chondrocytes 
through glycolytic metabolism. Each of these contributory factors during the initial 
stages of chondrogenesis enabled the stimulation of genes associated with the 
chondrogenic lineage such as SOX-9, collagen type II and aggrecan (Lefebvre and 
Crombrugghe, 1998; Kulyk et al., 2000; Akiyama et al., 2002).  
 
Expansion of chondrocytes in monolayer results in an increase in oxygen consumption 
with time in culture and therefore greater utilisation of oxidative phosphorylation 
(Heywood and Lee, 2008). The present investigation shows the opposite effect, as 
initially, MSCs have a high rate of oxygen consumption but subsequently reduce their 
consumption upon differentiation, although it does not reduce to the rates obtained for 
mature chondrocytes at early time points in monolayer culture. Therefore, the culture 
conditions and expression of genes associated with glycolysis enables the MSCs to 
have a predominantly glycolytic metabolism without the requirement for oxygen 
consumption during chondrogenic differentiation.  
 
In contrast, osteogenic differentiation of MSCs maintained the mixed metabolism 
described for proliferative MSCs, as they consume oxygen and produce lactate during 
their differentiation process (Figure 4.6/Appendix A.3; Figure A.14 and Figure 4.10). 
This clarifies the initial observations for osteoblasts cultured under normoxia, 
whereby these cells demonstrate aerobic glycolysis or the Warburg effect (Borle et al., 
1960a; Borle et al., 1960b; Cohn and Forscher, 1962; Felix et al., 1978). However, 
comparison of the oxygen consumption during osteogenic and chondrogenic 
differentiation shows that there was a significant reduction in oxygen consumption 
during chondrogenic differentiation. Thus, the metabolism of MSCs changes 
dependent upon the differentiation conditions, in a manner that reflects the metabolic 
phenotype of the mature cells. This is displayed through analysis of the oxygen 
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consumption corrected data for chondrogenic (Appendix A.3; Figure A.13) and 
osteogenic (Appendix A.3; Figure A.14) cultures. Initially at day 0, there was no 
significant difference in oxygen consumption for all cultures. However, proceeding 
from this time point, significant differences were displayed between chondrogenic and 
osteogenic cultures but not with their respective controls. Furthermore, comparison of 
their respective controls showed significant differences between them and therefore, 
indicating that the culture conditions may have influenced the metabolism of the 
mature cell phenotype and thereby the differentiation process.  
 
In comparison with osteogenic control cultures, there was a significant reduction in 
lactate production and oxygen consumption from day 7 onwards during culture 
(Figure 4.6 and Figure 4.10). However, corrected consumption data demonstrated 
higher oxygen consumption rates for osteogenic cultures that did not significantly 
alter during culture or in comparison with control cultures (Appendix A.3; Figure 
A.14). The reduction in lactate production rate during osteogenic culture indicates a 
reduction in the utilisation of glycolysis compared with oxidative phosphorylation for 
cellular ATP production. Analysis of the proportions of glycolysis and oxidative 
phosphorylation utilised for ATP production showed that there were similar 
proportions in both control and osteogenic cultures (Figure 4.11), although 
calculations using corrected oxygen consumption data revealed a significant increase 
in ATP generation via oxidative phosphorylation for osteogenic cultures compared to 
its control (Appendix A.3; Figure A.15) In both cases, comparisons with chondrogenic 
pellets demonstrated a significant enhancement in the utilisation of oxidative 
phosphorylation during osteogenic differentiation at the time points analysed. 
  
Previous investigations have shown that there was a significant increase in oxygen 
consumption upon differentiation towards the osteogenic lineage compared with 
undifferentiated MSCs (Chen et al., 2008). Prior to correcting for oxygen ingress, the 
present investigation showed that undifferentiated MSCs had a more active 
metabolism compared with osteogenic cultures, although studies analysing mature 
osteoblasts showed that oxygen consumption was estimated to be approximately 22.8 
fmol/hr/cell, similar to the results obtained in the present chapter, 31.7 + 7.4 
fmol/hr/cell after 21 days in culture (Smith et al., 1973). However, upon correction for 
oxygen ingress (Appendix A.3; Figure A.14), osteogenic cultures showed 
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substantially increased consumption rates (Day 21 - 98.1 fmol/hr/cell) and were found 
to be similar to the oxygen consumption rates described by Komorova et. al. (2000) 
for rat osteoblasts under similar culture conditions. The glucose consumption and 
lactate production rates after 21 days in culture were also found to correlate with data 
obtained from previous investigations (Komarova et al., 2000). 
 
The observation that MSCs differentiated towards the osteogenic lineage had a 
significantly increased requirement for oxygen consumption compared with 
chondrogenic MSCs, could help to explain the inhibition of osteogenic differentiation 
upon culture under hypoxia, as they are unable to meet their requirements for 
osteogenic differentiation at the earliest time points (Warren et al., 2001; Salim et al., 
2004; Malladi et al., 2006; d'Ippolito et al., 2006a). These studies have demonstrated 
that the early osteogenic marker, Runx-2, is inhibited under hypoxic conditions and 
therefore the resulting osteogenic gene cascade does not occur. Chen et. al. (2008) 
showed that enzymes associated with glycolysis are not expressed in osteogenic 
cultures compared with proliferating MSCs. Thus, inhibition of osteogenic 
differentiation under hypoxia may be partially associated with the inherent 
metabolism of the cells. 
 
A factor not taken into account within these previous studies is the effect of individual 
differentiation components on the measured metabolic parameters during both 
chondrogenesis and osteogenesis.  Dexamethasone is a hormone utilised in the 
differentiation processes of chondrogenesis and osteogenesis (Table 1.2). However, 
dexamethasone has been shown to have effects on cellular oxygen and glucose 
consumption (Garcia et al., 2003; Roussel et al., 2004; Desquiret et al., 2008). Garcia 
et. al. (2003) showed that treating neutrophils with dexamethasone resulted in 
increased glucose consumption and reduced lactate production, which may be 
indicative of increased ATP production via oxidative phosphorylation. However, 
studies assessing the effects of dexamethasone on hepatocyte oxygen consumption 
showed that oxygen consumption was increased in its presence, although the 
efficiency of ATP generation from oxidative phosphorylation was reduced and there 
was greater proton leak from the mitochondria (Roussel et al., 2004; Desquiret et al., 
2008). It should be noted that the effects of dexamethasone are cell-dependent and 
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may be induced into different effects dependent upon the culture system and medium 
components.  
 
An example of this phenomena, is the effect of TGF-s on cellular metabolism 
(Thannickal and Fanburg, 1995; Nowak and Schnellmann, 1996b; Herrera et al., 
2001; Herrera et al., 2004; Yoon et al., 2005; Black et al., 2007). Lung epithelial cells 
and hepatocytes upon treatment with TGF- induce ROS generation derived from 
increased mitochondrial membrane potential and leads to premature senescence and 
apoptosis in these cell types (Thannickal and Fanburg, 1995). In contrast, renal kidney 
cells treated with TGF-displayed increased glucose consumption and lactate 
production, along with a significant reduction in oxygen consumption (Nowak and 
Schnellmann, 1996b). It should be noted that the concentrations used in these studies 
were similar to that used for stimulation of MSC chondrogenesis. It may be 
hypothesized that MSC response to the presence of TGF- may have resulted in the 
latter effect and may have been an additional cause for chondrogenic differentiation 
due to its stimulation of the glycolytic pathway. Its presence within chondrogenic 
medium may also act to suppress the metabolic effects resulting from dexamethsone. 
In contrast, dexamethasone may have enabled osteogenic differentiation through 
stimulating increased oxidative phosphorylation and ROS production that have been 
shown to be required for osteogenesis (Heng et al., 2004; Chen et al., 2008). This 
latter observation is relevant upon analysis of Figure A.15 (Appendix A.3) that 
utilised the oxygen corrected data, as there were significant differences in oxidative 
phosphorylation ATP generation between osteogenic MSCs and its control sample, 
which may be related to the presence of dexamethasone in osteogenic medium. 
 
Further to these components, the presence of L-ascorbic acid-2-phosphate within the 
medium helps in the stimulation of collagen synthesis in both osteogenic and 
chondrogenic differentiation, although it has also been shown to induce greater 
oxidative phosphorylation for renal proximal cells and growth plate chondrocytes 
(Shapiro et al., 1991; Nowak and Schnellmann, 1996a). L-ascorbic acid-2-phosphate 
has been used in culture medium as its degradation produces L-ascorbic acid or 
ascorbate and has been found to be a more stable compound compared to ascorbate, 
that has been directly added to the culture medium (Nowak and Schnellmann, 1996a). 
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The presence of ascorbate acts as a scavenger for ROS products and protects the cells 
from DNA damage resulting from its production. This latter point may be influential 
in terms of chondrogenic differentiation of MSCs, although it needs to be seen what 
effects it has within the present culture system. -glycerophosphate is utilised within 
osteogenic medium to stimulate mineralisation of MSCs towards the osteogenic 
lineage, although previous investigations have shown that its helps to increase 
mitochondrial membrane potential, allowing increased oxygen consumption and 
subsequent ATP generation via oxidative phosphorylation and ROS generation for 
induction of signalling pathways (Klein et al., 1993). In order to ascertain the effects 
of each of these components on MSC metabolism, each of these components need to 
be assessed individually within the medium to assess their effects on cellular 
metabolism. 
 
Sodium azide was the only metabolic modulator utilised within these studies, as the 
investigation primarily studied the underlying metabolism during differentiation and 
so only an assessment of estimated ATP production generated from oxidative 
phosphorylation and glycolysis was required. Therefore, analysis of the total cellular 
oxidative capacity using CCCP was not required. Furthermore, there would have been 
difficulty in obtaining an adequate signal for the oxygen consumption derived from 
the chondrogenic pellets using CCCP. In the present investigation, two chondrogenic 
pellets were required per well to obtain an adequate signal, which was also difficult to 
assess in certain cases. A method that may be utilised to assess chondrogenic 
differentiation using CCCP would be to enzymatically degrade the pellet and then 
measure oxygen consumption from these cells, although chondrogenic markers need 
to be used to assess their point of differentiation prior to assessment using this 
method. 
 
The differentiation of MSCs towards the chondrogenic lineage was confirmed through 
toluidine blue staining and quantitative analysis of GAGs within the pellet (Figure 
4.13 and Figure 4.14). During chondrogenic differentiation of MSCs, the number of 
cells within the pellet reduces with time in culture, as indicated in previous studies 
(Figure 4.12) (Wang et al., 2005). MSCs differentiated within chondrogenic medium 
resulted in significant amounts of GAG production within the pellet compared with 
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control cultures on days 14 and 21 in culture (Figure 4.13). This was further 
confirmed through analysis of toluidine blue stained MSC pellets (Figure 4.14).  
 
In terms of MSC differentiation towards the osteogenic lineage, alkaline phosphatase 
enzyme activity and alizarin red staining were used to confirm the differentiated 
phenotype (Figure 4.16 and Figure 4.17). Alkaline phosphatase is a well-characterised 
marker for osteogenic differentiation (Jaiswal et al., 1997; Peter et al., 1998; Mendes 
et al., 2004; Song et al., 2009). Alkaline phosphatase is an enzyme involved during 
the process of bone mineralisation, specifically cleaving the phosphate groups 
secreted within unmineralised tissue. In vitro osteogenesis requires the presence of -
glycerophosphate to act as a substrate for the alkaline phosphatase to enable bone 
formation, although L-ascrobic acid-2-phosphate and dexamethasone enhance the 
enzymatic activity (Cheng et al., 1996; Peter et al., 1998; Mendes et al., 2004; Song et 
al., 2009).  However, alkaline phosphatase is known to be present in many tissues 
such as the liver and kidney, apart from being a marker of osteogenic differentiation. 
Figure 4.16 shows that the osteogenic MSC samples had a significant increase in 
alkaline phosphatase activity compared with control cultures, indicating 
differentiation towards the osteogenic lineage. This observation was confirmed 
through staining of calcium deposition after 21 days in culture with alizarin red, 
whereby osteogenic cultures stained for these deposits (Figure 4.17). 
 
The present investigation shows that the metabolism of MSCs alters during 
differentiation towards specific cell lineages and that oxygen consumption and 
oxidative phosphorylation may be required for ostogenic differentiation, whereas 
glycolysis and minimal oxygen consumption is associated with chondrogenic 
differentiation. The cultured oxygen tension could either inhibit or enhance 
differentiation of MSCs towards specific lineages, due in part to the initial metabolic 
requirements for their differentiation. This forms the basis of the final experimental 
chapter of this thesis.  
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5 INFLUENCE OF OXYGEN TENSION ON THE 
PROLIFERATION AND DIFFERENTIATION OF 
MSCs 
5.1 Introduction 
The oxygen tension within the bone marrow has been measured to be approximately 
4-7% oxygen (section 1.5.1). Expansion of MSCs under normoxic culture conditions 
has been shown to result in premature senescence after approximately 11 population 
doublings (Moussavi-Harami et al., 2004). Recent studies have shown that culturing 
MSCs under physiological hypoxia (2-5% oxygen) results in increased MSC 
proliferation and cell survival (Moussavi-Harami et al., 2004; Grayson et al., 2006; 
Fehrer et al., 2007; Grayson et al., 2007). A contributory factor for the reduction in 
population doublings is the increased production of ROS under normoxia, associated 
with the utilisation of oxidative phosphorylation by cells for ATP production 
(Moussavi-Harami et al., 2004; Martin et al., 2004). The present thesis has shown that 
MSCs have a mixed metabolism, utilising both oxidative phosphorylation and 
glycolysis for their ATP production (Chapter 2 and 3). Recent studies have shown that 
MSCs expanded under  hypoxic conditions demonstrated an enhancement in lactate 
production, compared with normoxic cultures (Moussavi-Harami et al., 2004; Wang 
et al., 2005; Grayson et al., 2006). 
 
Grayson et. al. (2006) cultured MSCs on PET scaffolds under 20% and 2% oxygen 
culture conditions. Cells expanded at 20% oxygen, proliferated rapidly compared with 
cells cultured in 2% oxygen for the initial 10 days in culture. Thereafter, cells under 
both oxygen conditions showed no significant differences in cell doubling time but 
cells expanded under 2% oxygen continued to proliferate after 25 days in culture, 
whereas 20% oxygen cultures ceased proliferation. The change in population growth 
under normoxia is associated with cellular morphology (Sethe et al., 2006; Fehrer et 
al., 2007; Grayson et al., 2007). MSCs expanded in hypoxia after four passages in 
culture maintained their fibroblastic morphology, whereas MSCs cultured under 
normoxia began to develop into larger and less fibroblastic cells. A consequence of 
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the elongated proliferative phase is the greater population of viable MSCs generated in 
cultures expanded under hypoxia (Fehrer et al., 2007).  
 
The isolation of MSC colonies has been suggested to be influenced by the level of 
cultured oxygen, as hypoxic culture increased the number of cell colonies and 
therefore the cell population recovered at first passage (Lennon et al., 2001; Fehrer et 
al., 2007). In certain cases, sub-populations of MSCs have been isolated upon culture 
under hypoxic conditions (d'Ippolito et al., 2004; d'Ippolito et al., 2006a). In general, 
previous investigations have shown that hypoxia-cultured MSCs demonstrate the 
ability to maintain their multipotency with time in culture and in some cases, express 
the gene, OCT-4, that is reported to be a marker for pluripotency in ESCs (d'Ippolito 
et al., 2004; d'Ippolito et al., 2006a; Fehrer et al., 2007; Grayson et al., 2007).   
 
MSC differentiation has been shown to be affected by the cultured oxygen tension 
(section 1.5.4). Lennon et. al. (2001) showed that MSC differentiation towards the 
chondrogenic and osteogenic lineages was enhanced in the presence of hypoxic 
culture conditions compared with normoxic conditions. However, recent studies have 
shown that MSC differentiation towards the osteogenic lineage is inhibited under 
hypoxic conditions (Salim et al., 2004; Malladi et al., 2006; d'Ippolito et al., 2006a; 
Potier et al., 2007a). Previous studies have implicated the inhibited expression of 
Runx-2, as the primary reason for the non-differentiation of MSCs towards the 
osteogenic lineage under hypoxia (Salim et al., 2004; Utting et al., 2006).    
 
Hypoxia has been shown to enable differentiation towards the chondrogenic lineage 
(Lennon et al., 2001; Wang et al., 2005; Robins et al., 2005). Dedifferentiated 
chondrocytes have also been shown to redifferentiate upon culture in hypoxic 
conditions and resume their production of cartilage-specific extracellular matrix 
molecules such as collagen type II, GAGs and collagen type X (Grimshaw and 
Mason, 2000; Murphy and Sambanis, 2001a; Domm et al., 2004; Malda et al., 2004b). 
However, Malladi et. al. (2006) showed that hypoxia inhibited formation of cartilage 
matrix molecules in micromass cultures which was presumed to be associated with the 
formation of oxygen gradients.  
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Previous studies have shown the benefits of culturing MSCs under hypoxic culture 
conditions, although the methods of cell isolation and culture vary between each of 
these studies. In addition, the culture of the cells under in vitro hypoxic conditions was 
not continuous in these studies from the first point of extraction. The same limitations 
are associated with the differentiation studies, as some of the studies used 3D alginate 
beads and micromass cultures for chondrogenic studies and pellet or standard 
monolayer culture for osteogenic differentiation (Wang et al., 2005; Grayson et al., 
2006; Grayson et al., 2007). 
 
Thus, the following investigation will isolate the MSCs directly from a bone marrow 
sample and culture the cells under continuous and uninterrupted 20%, 5% and 2% 
oxygen conditions. The hypoxic conditions used in the study were 5% and 2% 
oxygen, as the former represented the oxygen tension measured within bone marrow 
(4-7% oxygen), whilst 2% oxygen represents the lower scale of hypoxia and has been 
used in previous investigations (Grant and Smith, 1963; d'Ippolito et al., 2004; Fehrer 
et al., 2007; Grayson et al., 2007).  Using the conclusions from previous 
investigations, it was hypothesized that human MSCs can undergo greater population 
doublings without concomitant senescence  upon culture under 5% and 2% oxygen 
conditions, whilst chondrogenic differentiation is enhanced under hypoxic conditions 
and osteogenic differentiation inhibited, upon culture under hypoxia.      
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5.2 Methodology 
5.2.1 Initiation of bone marrow and isolation of MSCs 
Bone marrow samples were procured from a commercial source (LonzaTM, 
Wokingham, UK). Two bone samples from male donors aged 21 and 28 were used. 
The donors had given informed consent for their cells to be used for research purposes 
prior to bone marrow extraction. The bone marrow was aspirated from two separate 
sites of the iliac crest using a 15 gauge Illinois crest bone marrow aspiration needle 
attached to a syringe containing 1000 units/ml heparin sodium solution to prevent 
clotting. The bone marrow-heparin cell suspension was transferred into a tube and 
sent to host laboratory for processing. 
 
 
 
Figure 5.1. Photograph and schematic diagram of the XvivoTM oxygen controlled culture system. 
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The tubes containing bone marrow were opened inside an XvivoTM controlled oxygen 
culture system (Figure 5.1; BiospherixTM, Redfield, New Jersey, USA). The XvivoTM 
system has two workstations or workspaces for manipulation of MSCs under 
prescribed oxygen conditions. The workstation contains a microscope and cell culture 
incubators to enable visualisation and culture of MSCs under their cultured oxygen 
level. The oxygen conditions are controlled using the Xvivo software (BiospherixTM, 
Redfield, New Jersey, USA) that monitors the oxygen and carbon dioxide levels 
through sensors inside the workspaces and culture chambers. The oxygen and carbon 
dioxide are set using the software and the levels are brought to the required levels 
using nitrogen gas. The sensitivity of the oxygen levels within the incubators and 
workstation is + 0.1%. Equipment and reagents required for the manipulation of cells 
are transferred into the workspace area through the use of buffer chambers that are 
brought down to the workspace oxygen level prior to entry into the system. The 
XvivoTM system enables manipulation of cells at appropriate oxygen conditions and 
ensures culture of cells under uninterrupted oxygen conditions.      
 
Medium for culturing of MSCs, -MEM + 8.5% FBS, was incubated at 370C/5% CO2 
with gas phase oxygen levels set at 20%, 5% and 2% oxygen. The oxygen level within 
the workspace of the BiospherixTM was set at 5% oxygen. The bone marrow-heparin 
cell suspensions were transferred into 50 ml polypropylene tubes and were centrifuged 
at 500 x g. The heparin solution was aspirated from the tubes, and bone marrow was 
resuspended in 20 ml -MEM + 8.5% FBS equilibrated at 5% oxygen using a 50 ml 
syringe with a 20G needle attached. A 20 l aliquot of cell suspension was removed 
from each bone marrow sample. A 10 l aliquot of the sample was removed and 
diluted in 990 l red blood cell lysing buffer (Sigma-Aldrich, Poole, UK). Once the 
red blood cells had become lysed, a cell count was performed using the trypan blue 
exclusion assay (section 2.2.4).  
 
The number of mononuclear cells was recorded and the bone marrow cell suspension 
was aliquoted into 75 cm2 culture flasks at a seeding density of 5 x 105 mononuclear 
cells/cm2. The flasks were randomly allocated into equal numbers of flasks for each 
oxygen tension and were fed -MEM + 8.5% FBS pre-equilibrated at either 20%, 5% 
and 2% oxygen. The flasks were labelled and placed in oxygen controlled 370C/5% 
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CO2 incubators set at the equivalent oxygen conditions. After six days of culture, the 
medium and marrow suspension was aspirated and the flasks were washed using PBS 
and replenished with oxygen equilibrated -MEM + 8.5% FBS. This initial culture 
phase has been termed passage 0 for the purposes of this thesis.              
 
5.2.2 Cell colony counting and cell numbers per colony 
The aspiration of marrow-medium suspension, allows for the visualisation of cell 
colonies on the surface of the culture flask. A cell colony was defined as a group of 
adherent cells with a fibroblastic morphology, equal or greater than 16 cells (4 
population doublings). The number and appearance of these colonies at each oxygen 
tension was monitored throughout the initial culture, prior to the first trypsinisation. 
Photomicrographs of cell colonies were taken at appropriate time periods during the 
initial phase of culture. 
 
Once the colonies had become large and heavily confluent in the centre, the flasks 
were trypsinised and the number of viable cells recovered from the flask was 
calculated using the trypan exclusion assay (section 2.2.4). The total number of cells 
within the flask was normalised to the number of colonies at the point of trypsinisation 
to calculate the number of cells per colony within each flask and at each oxygen 
tension. Cells were then seeded at a cell density of 2 x 103 cells/cm2 and these cultures 
were termed passage 1.    
 
5.2.3 Cell maintenance in monolayer culture 
Cell cultures were passaged according to the protocols described in section 2.2.3. Cell 
samples from different donors were separated to ensure no cross-contamination 
between different donors. Cell number, cell seeding density and date were recorded at 
each passage and cultures were visualised using an inverted microscope (Leica 
Microsystems GmBH, Wetzlar, Germany).  Photomicrographs of the cells were taken 
at regular intervals at each of the various oxygen tensions. All manipulation was 
performed within the Biospherix workspace to ensure an uninterrupted oxygen 
environment.    
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5.2.4 Analysis of cell population data 
The number of cells within each flask at confluence was recorded for each set of 
flasks at each of the oxygen tensions and for each donor. The population growth 
curves and doubling times for cells cultured at 20%, 5% and 2% oxygen were 
generated using the equations described in section 2.2.6. The cell population data were 
calculated separately for both donors.    
 
5.2.5 -galactosidase assay and senescence staining 
Cells after five passages were assessed for the senescence marker, -galactosidase, 
using the Senescence cells histochemical staining kit (Sigma-Aldrich, Poole, UK). 
The staining kit assesses the -galactosidase activity at pH 6 for cell cultures and was 
first used as an indicator of senescence by Dimri et. al. (1995). -galactosidase is an 
enzyme associated with the lysosomes of cells and has been shown to have increased 
expression at pH 6 amongst senescent cells and has been used as a marker for cell 
aging under defined conditions (Dimri et al., 1995b; Cristofalo, 2005). The assay 
measures the substrate produced by the -galactosidase enzyme. 
 
Table 5.1. Components of -galactosidase staining solution for staining a well in a 6-well plate. 
Reagents Volume 
Final 
concentration 
Supplier 
X-gal solution (40 mM) 0.25 ml 1 mM Sigma-Aldrich, Poole, UK 
Potassium ferricyanide (400 mM) 0.125 ml 0.5 mM Sigma-Aldrich, Poole, UK 
Potassium ferrocyanide (400 mM) 0.125 ml 0.5 mM Sigma-Aldrich, Poole, UK 
10 x Staining solution 1 ml x 1 Sigma-Aldrich, Poole, UK 
Ultrapure water  8.5 ml - - 
 
Cells trypsinised at passage 4 (section 2.2.3), were seeded at a cell seeding density of 
2 x 103 cells/cm2 into 6-well culture plates (Corning, Acton, USA). The cells were 
cultured under 20%, 5% or 2% oxygen until cells were 50-70% confluent. The 
medium was aspirated from the wells and the cells were washed twice using PBS. The 
PBS was replaced with fixation solution (20% formaldehyde and 2% glutaraldehyde) 
and incubated at room temperature for 7 minutes. A -galactosidase staining solution 
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was prepared using the components outlined in Table 5.1. The solution was filtered 
prior to staining cultures. 
   
The fixation solution was aspirated from the wells and the cells were washed three 
times with PBS. Samples were stained using 1 ml -galactosidase staining solution for 
each well of the plate and were incubated at 370C for 24 hours. The cells were 
examined under a bench-top inverted microscope to observe the number of senescent 
cells (blue stained cells). The number of cells within each well was counted and used 
to calculate the percentage of senescent cells in each well.  
 
5.2.6 Cell morphological parameters and analysis of MSC morphology 
Quantitative analysis of MSC morphology has not been performed previously despite 
observable changes in morphology being documented (Sethe et al., 2006; Fehrer et 
al., 2007; Grayson et al., 2007). The described morphology for MSCs is a small 
spindle-shaped morphology (Bruder et al., 1997; Grayson et al., 2007). Studies have 
also reported the existence of MSC sub-populations through analysis of their cellular 
morphology (Colter et al., 2000; Colter et al., 2001; Sekiya et al., 2002a). 
 
 
Figure 5.2. A diagram showing the parameters used to quantify cell shape and cell spreading. 
 
There are two main categories of quantitative measure for cell morphology: cell shape 
and cell spreading. The parameters for cell shape are shape factor and aspect ratio, 
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whilst cell spreading measurements are compactness and ferret diameter. Each of 
these parameters are measured relative to a circle. The shape factor is the ratio 
between the cell area (A) relative to its perimeter (P) (equation 5.1), whilst the aspect 
ratio is the ratio between the major axis (L1) and the minor axis (L2) (Figure 5.2).    
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The parameters that measure cell spreading are compactness and ferret diameter. The 
ferret diameter is defined as the longest distance between any two points of the cell 
(Figure 5.2). Compactness (equation 5.3) is similar to the shape factor and is a 
measure of the circularity of the cell. 
 
A
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2
                 (5.3) 
 
These parameters were used to quantify the cellular morphology and changes in MSC 
morphology with time in culture and under each oxygen condition. Prior to 
measurement of morphological parameters, an exclusion criteria was created to select 
images/cells that could or should be analysed. The exclusion criterion that was used in 
the present investigation were: - 
 
1. Cells not fully observable within the photomicrograph were not analysed. 
2. Overlapping cells are not included in the analysis. 
3. Images that contain approximately greater than 70% of cells overlapping 
were rejected. 
4. The minimum number of cells per photomicrograph to be used for 
analysis, should contain at least 5 cells. 
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Individual MSCs (cells with a fibroblastic or similar morphology) in each of the 
photomicrographs taken for each of the oxygen conditions and passage were assessed 
using SigmaScan Pro Version 5 (SYSTAT Software Inc., CA., USA). A point to point 
or tracing method was used to analyse each individual cell in the photograph. In brief, 
a trace-point to point mode was selected, to enable points to be made around the 
perimeter of a cell. Prior to calculation of parameters, the image was calibrated 
through using the scale bar attached to each individual photo by converting the 
number of pixels equivalent to the length of the scale bar into the distance the scale 
bar represents, i.e. 500 pixels represents 200 m. The perimeter of the cell was traced 
through a series of points around the cell that varied depending upon the complexity 
of the cell geometry. Once the trace was closed, values were obtained for the 
parameters described. The data collected for the shape factor, aspect ratio, ferret 
diameter, compactness and area were collected for assessment of cell morphology. 
The number of cells counted for each oxygen condition, passage and time point are 
shown in Table 5.2. Photomicrographs of cell colonies were also assessed for the 
diameter and area of individual colonies. 
 
Table 5.2. The number of cells counted for analysis of cell morphological parameters. Refer to 
Appendix A.1 for experimental results. 
Passage Number and Day time points 
P0 P1 P2 P3 P4 P5 
Expansion 
oxygen 
tension 
8 14 1 3 6 8 14 1 3 6 8 14 3 8 3 6 8 14 7 
20% 11 44 52 252 10 20 44 42 74 28 32 101 52 120 122 58 20 134 21 
5% 31 27 114 174 74 176 89 160 38 40 86 55 144 46 30 43 148 52 38 
2% 33 61 164 32 23 140 64 78 12 32 40 61 142 24 112 78 62 38 15 
 
5.2.7 Measurement of oxygen and glucose consumption and lactate 
production of MSCs 
MSCs cultured under 20%, 5% and 2% oxygen controlled conditions (370C/5% CO2) 
were examined for their oxygen and glucose consumption and lactate production at 
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passages 3 and 4 during culture. Cells were trypsinised at 80–90% confluence and a 
cell count was performed using the protocols outlined in section 2.2.3 and 2.2.4.  
 
The medium used for the oxygen consumption analysis, -MEM + 8.5% FBS, was 
equilibrated at 20% O2/5% CO2/370C prior to experimentation. Cells were 
resuspended and aliquoted into wells of the 384-well oxygen biosensor plate and 
separate 384-well plates at a volume of 130 l that corresponded to 1.5 x 105 
cells/well. In addition, MSCs expanded at each oxygen condition were resuspended in 
medium containing 10 mM sodium azide and were prepared in the same manner.  
 
The oxygen consumption of the cells expanded at different oxygen conditions was 
assessed using the methods described in section 2.2.9 with 0.1 M sodium sulphite 
(Sigma-Aldrich, Poole, UK) and cell-free medium samples acting as controls for the 
experiment. The biosensor plate was sealed with a sterile plate sealer and placed in a 
fluorometer set to read the fluorescence under incubator (370C) conditions. The 
fluorescence was measured at an excitation wavelength of 485nm and emission 
wavelength of 590nm. Oxygen consumption and per cell consumption rates were 
calculated using the protocols described in section 2.2.10. Medium was removed from 
384-well plates at 1, 2, 4 and 6 hour time points and stored at -200C prior to analysis, 
along with cell-free medium controls. The glucose consumption and lactate 
production within the samples were measured using the glucose and lactate assays 
outlined in section 2.2.11. The rates of glucose consumption and lactate production 
were calculated as described in the stated section.   
      
5.2.8 Osteogenic culture of MSCs 
Cells expanded at 20%, 5% and 2% oxygen were trypsinised at passage 2 and seeded 
at a density of 2 x 103 cells/cm2 into the wells of 6-well and 12-well culture plates 
(Corning, Acton, USA) and placed within incubators at their expansion oxygen 
tension. The cells were allowed to attach to the well plate for 24 hours. Medium was 
removed from a set of wells in each culture plate and replaced with osteogenic 
medium (section 2.2.7.1). Osteogenic medium was pre-equilibrated at the appropriate 
oxygen tension prior to feeding MSCs cultured at 5% and 2% oxygen. The cells were 
replenished every 2-3 days with osteogenic medium, whilst a set of cultures at 20% 
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oxygen were fed with -MEM + 8.5% FBS. The 6-well culture plates were used for 
the analysis of calcium deposition using alizarin red staining technique (section 
2.2.7.1). The 12-well plates were utilised for analysis of alkaline phosphatase enzyme 
activity using the protocol detailed in section 4.2.5 for each oxygen tension. 
 
Further to the experiments in this study, cells pre-cultured at 20% and 2% oxygen 
were seeded at 2 x 103 cell/cm2 into 6-well and 12-well cell culture plates. Cells were 
allowed to attach and then cells expanded at 20% oxygen were incubated and 
differentiated at 2% oxygen, whilst cells expanded at 2% oxygen were incubated and 
differentiated at 20% oxygen. Controls for these studies were cells differentiated at 
their expansion oxygen tension and cells pre-cultured at either 2% or 20% oxygen 
were expanded in proliferation medium at their pre-cultured oxygen tension (section 
2.2.1). 
  
5.2.9 Chondrogenic culture of MSCs 
MSCs expanded to passage 2 at 20%, 5% and 2% oxygen were trypsinised upon 
reaching 80-90% confluence using the protocol described in section 2.2.3. The 
number of cells was counted using the trypan blue exclusion assay (section 2.2.4) and 
cell pellets were prepared as described in section 2.2.7.3. The cell pellets were 
incubated at their cultured oxygen tension with control chondrogenic medium pre-
equilibrated at the relevant oxygen tensions (20%, 5% or 2% oxygen) and 
supplemented with TGF-3 before replenishing medium for chondrogenic pellets. The 
pellets were allowed to form during a 24 hour period and then transferred into fresh 15 
ml polypropylene tubes for the remaining time in culture. A further set of pellet 
cultures at 20% oxygen were fed control chondrogenic medium. 
 
Representative pellets for each oxygen tension were removed on days 1, 7, 14 and 21 
for GAG and DNA analysis using the protocol described in section 4.2.4. The pellets 
were digested in the presence of papain and stored frozen at -200C prior to analysis. 
Representative pellets from each oxygen tension were also removed for Toluidine 
blue staining after 21 days in culture (section 2.2.7.3).  
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5.2.10 Statistical analysis 
The comparison of colony number, cell number and cells per colony were assessed 
within their respective donor. Comparisons were made using single-factor ANOVA 
(= 0.05). If there was significance within the data (p < 0.05), then post-hoc Student 
t-test with Bonferroni correction was applied. Per cell oxygen and glucose 
consumption and lactate production rates, GAG deposition and cell number within 
chondrogenic pellets, alkaline phosphatase activity and the proportion of senescent 
cells for each oxygen condition were assessed between their respective oxygen culture 
conditions using the method described. Statistical comparisons between population 
doubling time and oxygen tension for each respective donor were assessed using two-
factor ANOVA (= 0.05) and if there was significance (p < 0.05), the same post-hoc 
test was used. 
 
Cell morphology parameters were assessed using non-parametric methods due to the 
number of cells for each group of data (Table 5.2) and after assessing the normality of 
the data. Comparisons for each parameter between passages were tested for 
significance using Kruskal-Wallis test (= 0.05). If there was significance within the 
data (p < 0.05), then a Mann-Whitney U-test was applied to check for significant 
groups.  
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5.3 Results 
5.3.1 Colony formation and cell morphology 
 
 
Figure 5.3. Representative photomicrographs of colonies formed under (a) 20%, (b) 5% and (c) 
2% oxygen conditions on day 8 of culture.   
 
Human bone marrow procured from a commercial source (Lonza, Wokingham, UK) 
was used to isolate human MSCs and cultured at either 20%, 5% or 2% oxygen. The 
initial isolation was conducted within a controlled oxygen environment set at 5% 
oxygen and cells were seeded at 5 x 105 cells/cm2 into 75 cm2 cell culture flasks. The 
flasks were randomly selected for culture at either 20%, 5% or 2% oxygen for the 
duration of the investigation unless required for experimentation.  
 
Analysis on day 6 of culture, revealed the presence of colonies at each of the oxygen 
tensions. A colony was assumed to have derived from a single cell (Figure 5.3). The 
number of colonies in each flask at each of the various oxygen tensions was 
determined during the duration of culture until the first passage.  Figure 5.4 shows that 
(a) (b) 
(c) 
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there was no significant difference in the number of colonies formed at 20% and 2% 
oxygen, whereas there was a significant decrease in the number of colonies formed at 
5% oxygen for both donors (Student t-test; p < 0.05). However, the number of cells 
recovered at P0 (Figure 5.5) was significantly greater at 20% oxygen compared with 
5% and 2% oxygen for both donors (Student t-test; p < 0.05).  
 
 
Figure 5.4. The number of colonies present for donor A ( )  and B ( ) upon culture under 20%, 
5% and 2% oxygen. Data represent mean + S.D., donor A [n=4] and donor B [n = 3]; Bonferroni 
corrected student t-test: * p< 0.05. 
 
Normalising the number of cells recovered upon trypsinisation to the colony number 
generated a new parameter, cells per colony. The greatest number of cells per colony 
was recovered for cells cultured at 20% oxygen for both donors (Figure 5.6). There 
was no significant difference in the number of cells per colony for donor B (single-
factor ANOVA; p > 0.05), although a trend towards fewer cells per colony under 5% 
or 2% oxygen conditions compared with culture under 20% oxygen was apparent. 
There was a significant reduction in the number of cells per colony in donor A for the 
2% and 5% oxygen culture groups relative to cells expanded at 20% oxygen (Student 
t-test; p < 0.05).  
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Figure 5.5. The number of MSCs recovered at P0 from donors A ( ) and B ( ) cultured at 
varying oxygen tension. Data represent mean + S.D., donor A [n = 4] and donor B [n = 3]; 
Bonferroni corrected student t-test: * p< 0.05. 
 
Figure 5.6. The number of cells/colony recovered at P0 for donor A ( ) and B ( ) for MSCs 
cultured under varying oxygen tension. Data represent mean + S.D., donor A [n = 4] and donor B 
[n = 3]; Bonferroni corrected student t-test: * p< 0.05. 
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Figure 5.7. The diameter of MSC colonies cultured at 20%, 5% and 2% oxygen. Data represent 
median + inter-quartile range for n = 6; Mann-Whitney U-test: * p< 0.05. 
 
The size of the colonies produced at 20% and 5% oxygen was greater than those at 2% 
oxygen (Figure 5.7). There was found to be a significant difference in the diameter of 
the colonies, between those formed at 2% oxygen compared with 5% and 20% oxygen 
(Mann-Whitney U-test; p < 0.05). Assessment of the cell morphology showed that 
under each of the oxygen tensions, most MSCs displayed a typically fibroblastic 
morphology. However, further examination of the cultures revealed the presence of 
rounded cell morphologies, indicative of a mixed cell population. Analysis of the 
cellular morphology (Appendix A.1; Figure A.1) within the colonies shows that cells 
cultured under 2% oxygen were significantly different for the measured parameters 
compared with 5% and 20% oxygen (Mann Whitney U-test; p < 0.05).  There was 
found to be no significant difference between MSCs cultured at 5% and 20% oxygen 
for each of the morphological parameters (Mann-Whitney U-test; p > 0.05). 
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5.3.2 Cell morphology and population growth characteristics 
MSCs expanded under each oxygen tension had no significant differences in terms of 
their morphological parameters (Appendix A.1; Figures A.2 - A.6), both between 
passages 1-4 and between oxygen tension at each passage (Kruskal-Wallis; p > 0.05). 
The quantitative data show that the morphology of the cells became more 
homogeneous with time in culture under each oxygen condition. Subsequently, there 
was found to be no significant difference for each morphological parameter between 
expanded MSCs compared with P0 MSCs for each oxygen condition (Kruskal-Wallis; 
p > 0.05). Representative photomicrographs are presented in Figure 5.8. 
   
The cell proliferation data were initially calculated as a function of the cumulative cell 
number with time in culture for both donors A and B. At P1, the number of cells from 
initial culture was greatest for cells at 20% oxygen with 2% oxygen containing the 
fewest number of cells (Figure 5.5). The cumulative population growth curve 
normalised to cells recovered at day 1, represents a fold increase from that point and 
indicates that cells grown under 20% oxygen proliferated at a faster rate compared 
with cells cultured under 5% and 2% oxygen for both donors (Figure 5.9).  
 
The cumulative growth curve produced for both donors A and B suggests an 
exponential growth, which once plotted on a logarithmic scale produces a polynomial 
curve that may be illustrated by a linear relationship between time fold increase on the 
semi-log plot (Figure 5.10). Cells cultured at 5% and 2% oxygen culture had a longer 
lag phase compared with 20% oxygen cultures before commencing their exponential 
phase. A plateau phase was not observed in the investigation, due to the cell culture 
not proceeding beyond five passages.  
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Figure 5.8. Representative photomicrographs of cells cultured at P1 day 5 (a-c) and P4 day 3 (d-
f). Cells were cultured at 20% oxygen (a, d), 5% oxygen (b, e) and 2% oxygen (c, f). 
 
 
(a) 
(b) 
(c) 
(e) 
(f) 
(d) 
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Figure 5.9. Cumulative population growth curve with respect to cumulative fold increase in cell 
population for human MSCs during time in culture under varying oxygen conditions for (a) 
donor A [20% ( )  5% ( ), 2% ( )] and (b) donor B [(20% ( ), 5% ( ) and 2%( )].  
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Figure 5.10. Population growth curve in terms of potential number of human MSCs during time 
in culture post P0 under varying oxygen conditions for (a) donor A [20% ( )  5% ( ), 2% 
( )],  and (b) donor B [20% ( ), 5% ( ) and 2%( )]. Doubling rates are shown in Table 5.3. 
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Table 5.3. The cell doubling times for cells grown under 20%, 5% and 2% oxygen conditions 
derived from Figure 5.10 for human MSCs from donors A and B. 
Population doubling time (hours) 
20% 5% 2% Passage  
A B A B A B 
P1 99.13 + 20.3 72.3 + 8.3 143.9 + 13.2 99.3 + 12.9 164.4 + 21.7 169.2 + 20.5 
P2 137.5 + 25.8 80.9 + 5.1 134.6 + 29.4 146 + 10.9 156.4 + 22.5 184.2 + 34.5 
P3 139.6 + 7.5 154.4 + 30.9 146.9 + 6.9 159.9 + 19.8 165.4 + 37.8 133.8 + 13.1 
P4 161.6 + 14.6 190.0 + 33.0 143.8 + 7.7 147.8 + 24.4 134.3 + 7.3 143.6 + 6.6 
 
 
Figure 5.10 illustrates the potential number of cells that could be acquired following 
expansion at 2%, 5% and 20% oxygen using the number of cells obtained at first 
trypsinisation (data from Figure 5.5) as the time zero starting point. The data suggest a 
greater number of cells may be obtained at 20% oxygen compared with 5% or 2% 
oxygen. The cell doubling time was calculated between passages 1-4, using the 
formula described in section 2.2.6 (Table 5.3). A general trend shown in both donors 
is that population doubling time at passage 1 was significantly shorter for MSCs 
cultured at 20% oxygen, compared with 5% and 2% oxygen (Student t-test; p < 0.05). 
However, cells expanded at 20% oxygen significantly increased their population 
doubling time with each subsequent passage during the culture period (Student t-test; 
p < 0.05). There were no significant differences in the population doubling time 
between each of the three oxygen conditions at passage 3 for donor B and passage 2 
for donor A (2-factor ANOVA; p > 0.05). Cells expanded under 5% oxygen showed 
no significant differences in population doubling time between passages 2-4 in 
culture, whilst MSCs expanded at 2% oxygen showed no significant differences in 
doubling time throughout the course of culture (2-factor ANOVA; p > 0.05).  
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5.3.3 Oxygen and glucose consumption and lactate production of human 
MSCs grown under 20%, 5% and 2% oxygen 
 
 
Figure 5.11. The per cell oxygen consumption rate for human MSCs pre-cultured at 20%, 5% 
and 2% oxygen. Data represent mean + S.D. of n = 6; Bonferroni corrected student t-test: * p< 
0.05. Corrected data are presented in Appendix A.3, Figure A.16. Donor data are presented in 
Appendix A.4, Figure A.18a. 
 
Oxygen and glucose consumption and lactate production rates were measured for 
MSCs at passages 3 and 4 following culture at 20%, 5% and 2% oxygen. The results 
for the oxygen consumption rate (Figure 5.11) indicate that there was a significant 
increase in the consumption rate for cells expanded at 20% oxygen compared with 5% 
and 2% oxygen cultures (Student t-test; p < 0.05). There was no significant difference 
in the consumption rate between cells expanded at either 5% or 2% oxygen (Student t-
test; p > 0.05). The corrected consumption rates are described in Figure A.16 
(Appendix A.3) and show the same patterns described in Figure 5.11. Furthermore, 
the data from donor A and B were grouped together, as there was no significant 
difference (Student t-test; p > 0.05) in oxygen consumption rate between the donors 
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for each oxygen tension in either the corrected or uncorrected consumption rate data 
(Appendix A.4, Figure A.18).   
 
 
Figure 5.12. The per cell glucose consumption ( ) and lactate production rate ( ) for human 
MSCs pre-cultured at 20%, 5% and 2% oxygen. Data represent mean + S.D. of n = 6; Bonferroni 
corrected student t-test: * p< 0.05. Donor data are presented in Appendix A.4, Figure A.19. 
 
In terms of the glucose consumption and lactate production rate (Figure 5.12), cells 
expanded at 20% oxygen had a significantly lower glucose consumption compared 
with cells expanded at 2% oxygen (Student t-test; p < 0.05). MSCs expanded at 20% 
oxygen had a significantly reduced lactate production rate compared with the lowered 
oxygen conditions (Student t-test; p < 0.05). However, MSCs expanded at 5% and 2% 
oxygen had no significant differences with regards to both their glucose consumption 
and lactate production rates (Student t-test; p > 0.05). A comparison between the 
donors shows no significant difference in either glucose consumption or lactate 
production rate (Student t-test; p > 0.05) between the donors for each expansion 
oxygen tension (Appendix A.4; Figure A.19). The presence of sodium azide in the 
medium induced a significant reduction in the MSC oxygen consumption rate for each 
oxygen condition (Table 5.4). However, there was no significant difference in the 
MSC glucose consumption and lactate production rate between cultures with or 
without the presence of sodium azide for each pre-expanded MSC oxygen tension 
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(Student t-test; p > 0.05). Table A.5 in Appendix A.3 shows that data corrected for 
oxygen ingress demonstrated significant increases in absolute values for per cell 
oxygen consumption rate under each oxygen tension with or without the presence of 
sodium azide, although there were no changes in statistical differences. Furthermore, 
data presented in the form of their respective donor demonstrated similar patterns with 
or without the presence of sodium azide for both corrected and uncorrected oxygen 
consumption data (Appendix A.4; Tables A.6 - A.9) and repeated the statistical 
differences described for Table 5.4. 
 
Table 5.4. Oxygen and glucose consumption and lactate production rate of human MSCs pre-
expanded at 20%, 5% and 2% oxygen with or without the presence of 10 mM sodium azide. Data 
represent mean + S.D. of n = 6.  Corrected data presented in Appendix A.3, Table A.5. Donor 
data are presented in Appendix A.4, Tables A.6 and A.7. 
Oxygen consumption 
rate/cell 
(fmol/hr/cell) 
Glucose consumption 
rate/cell (fmol/hr/cell) 
Lactate production rate/cell 
(fmol/hr/cell) 
Expansion 
oxygen 
tension 
Control 
Sodium 
azide 
Control 
Sodium 
azide 
Control 
Sodium 
 azide 
20% 69.7 + 8.8 19.4 + 5 225.4 + 41.4 182.1 + 42.7 649.52 + 109 686.9 + 156.6 
5% 33.2 + 3.0 14.4 + 2.3 262.4 + 53.3  235.3 + 27 783.7. + 173 734.9 + 234.8 
2% 41.6 + 10.4 16.6 + 1.7 328.8 + 47.4 321.1 + 41.8 874.4 + 132.8 863.52 + 186.8 
  
The oxygen and glucose consumption rate data from Table 5.4, were used to estimate 
the proportions of oxidative phosphorylation and glycolysis utilised for MSC ATP 
production under each oxygen tension as described in section 3.4 (Figure 5.13). The 
results show that cells expanded at 20% oxygen had greater ATP production (30%) 
through oxidative phosphorylation, than cells expanded at 5% and 2% oxygen, which 
had a greater proportion of ATP production (~ 90%) through glycolysis. These 
utilisations change when using the corrected oxygen consumption data (Appendix 
A.3, Table A.5), as cells expanded at 20% oxygen derived 35% of their total ATP 
production from oxidative phosphorylation whilst cells expanded at 5% and 2% 
oxygen only generated ~ 15% of their total ATP production from the same process 
(Appendix A.3; Figure A.17). Analysis of separated donor data demonstrated the same 
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relationships described, utilising either uncorrected oxygen (Appendix A.4, Figure 
A.20) or corrected oxygen (Appendix A.4, Figure A.20) consumption data. 
 
 
Figure 5.13. A representative graph showing the estimated proportions of ATP production 
generated from oxidative phosphorylation ( ) and glycolysis ( ) for cells pre-cultured under 
20%, 5% and 2% oxygen conditions. Estimations based on corrected data are shown in Appendix 
A.3, Figure A.17. Donor data are presented in Appendix A.4, Figure A.20. 
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5.3.4 -galactosidase assay and senescence staining 
 
 
Figure 5.14. Representative photomicrographs of unstained (a-c) and stained (d-f) senescent cells 
cultured under 20% (a, d); 5% (b, e) and 2% (c, f) oxygen at passage 5. 
 
 
(f) 
(d) 
(b) (e) 
(c) 
(a) 
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Figure 5.15. The percentage of senescent cells at passage 5 cultured under 20%, 5% and 2% 
oxygen conditions. Data represent mean + S.D. of n = 6; Donor A ( ) and Donoe B ( ); 
Bonferroni corrected student t-test: * p< 0.05. 
 
Passage 5 MSCs expanded under oxygen tension for both donors were seeded into 6-
well culture plates, to enable assessment of cellular senscence. The data from the 
cumulative population growth curves (Figure 5.9), suggest that the cells had 
undergone approximately 10 population doublings up to passage 5. Cells cultured at 
20% oxygen had a larger and more flattened morphology compared with cells cultured 
at 2% and 5% oxygen, which maintained their fibroblastic morphology (Figure 5.14).  
 
Analysis of cell morphological parameters demonstrated that the area and diameter of 
MSCs (Appendix A.1; Figure A.7) expanded for five passages at 20% oxygen had 
significantly increased compared to 5% and 2% oxygen cultures (Mann-Whitney U- 
test; p < 0.05).  A greater proportion of cells cultured at 20% oxygen stained for -
galactosidase, which was associated with the increased presence of larger and 
flattened cell morphologies under these conditions (Figure 5.15). This was found to be 
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significant compared with cultures expanded at 2% and 5% oxygen for both donors 
(Student t-test; p < 0.05). 
         
5.3.5 Chondrogenic differentiation of MSCs under varying oxygen tension 
 
 
Figure 5.16. Cell number for chondrogenic pellets expanded and differentiated at 20%, 5% and 
2% oxygen conditions. Data represent mean + S.D. of n = 6; 20% control [-TGF-3] ( ), 20% 
[+TGF-3] ( ), 5% ( ) and 2% ( ) oxygen conditions. 
 
The chondrogenic differentiation of MSCs was examined for cells expanded under 
each of the oxygen tensions and subsequently differentiated in pellet culture under the 
same oxygen tension. Analysis of the DNA content of the pellets revealed a reduction 
in cell number during the differentiation process that was similar under all oxygen 
conditions (Figure 5.16). However, none of the differences were found to be 
significant (single-factor ANOVA; p > 0.05).  
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Figure 5.17. A graph showing the change in GAG/DNA in chondrogenic pellets expanded and 
differentiated under 20% control [-TGF-3] ( ) 20%  [+TGF-3]( ), 5% ( ) and 2% ( ) oxygen 
conditions. Data represent mean + S.D. of n = 6; Bonferroni corrected student t-test: * p< 0.05.  
Control cultures were significantly different to 20% (+TGF-3 treated), 5% and 2% cultures at 
each time point (*p < 0.05). Donor data are presented in Appendix A.4, Figure A.22. 
 
Analysis of the GAG/DNA data revealed that all the cells within the pellets 
differentiated towards the chondrogenic lineage under their respective oxygen 
tensions as shown by an increase in GAG content with time in culture (Figure 5.17). 
There were no significant differences in the GAG/DNA for each of the oxygen 
tensions at each time point (single-factor ANOVA; p > 0.05), although the control 
values were significantly reduced (Student t-test; p < 0.05). Separation of data in 
terms of donor, demonstrated the same statistical differences within donors and 
similar relationships to that shown in Figure 5.17 (Appendix A.4; Figure A.22). The 
staining of the chondrogenic pellets shows that the GAGs were present around the 
periphery of the pellets for each oxygen condition (Figure 5.18).  
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Figure 5.18. Representative photomicrographs of chondrogenic MSC pellets stained for GAG 
deposition using toluidine blue for MSC pellets expanded and differentiated under (a) 20% 
control (-TGF-3), (b) 20% (+TGF-3), (c) 5% and (d) 2% oxygen conditions after 21 days in 
culture.  
(d) (c) 
(b) (a) 
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5.3.6 Osteogenic differentiation of MSCs under varying oxygen tension 
The osteogenic differentiation of MSCs expanded under 20%, 5% and 2% oxygen 
levels was initially assessed by differentiation at their expansion oxygen tension. 
Figure 5.19 shows that MSCs expanded and differentiated at 20% oxygen exhibited 
enhanced alkaline phosphatase activity compared to 5% and 2% oxygen conditions. 
There were no significant differences in alkaline phosphatase activity between 
samples expanded and differentiated at 5% or 2% oxygen, or when compared with 
control conditions at each time point (single-factor ANOVA; p > 0.05). Separation of 
the dara in terms of their respective donors demonstrates the same relationships and 
statistical differences described in Figure 5.19 (Appendix A.4; Figure A.23).  
 
 
Figure 5.19. Alkaline phosphatase activity of human MSCs pre-cultured and differentiated in 
ostoeogenic medium under 20%, 5% or 2% oxygen conditions. Data represent mean + S.D. of n = 
6; 20% control ( ), 20% osteogenesis ( ), 5% osteogenesis ( ) and 2% osteogenesis ( ). 
Donor data are presented in Appendix A.4, Figure A.23. 
 
A further marker for MSC osteogenic differentiation is alizarin red staining to show 
the presence of calcium deposits (Figure 5.20). Cells cultured at 20% oxygen showed 
the presence of calcium deposition after 21 days in culture, whereas control, 5% or 2% 
oxygen cultures showed no calcium deposition. 
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Figure 5.20. Representative photomicrographs of osteogenic cultures stained for calcium 
deposition using alizarin red for cells cultured under (a) 20% control , (b) 20%, (c) 5% and (d) 
2% oxygen conditions after 21 days in culture. 
 
 
 
(a) (b) 
(c) (d) 
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Figure 5.21. Alkaline phosphatase activity for human MSCs pre-cultured under 20% and 2% 
oxygen and differentiated in osteogenic medium under either 20% or 2% oxygen. Data represent 
mean + SEM of n = 6; 20%-20% oxygen control ( ) 20%-20% ostegenic ( ), 20-2% osteogenic 
( ), 2-2% control ( ),  2%-2% osteogenic ( ) and 2-20% osteogenic( ). 
 
A further investigation involved cells expanded at either 2% or 20% oxygen that were 
subsequently differentiated at both 2% and 20% oxygen. Cells expanded at 20% 
oxygen exhibited alkaline phosphatase activity above basal levels irrespective of the 
differentiation conditions, although activity was greatest for cells differentiated at 
20% oxygen in osteogenic medium (Figure 5.21). Limited activity was detected at day 
14 for cells differentiated at 2% oxygen and levels were lower than for the control 
condition at 20% oxygen. None of the cells expanded at 2% oxygen expressed 
appreciable alkaline phosphatase activity under any of the differentiation conditions 
assessed. Appreciable alizarin red staining was only observed in cells expanded at 
20% oxygen and differentiated under the same oxygen conditions in osteogenic 
medium (Figure 5.22).  
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Figure 5.22. Representative photomicrographs of osteogenic cultures stained for calcium 
deposition using alizarin red staining for cells pre-cultured under 20% (a, b) or 2% oxygen (c, d) 
and differentiated under either 20% oxygen (a, c) or 2% oxygen (b, d) after 21 days in culture.  
(a) (b) 
(c) 
20%             20% 
(d) 
2%              20% 
    20%               2% 2%              2% 
Expansion                   Differentiation 
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5.4 Discussion 
The present study investigated the effect of hypoxic (5% oxygen and 2% oxygen) 
conditions on the proliferation and differentiation of human bone marrow-derived 
MSCs. Previous investigations have utilised only one oxygen condition and compared 
with normoxic (20% oxygen) conditions. However, the present investigation 
evaluated all three oxygen conditions including normoxia to compare the proliferation 
and differentiation characteristics of MSCs. In addition, the cells in the present 
investigation were continuously cultured under their present oxygen due to the use of 
an oxygen controlled workstation and culture environment. 
 
Grayson et. al. (2006) and Fehrer et. al. (2007) showed that the number of colonies 
produced at 3% and 2% oxygen were significantly greater when compared to 
normoxic culture. The present study showed that the number of colonies formed under 
5% oxygen was significantly lower compared with colonies formed at 20% and 2% 
oxygen conditions. Moreover, the current data suggesting no difference in colony 
number between 20% and 2% oxygen is contradictory to previously reported data 
(Figure 5.4). It should be noted that the current and previous investigations used 
different methodologies for identification and counting of colonies (DiGirolamo et al., 
1999; Grayson et al., 2006). However, the current results from both donors were 
produced through random selection of culture flasks upon initial plating of human 
bone marrow, thus there was no bias in the data obtained. 
 
Whilst there was no significant difference in the number of colonies formed at 2% and 
20% oxygen, the size of the colonies were significantly smaller at 2% oxygen (Figure 
5.7). In correlation with this finding, the number of cells isolated after the colonies 
had become confluent at 2% oxygen was significantly lower compared with 5% and 
20% oxygen cultures for both donors (Figure 5.5). Normalising the cell population 
with the number of colonies within the flask resulted in the same pattern, as the 
number of cells per colony was significantly greater at 20% oxygen compared with 
5% and 2% oxygen cultures (Figure 5.6). Further analysis of the cell morphology 
parameters revealed that cells cultured at 2% oxygen had a more rounded morphology 
and were larger in size compared with 5% and 20% oxygen cultures, thus resulting in 
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the lower cell population isolated from 2% oxygen cultures despite a similar number 
of colonies to normoxic cultures (Appendix A.1; Figure A.1).  
 
Cells cultured at 5% oxygen were not significantly different for various cell 
morphological parameters compared to 20% oxygen cultures at P0, although the range 
of values for the measured parameters, indicates that in both 5% and 2% oxygen, sub-
populations of cells are generated that are not present in 20% oxygen cultures. Table 
1.1 shows the different types of cell populations generated from investigations 
associated with MSC isolation from the bone marrow. In the majority of cases, flow 
cytometry has been used to isolate these sub-populations. The culture conditions may 
also have a major input in their isolation. In particular, MIAMI cells were isolated 
through cell culture at 3% oxygen. The present investigation observed that within 
certain colonies, specifically at 2% oxygen and partially at 5% oxygen, a smaller 
fibroblastic morphology was observed, compared with cells cultured at normoxia that 
contained a greater proportion of cells with a larger spindle-shaped and fibroblastic 
morphology. The described cells correlate with the morphology described for 
recycling stem cells (RS-1 and RS-2) (Colter et al., 2000). However, the present study 
did not isolate specific colonies within the initial cultures but pooled the cells upon 
trypsinisation. The clonal expansion of specific colonies from the initial culture would 
help to characterise these presumed sub-populations that are produced upon culture at 
5% and 2% oxygen and also enable determination of cell multipotency for these 
specific cell clones (Muraglia et al., 2000).  
 
The range of cell morphologies generated from the initial colonies indicates the mixed 
cell population described in many previous MSC studies (Haynesworth et al., 1992b; 
Majumdar et al., 2000). However, MSC expansion under each oxygen condition 
resulted in a more homogeneous cellular morphology with time in culture and there 
was found to be no significant difference in the morphological parameters between 
passages 1-4 (Appendix A.1; Figures A.2 - A.6). Morphologically, the cells were 
similar under each oxygen condition. 
 
The data obtained from the morphological parameters contained limitations, related to 
the image quality and data acquisition from the images. In terms of image quality, 
there were areas of the images with varying resolution and contrast, resulting in 
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difficulties analysing individual cells. Furthermore, the images were taken at different 
points within different culture flasks and thus may have resulted in a sample 
population of cells being assessed, which may not be indicative of the whole cell 
population. In particular, cell overlap was prevalent in images taken of cell within 
colonies or P0 cells and so only certain cell morphologies were assessed. These latter 
limitations may be rectified through clonally expanding the cells from initial colony 
formation. Clonal expansion would enable isolation of separate colonies and allow 
these colonies to be cultured separately, thereby enabling an assessment of the 
different morphologies produced under each oxygen condition. This technique may 
also be used for other MSC characteristics as described later within this discussion.   
 
The acquisition of data from the photomicrographs had its limitations due to the 
software being unable to detect and normalise for brightness, meaning that if the cell 
had a varying brightness from one part of the cell to the other, it could not recognise a 
dark area due to a cell being present or if it was only a dark part of the image. A lot of 
noise was detected using the software due to the fact that certain intensity bands 
correlated with a ‘cell’. The use of the trace method reduced the presence of noise and 
assessments of the raw data enabled exclusion of these data. To overcome these 
limitations regarding data acquisition, fluorescent dyes may be used on a set of cells 
and thus enable staining of single cells that would help acquire data of greater 
accuracy. This would also help to utilise more sophisticated image analysis techniques 
such as colour intensity filtering to recognise single cells and reduce noise produced 
from the analysis.  
 
Despite similar cellular morphology under each oxygen tension, the expansion of the 
cells was significantly different for the described culture conditions. It should be noted 
that the two donors differ in their expansion rate with donor B exhibiting a more rapid 
expansion (Figure 5.9, Figure 5.10 and Table 5.3). These data demonstrate the donor 
to donor variation that has been described in various studies both in terms of MSC 
proliferation and differentiation (Jaiswal et al., 1997; Bruder et al., 1997; Majumdar et 
al., 2000). However, the differences described for the various oxygen conditions were 
consistent for each donor, in spite of the variability in absolute expansion rate. 
Moreover, comparison of the population growth data, specifically for MSCs at 20% 
oxygen with MSCs procured from a commercial source (Lonza, Wokingham, UK) 
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described in chapter 2, reveals a significant difference between cells derived from 
fresh bone marrow, described in this chapter and the pre-cultured MSCs shown in 
chapter 2 (Table 2.8). However, cell population doubling times for MSCs cultured 
under normoxia within this chapter were found to be comparable to  a previous study, 
that expanded MSCs from initial bone marrow isolation under normoxia (Campbell et 
al., 2005). 
     
MSCs expanded under normoxia had a significant reduction in their population 
doubling time compared with 5% and 2% oxygen cultures at passage 1. The doubling 
time significantly increased with time in culture, resulting in no significant difference 
between the culture conditions at passages 2-4 (Table 5.3). The increased population 
doubling time with passage at 20% oxygen suggests that the cells may have 
approached their population doubling limit after five passages in culture. Moussavi-
Harami et. al. (2004) showed that human MSCs transfected with human telomerase 
reverse transcriptase (hTERT), had a population doubling limit of 11 population 
doublings. The current investigation did not expand the cells beyond passage five and 
did not examine the full proliferative potential of MSCs under the various oxygen 
conditions. However, previous investigations have shown that MSCs cultured under 
hypoxia, proliferate for a longer period compared with normoxia, despite the latter 
conditions generating greater MSC populations during the initial phases of culture 
(Grayson et al., 2006). The proliferation growth curves for both donors A and B 
during these cultures in the present investigation correlate with these previous studies 
(Figure 5.9 and Figure 5.10).  
 
The increased population doubling time for cells cultured at 20% oxygen could 
indicate that the cells are undergoing premature senescence. The presence of senescent 
cells within the cell populations was assessed after five passages using the -
galactosidase assay. The assay has its limitations, although many authors have used 
the assay to indicate the presence of senescent cells (Dimri et al., 1995b; Cristofalo, 
2005). In addition to using the assay, the cell morphology parameters were assessed 
for the cells at the indicated passage (Appendix A.1; Figure A.7). 
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There were greater populations of senescent MSCs present upon culture at 20% 
oxygen, approximately 20%, whereas under hypoxia (5% or 2% oxygen), only 5-10% 
of cells expressed the senescence marker (Figure 5.15). In conjunction with the 
proliferation growth curves, these data suggest that culture at 20% oxygen produces 
greater cell numbers for a shorter period of time compared with hypoxia, although a 
greater proportion of these cells are senescent after five passages or approximately 10 
population doublings, which may retard further expansion beyond this stage.  The 
cells cultured at 20% oxygen exhibited a flattened morphology, with a significantly 
larger area and diameter compared with cells cultured under hypoxia that maintained 
their fibroblastic morphology at passage five (Appendix A.1; Figure A.7). The change 
in cell shape is consistent with senescence and may be associated with increased 
volume of the cytoplasm through accumulation of degraded organelles and 
lysomomes (Robbins et al., 1970). Cells cultured at 2% or 5% oxygen retained a 
similar population doubling time from passages 1-4 and did not demonstrate 
alterations in morphology nor the significant presence of -galactosidase, suggesting a 
lack of senescence. Accordingly, these findings suggest that MSCs cultured under 
hypoxia are able to undergo greater population doublings with minimal premature 
senescence. 
 
The increased cellular senescence of MSCs cultured under 20% oxygen may be 
primarily associated with the cultured oxygen tension and the generation of ROS. The 
present thesis has shown that MSCs have a mixed metabolism and utilise both 
glycolysis and oxidative phosphorylation pathways for their ATP production (Chapter 
2). However, the consumption of oxygen and therefore utilisation of oxidative 
phosphorylation leads to ROS generation which has been shown to induce premature 
senescence (Moussavi-Harami et al., 2004; Martin et al., 2004).   
 
The present investigation showed that cells expanded at 20% oxygen had a 
significantly greater oxygen consumption rate compared with 5% and 2% oxygen 
expansion, which had significant increases in glucose consumption and lactate 
production rates (Figure 5.11/Appendix A.3; Figure A.16 and Figure 5.12). Thus, the 
increased utilisation of oxidative phosphorylation for MSCs cultured under normoxia, 
may have contributed to the increased senescence (Figure 5.13/Appendix A.3; Figure 
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A.17). The production of ROS was not measured in the present investigation, although 
previous studies show that culturing cells under normoxia, induces greater ROS 
production (Moussavi-Harami et al., 2004; Martin et al., 2004). MSCs cultured at 5% 
and 2% oxygen utilise glycolysis for a greater proportion of their ATP production 
with a reduced requirement for oxygen consumption and oxidative phosphorylation. 
However, the current data do show that MSCs utilise oxidative phosphorylation 
during expansion in low oxygen conditions, albeit at a lower level compared to 20% 
oxygen conditions and therefore maintain a mixed metabolism during expansion. The 
higher level of glycolysis displayed by MSCs under hypoxia correlates with results 
from previous investigations (Wang et al., 2005; Grayson et al., 2006; Follmar et al., 
2006; Mischen et al., 2008). 
 
MSCs cultured under hypoxia may proliferate for a longer period comparative to 
normoxia due to a reduction in cellular senescence, although the data presented in this 
chapter suggest that cells cultured under these conditions take longer to reach a 
required number of cells. This needs to be borne in mind during the development of 
tissue engineering strategies and may suggest a greater applicability of hypoxic 
expansion for allogeneic rather than autologous approaches. However, a primary 
importance with regards to their application is that the cells maintain their 
multipotentiality.  
 
The present investigation cultured MSCs until passage two prior to differentiation 
under their proliferation conditions for assessment of differentiation towards the 
osteogenic and chondrogenic lineage. Cells expanded at 20% oxygen had the ability to 
differentiate to both osteogenic and chondrogenic lineages at 20% oxygen. In the case 
of osteogenic differentiation, alkaline phosphatase activity was significantly increased 
compared with control cultures (Figure 5.19).  Osteogenesis was further demonstrated 
by alizarin red staining that indicated the presence of calcium deposits after 21 days in 
culture (Figure 5.20b). The presence of GAGs within cell pellets cultured in 
chondrogenic medium and the positive staining of the extracellular matrix for these 
macromolecules, compared with control cultures, showed that MSCs had 
differentiated towards the chondrogenic lineage (Figure 5.17 and Figure 5.18b).  
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However, the data obtained for MSCs expanded and differentiated under 5% and 2% 
oxygen cultures demonstrates differences in multipotentiality compared to 20% 
oxygen conditions or normoxia. Hypoxia has been shown in previous studies to 
enhance chondrogenic differentiation of MSCs, particularly through expression of the 
early chondrogenic marker, SOX-9 (Lennon et al., 2001; Wang et al., 2005; Robins et 
al., 2005). The present study measured the amount of GAGs within the cell pellets of 
MSCs differentiated under each oxygen condition. Pellets cultured under all 
conditions demonstrated a loss in cell number with time in culture (Figure 5.16). 
These findings have also been shown in previous studies using MSCs differentiated 
towards the chondrogenic lineage and may be associated with cell death towards the 
centre of the pellet (Wang et al., 2005). There was no significant difference in the 
amount of GAGs produced between MSCs differentiated under each oxygen condition 
(Figure 5.17). Wang et. al. (2005) showed similar results, as there was no significant 
difference in proteoglycan deposition between cells cultured at 20% or 5% oxygen. 
However, there was evidence that matrix molecules such as collagen did significantly 
increase upon culture at 5% oxygen, which correlates with previous investigations and 
may be associated with earlier SOX-9 expression that controls expression of collagen 
genes associated with chondrogenesis (Murphy and Sambanis, 2001b; Domm et al., 
2002; Malda et al., 2004b; Robins et al., 2005). A recent study has shown that the 
expression of various chondrogenic genes was not significantly enhanced under 
hypoxia compared with normoxic cultures (Pilgaard et al., 2009a).  
 
The findings indicate that MSCs expanded under hypoxia have the ability to 
differentiate towards the chondrogenic lineage, under their expansion conditions. The 
expression of chondrogenic genes under hypoxia may be associated with the pellet 
culture system that enables the stimulation of a glycolytic metabolism via the 
expression of HIF-1 (Schipani et al., 2001; Schipani, 2005).  HIF-1 has been 
shown to control the metabolism of cells under hypoxia, specifically promoting the 
expression of genes associated with glycolysis and their associated enzymes 
(Rajpurohit et al., 1996; Semenza, 2000; Seagroves et al., 2001). Thus, the 
combination of hypoxia and the basal metabolism may enable chondrogenic 
differentiation under hypoxic conditions.  
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However, the opposite effects were reported for osteogenic differentiation of MSCs, 
as cells expanded and differentiated under hypoxia did not show either calcium 
deposition or elevated alkaline phosphatase activity (Figure 5.19 and Figure 5.20). 
The implication from the initial investigation was that MSC expansion under low 
oxygen inhibited differentiation towards the osteogenic lineage, correlating with 
previous studies (Warren et al., 2001; Arnett et al., 2003; Salim et al., 2004; d'Ippolito 
et al., 2006a; Potier et al., 2007a). Tuncay et. al. (1994) showed that osteoblasts had 
inhibited collagen synthesis and alkaline phosphatase activity upon culture under 10% 
oxygen but recover their normal levels once placed under normoxia. The same 
phenomenon has been shown for MSCs expanded under hypoxia, whereby they are 
able to differentiate towards the osteogenic lineage upon culture at 20% oxygen 
(Lennon et al., 2001; d'Ippolito et al., 2004; Fehrer et al., 2007; Grayson et al., 2007). 
 
A further investigation showed that cells expanded under normoxia and then 
differentiated under 2% oxygen, failed to exhibit osteogenic differentiation, as there 
was no alizarin red staining for calcium deposits and minimal alkaline phosphatase 
activity (Figure 5.21 and Figure 5.22). However, differentiation of these MSCs under 
normoxia induced differentiation towards the osteogenic phenotype. Cells expanded at 
2% oxygen, did not express indicators of osteogenic differentiation upon culture at 
either 20% or 2% oxygen. The reason for the MSCs not differentiating towards the 
osteogenic lineage under low oxygen conditions for cells expanded at either 20% or 
2% oxygen may be associated with the inhibition of osteogenic-specific genes such as 
Runx-2 (Warren et al., 2001; Park et al., 2002; Salim et al., 2004; Potier et al., 
2007a). A further explaination for the inhibited osteogenesis may be the inherent 
metabolism during differentiation. The present thesis and previous studies have shown 
that MSCs  have a mixed metabolism with oxidative phosphorylation contributing to 
the energy production during differentiation (Komarova et al., 2000; Chen et al., 
2008). As previously discussed for chondogenic differentiation, HIF-1 is expressed 
under hypoxia and therefore genes associated with glycolysis are expressed, thus 
reducing the oxygen consumption of MSCs. Thus, the expression of HIF-1 may 
prevent osteogenic differentiation through control of the cellular metabolism. Recent 
evidence has suggested that the expression of HIF-1 inhibits Runx-2 expression and 
the associated cascade of osteogenic genes (Warren et al., 2001; Salim et al., 2004). 
                                                                   Chapter 5: Influence of oxygen tension on MSCs   
 - 206 -  
Most significantly, the last part of the investigation shows that MSCs isolated and 
expanded under low oxygen conditions do not show the ability to differentiate towards 
the osteogenic lineage under normoxia (20% oxygen), which is contradictory to 
studies showing that MSCs maintain their multipotency under these conditions 
(d'Ippolito et al., 2004; Fehrer et al., 2007; Grayson et al., 2007). It should be noted 
that in some of the previous studies that have observed differentiation towards the 
osteogenic lineage, MSCs have been differentiated using either pellet cultures or 3D 
constructs rather than a monolayer culture (Lennon et al., 2001; Grayson et al., 2006; 
Grayson et al., 2007). Thus, MSCs cultured under hypoxia have the ability to 
differentiate towards lineages associated with hypoxic tissues, specifically cartilage in 
the present investigation. This phenomenon may be associated with the selection of 
chondroprogenitors, potentially at the earliest colony-forming stage of expansion (Xu 
et al., 2007). 
 
Indeed, Xu et. al. (2007) showed similar results to the present investigation using 
adipose-derived MSCs and showed that hypoxia enabled the isolation of 
chondroprogenitors with reduced osteogenic capacity. The present thesis has shown 
that colonies derived from hypoxia and normoxia had distinct colony-forming 
characteristics and a range of cell morphologies within different colonies. Thus, 
various sub-populations could be selectively derived, with continuous hypoxic culture 
resulting in MSCs with the ability to differentiate towards the chondrogenic lineage 
only, whereas normoxic cultures resulted in a greater percentage of MSCs with the 
ability to differentiate towards the osteogenic lineage. The latter observation is 
supported by clonal expansion studies, whereby a large percentage of MSCs (80%) 
could differentiate towards the osteogenic lineage (Muraglia et al., 2000). In addition, 
studies have utilised different cell culture conditions, such as fibronectin coated 
dishes, for culturing MSCs with differing multipotentiality (d'Ippolito et al., 2004). 
Therefore, future investigations may choose to analyse sub-populations of MSCs 
isolated under hypoxia with clonal expansion used to investigate the differentiation 
potential of MSCs derived from each oxygen condition.  
 
The present investigation shows that MSCs cultured under hypoxia are able to 
proliferate for a greater number of population doublings without cells becoming 
senescent compared with normoxia. However, culturing MSCs under these conditions, 
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results in cells that can differentiate towards the chondrogenic lineage but do not 
exhibit the capacity for osteogenic differentiation.  
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6 FINAL DISCUSSION 
Tissue engineering applications for the regeneration of tissues often require a 
substantial population of cells (section 1.1). It has been estimated that within the bone 
marrow, approximately 0.001% of its total population are MSCs. Isolation and 
expansion of MSCs using standard culture techniques has been used to generate the 
requisite number for tissue engineering applications, such as the repair of cartilage and 
bone defects. It may be estimated that for a small cartilage defect, approximately 5 x 
106 cells are required, which may be obtained after 10 population doublings. In terms 
of a similar sized bone defect, 8 x 106 cells may be required and therefore 11 
population doublings are needed. However, it has been shown in previous 
investigations that MSCs have limited expansion under normoxic conditions due to 
the phenomenon of cellular senescence (Pittenger et al., 1999; Moussavi-Harami et 
al., 2004). Furthermore, the multipotency of MSCs has been shown to be reduced at 
later population doublings (Muraglia et al., 2000). In terms of repairing tissue defects, 
a single autologous cell transplantation would require cell numbers described above, 
but a greater population of cells is required for off-the-shelf or allogeneic treatments.  
 
MSCs reside in vivo at oxygen tensions between 4-7% oxygen (Grant and Smith, 
1963; Kofoed et al., 1985). In relation to the expansion of MSCs, previous studies 
have shown that upon culture under hypoxia, MSCs are able to proliferate for a 
greater number of population doublings compared with normoxic cultures without 
concomitant increases in senescence at later population doublings (Wang et al., 2005; 
Grayson et al., 2006; Fehrer et al., 2007; Grayson et al., 2007; Xu et al., 2007). 
Furthermore, these studies showed that hypoxia-expanded MSCs maintained their 
multipotency at later population doublings. However, differentiation towards the 
osteogenic lineage has been shown to be inhibited under hypoxia (Muraglia et al., 
2000; Warren et al., 2001; Salim et al., 2004; Malladi et al., 2006; d'Ippolito et al., 
2006a; Potier et al., 2007a). Studies have also shown varying results in terms of the 
effect of oxygen tension on chondrogenesis, although it should be noted that different 
oxygen conditions were utilised in each of these studies (Lennon et al., 2001; Wang et 
al., 2005; Malladi et al., 2006; Xu et al., 2007; Pilgaard et al., 2009a).  
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A reason for the differences in MSC proliferation and differentiation under hypoxia 
may be associated with their inherent energy metabolism. In the case of MSC 
differentiation, changes in cellular metabolite consumption are associated with the 
mature cell phenotype and the differentiation conditions. Furthermore, previous 
studies did not culture MSCs under continuous and uninterrupted oxygen and different 
oxygen conditions were used in each study. The present thesis has focussed on the 
metabolism of MSCs during proliferation and differentiation, whilst the final 
experimental chapter of the thesis, assessed the effect of continuous and uninterrupted 
oxygen tension on the proliferation and differentiation of MSCs. The present chapter 
outlines the key findings from the thesis leading to hypothesized mechanistic 
pathways associated with the metabolism, proliferation and differentiation of MSCs. 
This provides the basis of future investigations derived from the present thesis. 
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6.1 Metabolism and proliferation of MSCs  
6.1.1 MSC metabolism for cells expanded under normoxia 
Investigations assessing the metabolism of MSCs expanded under normoxia have 
focussed primarily on their glucose consumption and lactate production (Wang et al., 
2005; Grayson et al., 2006; Follmar et al., 2006; Mischen et al., 2008). These studies 
have assumed that the cells have a predominantly glycolytic metabolism, although the 
culture of cells within 3D systems has been shown to result in poor cell viability 
within the central regions of the construct that may be related to the oxygen tension 
(Muschler et al., 2004; Malda et al., 2004a; Heywood, 2005). This observation 
indicates that MSCs may also utilise oxygen for their energy production and survival. 
However, investigations based upon these earlier studies have assessed the effect of 
glucose concentration on MSC proliferation and differentiation potential (Blazer et al., 
2002; Stolzing et al., 2006; Li et al., 2007). These studies showed that MSCs, cultured 
under high glucose had inhibited expansion and differentiation potential, due to 
increased cellular senescence. Cellular senescence has been shown to be related to 
ROS production, which is a by-product of oxidative phosphorylation that utilises 
oxygen consumption for ATP production (Moussavi-Harami et al., 2004; Martin et 
al., 2004; Heywood and Lee, 2008). The present thesis assessed the oxygen 
consumption of MSCs, alongside measurements of glucose consumption and lactate 
production to develop a detailed metabolic profile for MSCs expanded under 
normoxia.  
 
Chapter 2 showed that alongside glucose consumption and lactate production, MSCs 
consumed oxygen for their ATP production, which shows that MSCs have a mixed 
metabolism utilising both oxidative phosphorylation and glycolysis (Figure 2.10 - 
Figure 2.12). The rates of oxygen and glucose consumption and lactate production 
were shown not to significantly change with time in culture and shows that this mixed 
metabolism continued throughout the period of culture (Table 2.9/Appendix A.3; 
Table A.1 - Table 2.11). However, despite indications of a mixed metabolism, a larger 
proportion of ATP production is derived from glycolysis (86%/ corrected data, 69.1%) 
compared with oxidative phosphorylation (14%/ corrected data, 30.1%), although the 
full oxidative capacity was not utilised for this process (Table 3.9 and Table 3.10). 
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These further analyses were conducted through the use of metabolic modulators that 
provided an indication of the oxygen utilisation of various metabolic processes 
(Chapter 3). The finding that there was a substantial proportion of the oxidative 
capacity kept in reserve suggests that MSCs have an ability to increase their utilisation 
of oxidative phosphorylation when required. This was demonstrated through the use 
of the glucose inhibitor, 2-Deoxy-D-glucose, that resulted in increased oxygen 
consumption and therefore ATP production via oxidative phosphorylation (Figure 
3.7). These data indicate that MSCs have an ability to adapt their metabolism 
dependent upon the culture conditions. This observation may be relevant to 3D culture 
environments which may contain regions with depleted glucose and oxygen 
environments (Follmar et al., 2006; Mischen et al., 2008; Mylotte et al., 2008).  
  
The mixed metabolism displayed by MSCs during expansion under normoxia and 
therefore the utilisation of oxidative phosphorylation, may contribute to the cellular 
senscence displayed in the previous studies associated with changes in glucose 
environment (Blazer et al., 2002; Stolzing et al., 2006; Li et al., 2007). This has led to 
studies utilising hypoxia for MSC expansion to observe whether a reduced utilisation 
of oxidative phosphorylation enables MSCs to expand for a greater number of 
population doublings, although a similar effect may occur within 3D constructs due to 
cellular metabolite consumption and diffusion distance (Muschler et al., 2004; Malda 
et al., 2004a; Heywood, 2005).    
 
6.1.2 MSC proliferation and metabolism under hypoxia 
Previous studies have found that expansion of MSCs under hypoxic conditions 
resulted in greater population doublings compared with normoxia-expanded MSCs 
(Grayson et al., 2006; Fehrer et al., 2007; Grayson et al., 2007). Furthermore, the 
initial colony formation of MSCs and various stem cell types is also influenced by the 
cultured oxygen tension, including the isolation of sub-populations derived from these 
colonies (d'Ippolito et al., 2004; d'Ippolito et al., 2006a; Fehrer et al., 2007). The latter 
finding suggests that a more primitive sub-population of MSCs may be derived with 
culture under hypoxia. To investigate the effects of continuous and uninterrupted 
oxygen, we isolated MSCs from human bone marrow aspirates through attachment 
under normoxia and hypoxia and then expanding these cells under the same 
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conditions. Initially, there was a significant reduction in the number of colonies 
isolated under 5% oxygen compared with 2% and 20% oxygen (Figure 5.4). However, 
MSCs isolated under normoxia had greater numbers of cells and cells per colony 
compared with hypoxia (Figure 5.5 and Figure 5.6). The greater MSC population 
isolated under normoxia, resulted in a faster doubling rate for first passage MSCs 
compared with first passage hypoxic cultures. However, between each oxygen 
condition, there was no significant difference in doubling time after two passages in 
culture, although there are potentially greater numbers of cells under normoxia due to 
the initial phase of culture (Figure 5.10). The growth curves obtained from the current 
investigation are similar to previous investigations (Grayson et al., 2006). MSCs 
cultured under normoxia displayed significant increases in population doubling time 
with each subsequent passage (Table 5.3). This observation indicates that the cells had 
begun to age or approach their population doubling limit. This results in cellular 
senescence and is in agreement with previous studies  (DiGirolamo et al., 1999; 
Stenderup et al., 2003). The present investigation has shown that there was a greater 
proportion of senescent cells after five passages under normoxia compared with 
hypoxic culture (Figure 5.15). These findings suggest that MSCs can potentially 
undergo greater population doublings under hypoxic culture.  
 
The increased cellular senescence may be associated with the underlying metabolism 
of the cells. MSCs cultured under normoxia demonstrated a mixed metabolism 
utilising both oxidative phosphorylation and glycolysis for their ATP production. 
However, MSCs cultured under hypoxia showed a significant reduction in oxygen 
consumption rate (Figure 5.11/Appendix A.3; Figure A.16) and an increase in their 
rate of lactate production (Figure 5.12) compared with normoxic cultures. To 
determine whether there was an increase in oxidative phosphorylation, the metabolic 
modulator, sodium azide, was used to determine whether there was an increase in 
oxidative phosphorylation for normoxic cultures. It was demonstrated that there was a 
significant reduction in oxidative phosphorylation following hypoxic expansion 
compared with normoxia-cultured MSCs (Figure 5.13/Appendix A.3; Figure A.17). 
Previous investigations have described that an increase in oxidative phosphorylation 
increases the rate of ROS generation (Moussavi-Harami et al., 2004; Martin et al., 
2004). The ability of MSCs to expand for greater population doublings under hypoxia 
may be beneficial for tissue engineering purposes, particularly the creation of 
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allogeneic cell sources. However, the mechanisms for premature senescence under 
normoxia are only partially explained by the underlying metabolism.  
 
 
Figure 6.1. A schematic diagram describing the factors controlling and consequences of MSC 
proliferation under hypoxic and normoxic culture conditions. Processes derived from the current 
thesis (-) and processes requiring further investigation or derived from previous studies (------). 
 
Figure 6.1 describes a possible mechanism for cellular senescence, based upon the 
findings of the present thesis, associated with cell proliferation and metabolism. The 
model also describes preventative measures of senescence under normoxia that are 
based upon previous investigations. The consumption of oxygen and thereby the 
process of oxidative phosphorylation and ROS generation has been implicated in 
cellular senescence, although these processes are also controlled by the stimulation of 
specific genes. An indicator of cell senescence is p53, which is expressed as the cells 
approach their population doubling limit. A further gene implicated in the process of 
senescence is p16 (Bahta et al., 2008). The gene is expressed when cells undergo 
senescence associated with environmental conditions, particularly the oxygen tension 
surrounding the cells. The genes controlling senescence were not examined in the 
present thesis and further studies should observe whether they are a potential cause of 
senescence and if they can be inhibited during expansion.  
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In each of the metabolic studies (Chapters 2 and 5) involving MSC expansion under 
normoxia, lactate was produced by the cells, despite the presence of high levels of 
oxygen. This phenomena has been described as the Warburg effect (Krebs, 1972). 
Previous studies have revealed a relationship between cellular metabolism and HIF-
1 (Semenza, 2000). Hypoxia prevents degradation of HIF-1, enabling the gene to 
translocate the nucleus and combine with HIF-1, initiating the activation of genes 
associated with glycolysis (Semenza, 2000; Kondoh et al., 2005; Henrotin et al., 
2005; Kondoh et al., 2007). The genes activate enzymes controlling anti-oxidants  
(e.g. superoxide dismutase) that reduce the impact of ROS generation and oxidative 
stress on cells, particularly under normoxia (Kondoh et al., 2005; Kondoh et al., 
2007). However, ROS production results in HIF-1 hydroxylation, leading to 
degradation and inactivation of the gene (Safran and Kaelin Jr., 2003).  The removal 
of HIF-1 has been shown to inhibit cell growth under hypoxia, indicating its 
importance in controlling glycolysis (Seagroves et al., 2001). Forristal et. al. (2009) 
showed that removal of HIF-1 inhibited cellular proliferation for human ESCs, thus 
indicating its importance in the survival of various stem cell types. Further 
examination of the role of HIF-1 induction and the cascade of genes associated with 
glycolysis should be performed to observe its influence on the underlying mechanisms 
for the survival of MSCs. 
 
The proliferation studies showed that despite the potentially greater population 
doublings achieved under hypoxia, greater numbers of MSCs may be achieved 
through normoxic culture over the first 20 days of expansion. A method to achieve 
greater population doublings under normoxia, through replicating hypoxia, may be to 
use either pharmacological agents or anti-oxidants. Pharmacological agents such as 
cobalt chloride, help to mimic hypoxia through stimulation of HIF-1 (Ren et al., 
2006) and potentially enables greater utilisation of glycolysis by MSCs under 
normoxia without the need to culture the cells under hypoxia. Anti-oxidants help to 
reduce the amount of ROS within cultures, thereby reducing cell senscence and 
enhancing MSC expansion to meet the cell numbers required for tissue engineering 
applications. An example of an anti-oxidant that may be studied is selenium (Ebert et 
al., 2006). 
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The greater number of population doublings that MSCs undergo during culture under 
hypoxia influences their multipotency. Previous investigations have shown that MSCs 
cultured under normoxia lose their multipotency with time in culture (Muraglia et al., 
2000). However, expansion under hypoxia, enables maintenance of MSC 
multipotency during subsequent culture under normoxia (d'Ippolito et al., 2004; 
Grayson et al., 2006; Fehrer et al., 2007; Grayson et al., 2007). On the other hand, 
MSC differentiation towards the chondrogenic and osteogenic lineage under hypoxia 
has yielded conflicting results (section 1.6.5). The reasons for the different responses 
may be associated with the underlying metabolism of the cells during differentiation, 
alongside the expression of different genes and extracellular matrix markers. This has 
consequences in terms of the creation of tissues from stem cells within 3D culture 
environments, as cellular metabolism may influence the differentiation of MSCs and 
therefore the quality of tissue formed. 
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6.2 MSC differentiation and metabolism under normoxia and 
hypoxia 
6.2.1 Chondrogenic and osteogenic MSC metabolism  
MSC differentiation towards specific lineages has been demonstrated through analysis 
of specific genes and deposition of specific extracellular matrix molecules (Jaiswal et 
al., 1997; Johnstone et al., 1998; Yoo et al., 1998). Markers for the osteogenic lineage 
include the genes Runx-2 and osteocalcin, and calcium deposition within its 
extracellular matrix. In terms of the chondrogenic lineage, SOX-9 and aggrecan are 
recognised gene markers, along with GAG production within the extracellular matrix. 
A further parameter that may be used to distinguish MSCs during differentiation into 
various lineages is their underlying metabolism. 
 
Previous studies assessing the metabolism of mature chondrocytes and osteoblasts 
have shown differences in their metabolism (Smith et al., 1973; Rajpurohit et al., 
1996; Komarova et al., 2000; Heywood and Lee, 2008). Freshly isolated chondrocytes 
prior to in vitro expansion had a low oxygen consumption rate (1.34 fmol/hr/cell), 
whilst a significant proportion of their ATP production was generated via glycolysis 
(Heywood and Lee, 2008). However, osteoblasts have a significantly greater oxygen 
consumption rate and oxidative phosphorylation utilisation compared with mature 
chondrocytes, although monolayer expansion under normoxia increases chondrocyte 
oxygen consumption rate and utilisation of oxidative phosphorylation (Heywood and 
Lee, 2008). These differences in metabolism may be associated with the oxygen 
tension in vivo, as chondrocytes reside under hypoxia, whilst osteoblasts are close to 
vascularised regions and therefore reside under higher oxygen tensions (Grant and 
Smith, 1963; Kofoed et al., 1985).  
 
Chondrogenic differentiation of MSCs resulted in a significant reduction in oxygen 
consumption rate after initial pellet formation, whilst there was no significant 
difference in either glucose consumption or lactate production rate throughout the 
culture period (Figure 4.5/Appendix A.3; Figure A.13, Figure 4.7 and Figure 4.8). In 
comparison, MSCs undergoing osteogenic differentiation had a significant increase in 
oxygen consumption compared with MSCs undergoing chondrogenic differentiation, 
                                                                   Chapter 6: Final Discussion 
 - 217 -  
and there were significant differences in the glucose consumption and lactate 
production rates during culture (Figure 4.6, Figure 4.9 and Figure 4.10). Furthermore, 
comparison with their respective control samples showed no significant differences 
between control and chondrogenic samples, whilst there were differences between 
osteogenic cultures and its respective control for all parameters, particularly oxygen 
consumption. However, correction for oxygen ingress demonstrated that osteogenic 
cultures and its control had significant increases in their per cell oxygen consumption 
rate, although there was found to be no significant difference in consumption rate with 
time in culture and its respective control at each time point (Appendix A.3, Figure 
A.14). The use of the metabolic modulator, sodium azide, showed that MSCs 
undergoing osteogenic differentiation had a significantly greater proportion of ATP 
production via oxidative phosphorylation compared with chondrogenic cultures 
(Figure 4.11/Appendix A.3; Figure A.15). Furthermore, estimations in ATP 
production generated from glycolysis and oxidative phosphorylation using the 
corrected oxygen consumption data, demonstrate significant differences between 
osteogenic samples and its control at both time points (Appendix A.3; Figure A.15). 
The differences observed between control and osteogenic cultures may be related to 
the differences in medium components between proliferation and osteogenic medium, 
particularly dexamethasone and -glycerophosphate (section 4.4). 
 
The differences in metabolism during chondrogenic and osteogenic differentiation 
may be related to the culture conditions and genes controlling metabolism, particularly 
in the case of chondrogenic differentiation (Rajpurohit et al., 1996; Semenza, 2000; 
Domm et al., 2002; Wang et al., 2005; Malladi et al., 2006; Coyle et al., 2009). MSC 
chondrogenic differentiation requires cells to be cultured within a pellet culture 
environment, replicating the embryological formation of cartilage and allowing cell-
cell contacts to be formed. The creation of the pellet leads to a hypoxic environment 
being formed within the pellet, resulting in the expression of HIF-1. HIF-1 has 
been shown to induce the expression of the early chondrogenic marker, SOX-9, 
initiates and leads to the expression of further chondrogenic-associated genes such as 
collagen type II and aggrecan (Lefebvre and Crombrugghe, 1998; Kulyk et al., 2000; 
Akiyama et al., 2002; Robins et al., 2005). Malladi et. al. (2007) showed that removal 
of HIF-1 resulted in inhibited chondrogenic differentiation of adipose-derived 
                                                                   Chapter 6: Final Discussion 
 - 218 -  
MSCs. In addition, previous investigations have shown its importance in the 
maintenance of a glycolytic metabolism, particularly in the function of mature 
chondrocytes (Rajpurohit et al., 1996; Semenza, 2000; Seagroves et al., 2001). 
Furthermore, chondrocytes expanded in monolayer under normoxia change from a 
rounded to a fibroblastic morphology, with a concomitant increase in cellular oxygen 
consumption and oxidative phosphorylation utilisation (Moussavi-Harami et al., 2004; 
Martin et al., 2004; Heywood and Lee, 2008). To restore their function, metabolism 
and tissue formation, chondrocytes are either cultured under hypoxia and/or 
encapsulated within 3D scaffolds (Murphy and Sambanis, 2001a; Murphy and 
Sambanis, 2001b; Domm et al., 2002; Domm et al., 2004; Malda et al., 2004b). The 
present thesis showed an inverse relationship to monolayer passaged or 
dedifferentiated chondrocytes. 
  
In contrast, MSC osteogenic differentiation occurred when cells were cultured in 
monolayer. As the differentiation process progressed, the cells gradually changed 
morphology and formed colonies. The increased utilisation of oxidative 
phosphorylation for MSCs during osteogenic differentiation may also be related to the 
expression of HIF-1, as its stimulation has been shown to prevent oxidative 
phosphorylation, alongside non-expression of the osteogenic marker, Runx-2 (Warren 
et al., 2001; Arnett et al., 2003; Utting et al., 2006). The resulting cascade of genes is 
then prevented and thus osteogenesis is inhibited. Furthermore, previous studies have 
observed that MSCs undergoing osteogenic differentiation utilise a significant amount 
of cellular oxidative capacity, indicating the requirement for oxidative 
phosphorylation during the differentiation process (Komarova et al., 2000; Chen et 
al., 2008). Therefore, the control of HIF-1 and the differences in the utilisation of 
oxidative phosphorylation and glycolysis may play an important role in MSC 
differentiation (Figure 6.2).  
 
The differences in metabolism between MSC chondrogenesis and osteogenesis, 
potentially via the expression of HIF-1, could also influence the development of 
tissues within 3D scaffolds. This has been shown in early bone marrow investigations 
that utilised diffusion chambers (Ashton et al., 1980; Bab et al., 1984; Bab et al., 
1986; Friedenstein et al., 1987). These studies showed that cartilage formed within the 
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central regions of the chamber, whilst marrow closest to the vascularised regions 
formed bone. Thus, in terms of oxygen levels, hypoxia was created within the centre 
of the chamber, thus stimulating HIF-1, glycolysis and chondrogenesis. The high 
oxygen conditions around the outside of the chamber helped to inhibit HIF-1 
stimulation, enabling cells to generate ATP via oxidative phosphorylation and 
subsequently stimulate osteogenesis within these areas. Thus, metabolism and oxygen 
tension are factors that potentially control MSC differentiation.   
 
6.2.2 MSC differentiation under variable oxygen tension 
Chapter 5 in this thesis showed that MSCs expanded under hypoxia could undergo 
potentially greater population doublings without significant increases in cellular 
senescence. Previous investigations have shown that MSC multipotency is maintained 
at these later population doublings upon differentiation under normoxia (d'Ippolito et 
al., 2004; Ezashi et al., 2005; Grayson et al., 2006; Fehrer et al., 2007; Grayson et al., 
2007). The maintenance of MSC multipotency is particularly important in tissue 
engineering applications, where cells have undergone a number of population 
doublings prior to their differentiation. Furthermore, MSC differentiation may be 
influenced by hypoxia, with the majority of studies suggesting that chondrogenesis is 
enhanced and osteogenesis inhibited under these conditions (section 1.6.5). However, 
the results of these investigations are conflicting, primarily due to the variability in 
oxygen tension investigated.  
 
The present thesis initially investigated the osteogenic and chondrogenic 
differentiation of MSCs under their expansion oxygen conditions. MSCs were able to 
differentiate towards the chondrogenic lineage under each oxygen condition, although 
there was no significant difference in the GAG production between oxygen conditions 
(Figure 5.17 and Figure 5.18). Some previous investigations using chondrocytes have 
described enhanced GAG deposition under hypoxia, whilst similar results to the 
present study have been obtained in other studies for MSCs differentiated towards the 
chondrogenic lineage (Lennon et al., 2001; Murphy and Sambanis, 2001a; Murphy 
and Sambanis, 2001b; Domm et al., 2002; Domm et al., 2004; Malda et al., 2004b; 
Wang et al., 2005; Xu et al., 2007; Coyle et al., 2009; Pilgaard et al., 2009a). The 
studies investigating MSC chondrogenesis under hypoxia have shown that the key 
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matrix molecule enhanced under these conditions was collagen, although a recent 
investigation showed that in terms of gene expression, there was no significant 
differences in the expression of collagen type II or X between oxygen conditions 
(Wang et al., 2005; Pilgaard et al., 2009a). Future studies may wish to focus on 
collagen deposition within the matrix under each oxygen condition, particularly the 
cartilage specific collagen type II and to determine if collagen type X production is 
inhibited under hypoxia, as this is a marker for hypertrophic cartilage that 
subsequently leads to bone formation.  
 
In contrast, osteogenic differentiation was only initiated when cells were expanded 
and differentiated under normoxia (Figure 5.19 - Figure 5.22). MSCs were unable to 
differentiate towards the osteogenic lineage upon culture under hypoxia after 
expansion under the same conditions, correlating with results from similar studies 
(Malladi et al., 2006; d'Ippolito et al., 2006a; Potier et al., 2007a). The reason for 
inhibited differentiation under hypoxia may be associated with the underlying 
metabolism of the cells during the process of osteogenesis. As described in chapter 4, 
MSCs differentiated towards the osteogenic lineage utilise both glycolysis and 
oxidative phosphorylation for their ATP production during the differentiation process. 
Oxidative phosphorylation is inhibited under hypoxia, as they were forced to switch to 
a predominantly glycolytic metabolism. Therefore, MSCs stimulated towards the 
osteogenic lineage under hypoxia demonstrated inhibited differentiation, potentially 
due to their metabolism and through inhibited expression of osteogenic genes such as 
Runx-2 and osteocalcin. The latter observation may be due to the stimulation of HIF-
1 that has been implicated in the inhibited expression of osteogenic genes (Warren et 
al., 2001; Arnett et al., 2003; Utting et al., 2006).  
 
Previous investigations have shown that MSCs expanded under hypoxia are able to 
maintain their multipotency, when differentiated at normoxia (d'Ippolito et al., 2004; 
Grayson et al., 2006; Fehrer et al., 2007; Grayson et al., 2007). A further investigation 
in the current thesis assessed whether MSCs expanded under hypoxia maintained their 
ability to differentiate to the osteogenic lineage under normoxia. The study showed 
that MSCs expanded under hypoxia were unable to differentiate towards the 
osteogenic lineage upon culture under normoxia, whilst osteogenesis was inhibited 
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under hypoxia for both sets of MSC cultures (Figure 5.21 and Figure 5.22). The 
reason for the inhibited differentiation under hypoxia has been described. However, 
the fact that MSCs expanded under hypoxia did not show differentiation during 
culture under normoxia, does not correlate with outcomes of previous investigations 
(d'Ippolito et al., 2004; Grayson et al., 2006; Fehrer et al., 2007; Grayson et al., 
2007). The reasons for the differences in differentiation potential between the present 
investigation and previous studies may be associated with a variety of reasons, 
although a specific mechanism cannot be ascertained from the present results.  
  
D’Ippolito et. al. (2004) isolated a sub-population of multipotent MSCs through 
isolation and culture under hypoxia. These cells were described as MIAMI cells. 
However, the culture surface used in these investigations was fibronectin coated rather 
than the standard tissue culture plastic used in the present study. Furthermore, MSCs 
were not expanded under continuous or uninterrupted oxygen conditions. These 
conditions may enable various MSCs to adhere and form colonies through control of 
cell adhesion molecules, particularly integrins that influence their attachment. The 
fibronectin coating on the flask surface replicates the initial conditions during 
gastrulation and later embryonic tissue development. The absence of fibronectin 
results in poor tissue development (George et al., 1993; Darribere and Schwarzbauer, 
2000). During embryological development, MSC integrins attach to the fibronectin 
and enable formation of the extracellular matrix during later stages of tissue 
development. The combination of hypoxia and fibronectin may have facilitated the 
isolation of a primitive cell type due to the replication of embryonic developmental 
conditions. In addition, the study used clonal expansion to further isolate the sub-
population prior to expansion. The present study used standard tissue culture plastic 
and continuous and uninterrupted hypoxia to isolate MSCs. The MSCs isolated appear 
to be chondroprogenitors rather than multipotent MSCs. In relation to the studies 
involving MIAMI cells, the continuous and uninterrupted oxygen conditions may 
have enabled selection of these chondroprogenitors due to the cell adhesion 
molecules. It may be speculated that the isolation of chondroprogenitors may be 
associated with the pooling of MSCs and therefore expansion under the same 
conditions enabled purification of these cells, correlating with a recent investigation 
(Xu et al., 2007). A future investigation could utilise clonal expansion to derive MSCs 
from each of the colonies formed under hypoxia and observe whether there are 
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multipotent MSCs present. Furthermore, studies have shown that the initial cell 
seeding density may influence the cultured MSCs, during the initial isolation phase 
and early stages of expansion (Colter et al., 2000; Colter et al., 2001; Javazon et al., 
2001). 
 
Previous investigations using hypoxia-expanded MSCs that demonstrated osteogenic 
differentiation when cultured under normoxia, utilised a method that differs from the 
standard monolayer protocol for osteogenic differentiation (Grayson et al., 2007). 
Grayson et. al. (2007) cultured MSCs in a pellet culture system similar to that used for 
MSC chondrogenesis. The pellets used in MSC chondrogenesis enable cell-cell 
contacts to be created and thus replicate the embryological process of cartilage. The 
mechanism for osteogenic differentiation within a pellet system has not been detailed, 
although the discussed investigation cultured the pellet in osteogenic medium and 
showed calcium deposits after 14 days in culture. Despite these results, the system 
may not have produced a calcified extracellular matrix throughout the whole pellet. 
This is because central regions would be hypoxic due to the cellular oxygen 
consumption and diffusion distances within the pellet. As discussed in chapter 4, MSC 
osteogenesis is believed to require oxygen consumption and oxidative 
phosphorylation. Furthermore, hypoxia has been shown to stimulate HIF-1, which is 
associated with inhibition of osteogenic genes (Warren et al., 2001; Arnett et al., 
2003; Salim et al., 2004; d'Ippolito et al., 2006a). Recent studies have shown that 
expression of VEGF, a marker for angiogenesis, is stimulated under hypoxia (Gerber 
et al., 1999; Nilsson et al., 2004; Potier et al., 2007a). Therefore, it may be 
hypothesized that the in vivo process of vascularisation could help to increase the 
oxygen level within the pellet, thereby suppressing HIF-1 expression and glycolysis, 
leading to osteogenesis. The described process resembles the embryological process 
of endochondral ossification. However, prior to endochondral ossification, cartilage is 
formed to provide the basis of bone formation and structure and the medium in the 
described culture system does not contain chondrogenic inductive factors such as 
TGF-3 (section 1.4.3). The process that the osteogenic pellet culture system is likely 
to replicate is intramembranous ossification, whereby MSCs directly differentiate into 
osteoblasts and form mineralised matrix. This is the method used in the standard 
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monolayer osteogenic cultures described in previous investigations and the present 
thesis.  
 
A further reason for inhibited osteogenesis under normoxia for hypoxia-expanded 
MSCs may be related to the cellular metabolism. MSCs expanded under hypoxia have 
reduced ATP generation via oxidative phosphorylation compared with normoxia-
expanded MSCs (Figure 5.13/Appendix A.3, Figure A.17). Thus, hypoxia-expanded 
MSCs, when subsequently cultured under normoxia may change their metabolism to 
increase their utilisation of oxidative phosphorylation. Therefore, the rapid change in 
metabolism may have inhibited MSC differentiation towards the osteogenic lineage. 
This may be related to the mitochondria within the cells and their oxidative capacity, 
as hypoxia may have isolated and expanded MSCs with few mitochondria, thus 
inhibiting oxidative phosphorylation under normoxia and preventing osteogenesis. 
Anti-oxidants may be used to maintain hypoxia-expanded MSC metabolism under 
normoxia, although for osteogenic differentiation, studies have described the 
requirement of ROS generation to initiate the processes required for osteogenesis 
(Heng et al., 2004). An observation associated with this concept is that alkaline 
phosphatase activity was significantly greater for MSCs expanded under normoxia 
compared with hypoxia, with no significant differences between normoxic control and 
normoxia-expanded MSCs cultured in osteogenic medium under hypoxia (Figure 
5.21).  
 
A combination of these factors may explain the inhibited osteogenic differentiation of 
hypoxia-expanded MSCs, although there is no direct elucidation of a mechanism for 
these findings. However, the use of MSCs isolated and expanded under hypoxia for 
bone formation may require a route that does not emanate directly from the MSC and 
is in relation to their metabolic requirements. Recent investigations have described a 
route for bone formation that replicates endochondral ossification  (Jukes et al., 2008; 
Farrell et al., 2009). Farrell et. al. (2009) pelleted MSCs in vitro and differentiated the 
cells towards the chondrogenic lineage for 21 days and then the medium was switched 
to osteogenic medium to enable bone formation. The switch in medium and resultant 
changes in oxygen tension within the pellet due to VEGF stimulation and angiogenic 
development, affect cellular metabolism of differentiated MSCs, resulting in bone 
formation. Furthermore, chondrogenic-primed MSCs seeded on collagen-GAG 
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scaffolds and inserted subcutaneously in vivo into an ectopic site resulted in bone 
formation via the route of endochondral ossification. A recent investigation has 
utilised the same method of culture for ESCs and found that chondrogenic-priming of 
these cells on ceramic particles prior to in vivo implantation produces greater amounts 
of bone compared with particles containing osteoblasts or MSCs cultured in 
osteogenic medium (Jukes et al., 2008). These studies link the concepts of MSC 
differentiation, oxygen tension and metabolism, for the creation of tissue engineered 
bone and are based on earlier studies utilising diffusion chambers (Ashton et al., 1980; 
Bab et al., 1984; Bab et al., 1986; Friedenstein et al., 1987).  
 
 
Figure 6.2. A schematic diagram describing the controlling factors for MSC differentiation based 
upon current thesis and previous investigations.  Processes derived from the thesis (-) and factors 
required for further investigation and based upon previous work (-----). 
 
Using the data from the present thesis and findings from previous investigations, a 
hypothetical mechanism for the development of tissue engineered bone through the 
process of endochondral ossification has been described in Figure 6.2. MSCs within 
pellet cultures differentiate towards the chondrogenic lineage in defined medium 
conditions. The stimulation of hypoxia either within the pellet due to cellular 
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consumption or through the surrounding oxygen tension enables chondrogenic 
differentiation and glycolysis to occur via the expression of HIF-1. VEGF 
expression and vascularisation due to the presence of hypoxia, raises the oxygen 
tension within the pellet, causing HIF-1 to degrade within the cells. This leads to 
increased cellular oxygen consumption and ATP generation via oxidative 
phosphorylation, which aids bone formation. The processes of chondrogenesis and 
osteogenesis may also be controlled through cell signalling pathways, specifically the 
Notch and Wnt signalling pathways (de Boer et al., 2004b; Hardingham et al., 2006). 
Further examination is required to justify the described model and its suitability for 
tissue engineered bone formation in 3D environments compared with other tissue 
engineering solutions such as osteoinductive scaffolds (Yuan et al., 2001).   
  
Furthermore, the model also recognises the differences in the initial MSC colony 
formation under different oxygen tensions on their differentiation capacity, with 
attachment and serum conditions possibly further influencing the cells isolated. Clonal 
expansion is required to further investigate the MSCs derived from hypoxic culture. 
Recent evidence has suggested that hypoxia and HIF-2 help to stimulate the 
expression of the pluripotency markers, OCT-4 and SOX-2, in both MSCs and ESCs, 
with its absence inhibiting cell differentiation potential (d'Ippolito et al., 2004; 
Grayson et al., 2006; Covello et al., 2006; Grayson et al., 2007; Forristal et al., 2009).  
Further examination of the role of HIF-2 and its role in preserving stem cell 
multipotentiality needs to be considered in future investigations.   
 
The expansion of MSCs under hypoxia helps to preserve the chondrogenic phenotype 
of MSCs, although previous investigations have shown that MSCs maintain their 
multipotency when expanded under hypoxia. However, these studies did not utilise 
continuous and uninterrupted oxygen to isolate and expand the cells, as described in 
the present thesis. The potential for greater population doublings and the preservation 
of chondrogenic differentiation capacity would enable hypoxia to be used for cartilage 
tissue engineering applications. The use of hypoxia-expanded cells in bone tissue 
engineering may require a route that does not directly emanate from an MSC and may 
be derived from a process replicating in vivo endochondral ossification as described in 
the model system (Figure 6.2).  
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6.3 Future work 
Effects of hypoxia mimicking reagents on MSC culture 
The proliferation studies within the thesis have shown that hypoxic culture of MSCs 
prevents premature senescence, although initially shorter doubling times and 
preservation of their multipotency was achieved for MSCs expanded under normoxia 
(Chapter 5). The use of pharmacological agents that mimic hypoxic culture may be 
used for MSCs cultured under normoxia, to potentially increase MSC population 
doublings, without the resultant increases in cellular senescence and loss in 
multipotency with time in culture.  
 
An example of this type of agent is cobalt chloride. Cobalt chloride enables the 
stimulation of HIF-1 under normoxic culture conditions, therefore mimicking the 
effect of hypoxia (Ren et al., 2006; Pacary et al., 2006). However, these studies have 
not assessed the metabolism of the cells during culture using these agents. Ren et. al. 
(2006) used bone marrow-derived MSCs from mice and found that proliferation was 
inhibited, compared to normal hypoxic culture. However, assessments have not been 
made for the proliferation and differentiation of human MSCs. Furthermore, there 
may be similar pharmacological agents that could be utilised.  
 
A further experiment would involve the selected upregulation of HIF-1expression 
via transfection techniques that may help to induce glycolysis-associated genes, upon 
culture under normoxia. The induction of the HIF-1 gene for proliferating MSCs 
would further require assessment of differentiation capacity to determine whether 
over-expression affects differentiation, in a similar scenario to MSCs transfected with 
hTERT (Simonsen et al., 2002; Shi et al., 2002; Yamamoto et al., 2006). 
 
Tissue regeneration in 3D constructs under variable oxygen tension 
The present thesis has described the effect of different oxygen tension on monolayer 
expansion of MSCs but the regeneration of tissues primarily requires the cells to be 
cultured in 3D environments. The present data may be utilised to develop 
computational models to predict the oxygen and glucose gradients within constructs 
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(Sengers et al., 2005). Previous investigations have cultured MSCs in monolayer and 
assessed the effects of different metabolite concentrations to reveal possible 
mechanisms for their survival under anoxic and ischemic conditions (Follmar et al., 
2006; Mischen et al., 2008; Mylotte et al., 2008).  
 
The use of 3D constructs would help to confirm the findings of the present studies, 
with regards to their metabolism, within a more physiologically relevant environment. 
Investigations involving MSCs cultured within alginate beads and polymer matrices 
have yielded similar results under normoxic and hypoxic culture conditions (Wang et 
al., 2005; Grayson et al., 2006; Markusen et al., 2006). However, these studies did not 
utilise continuous and uninterrupted oxygen conditions to culture the constructs, 
therefore studies using similar conditions to the present thesis should be undertaken. 
In the case of MSCs, cell viability has been shown to be poor within the central 
regions of 3D constructs with time in culture. The mechanisms for their survival may 
be related to other processes and thus strategies need to be assessed to improve tissue 
formation such as mechanical and biochemical stimulation (Muschler et al., 2004; 
Campbell, 2005).  
 
A method to improve the tissue formation of MSCs, particularly in the case of 
cartilage tissue engineering, has been to utilise mechanical loading and hypoxia 
(Huang et al., 2004; Wernike et al., 2008). Therefore, studies assessing cartilage tissue 
formation may wish to assess the utilisation of mechanical loading on hypoxia-
expanded MSCs and observe whether there is greater cartilage matrix formation under 
these conditions compared with normoxia-expanded MSCs. The results of the 
investigation would help to clarify if continous and uninterrupted hypoxic expansion 
isolates chondroprogenitors from the bone marrow. 
 
Gene expression profile and MSC sub-populations 
The assessment of the role of HIF-1 may further help to elucidate the associations 
between MSC metabolism and differentiation towards specific lineages. However, a 
gene that has been shown to control stem cell multipotency genes is HIF-2. HIF-2 
has been shown to the control the gene, OCT-4, which has been described as a marker 
of stem cell pluripotency in ESCs (Covello et al., 2006). Recent investigations 
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isolating MSCs under hypoxia, have demonstrated their ability to express HIF-2 and 
OCT-4, which results in these cells maintaining their multipotency at later passages in 
culture (d'Ippolito et al., 2004; Grayson et al., 2006; Grayson et al., 2007). 
Furthermore, the removal of HIF-1 or HIF-2 has led to inhibited proliferation and 
differentiation of MSCs, indicating its importance in stem cell behaviour (Forristal et 
al., 2009). 
 
The present investigation showed that MSCs expanded under hypoxia, only 
differentiated towards the chondrogenic lineage, suggesting reduced multipotentiality. 
However, isolation of MSCs under different isolation conditions apart from oxygen, 
could have resulted in the isolation of sub-populations with the ability to differentiate 
towards each of the mesodermal lineages. Thus, future studies may wish to further 
assess this area, through culturing bone marrow under different oxygen tensions, 
tissue culture substrates (e.g. fibronectin) and serum conditions to observe whether 
sub-populations of MSCs are isolated. These cells could be expanded and analysed for 
the expression of the HIF genes to observe how MSC differentiation potential is 
maintained upon expansion through mechanisms associated with HIF-2 and how 
metabolism and differentiation is controlled through mechanisms associated with HIF-
1.  
 
There are many other genes that may be selectively expressed due to culture under 
hypoxia and recent studies have begun to assess these expressed genes through 
microarray analysis (Forsyth et al., 2008; Pilgaard et al., 2009b). A detailed analysis 
of the gene expression profile for MSCs cultured under hypoxia, may help to develop 
an understanding of how the processes of metabolism, proliferation and differentiation 
are controlled under these conditions. In particular, future studies may wish to focus 
on the genes associated with Sonic hedgehog, Notch and Wnt signalling pathways that 
have been shown to control the differentiation and self-renewal properties of MSCs, 
although the effect of oxygen tension on these pathways has not been assessed within 
these studies (DeLise et al., 2000; Church et al., 2002; Reya et al., 2003; Anakwe et 
al., 2003; de Boer et al., 2004a; Hardingham et al., 2006). 
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6.4 Summary 
The development of tissue engineered systems creates metabolite gradients, 
particularly an oxygen gradient that leads to changes in cell behaviour within these 
environments. Previous studies have shown that expansion of MSCs under hypoxia 
(2-5% oxygen) results in greater population doublings and maintenance of their 
differentiation capacity upon culture under normoxia. The increased population 
doublings and differences in differentiation under different oxygen conditions may be 
related to the inherent metabolism of the cells. The studies in this thesis have 
examined the metabolism and the effects of continuous and uninterrupted oxygen 
during expansion and differentiation of MSCs. The key findings of the thesis are:- 
 
 Human MSCs have a mixed metabolism utilising both oxidative 
phosphorylation and glycolysis for their ATP production 
 
 Chondrogenic differentiation of MSCs resulted in reduced oxygen 
consumption with time in culture leading to a highly glycolytic metabolism. 
Osteogenic differentiation resulted in a significantly higher oxygen 
consumption compared with chondrogenic differentiated MSCs and the cells 
maintained the mixed metabolism of proliferating MSCs. 
 
 MSCs isolated under normoxia had greater numbers of cells and cells/colony 
compared with hypoxic cultures. However, MSCs expanded under hypoxia 
have the ability to undergo greater population doublings with reduced cellular 
senescence compared to normoxia-cultured MSCs. This may be related to 
reduced ROS production via the process of oxidative phosphorylation. 
 
 MSCs isolated and expanded under hypoxia were able to differentiate towards 
the chondrogenic lineage under their expansion conditions but showed no 
osteogenic differentiation under either hypoxia or normoxia. This may be 
related to the initial colony formation under hypoxia and changes in cell 
metabolism during the process of osteogenic differentiation.  
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A. APPENDICES 
A.1 Cellular morphology parameters 
 
 
Figure A.1. Measurements of cell morphological parameters, (a) compactness, (b) aspect retio, (c) 
area, (d) shape factor and (e) ferret diameter, for MSCs cultured at P0 for 20% ( ), 5% ( ) and 
2% ( ) oxygen cultures. Data represents median + inter-quratile range;  Mann-Whitney U-test: 
*p < 0.05. 
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Figure A.2. Measurements of area for MSCs cultured at (a) P1, (b) P2, (c) P3 and (d) P4 for 20% 
( ), 5% ( ) and 2% ( ) oxygen cultures. Data represents median + inter-quratile range. 
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Figure A.3. Measurements of the aspect ratio for MSCs cultured at (a) P1, (b) P2, (c) P3 and (d) 
P4 for 20% ( ), 5% ( ) and 2% ( ) oxygen cultures. Data represents median + inter-quratile 
range. 
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Figure A.4. Measurements of the compactness for MSCs cultured at (a) P1, (b) P2, (c) P3 and (d) 
P4 for 20% ( ), 5% ( ) and 2% ( ) oxygen cultures. Data represents median + inter-quratile 
range. 
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Figure A.5. Measurements of the ferret diameter for MSCs cultured at (a) P1, (b) P2, (c) P3 and 
(d) P4 for 20% ( ), 5% ( ) and 2% ( ) oxygen cultures. Data represents median + inter-quratile 
range. 
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Figure A.6. Measurements of the shape factor for MSCs cultured at (a) P1, (b) P2, (c) P3 and (d) 
P4 for 20% ( ), 5% ( ) and 2% ( ) oxygen cultures. Data represents median + inter-quratile 
range. 
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Figure A.7. Measurements of cell morphological parameters, (a) compactness, (b) aspect retio, (c) 
area, (d) shape factor and (e) ferret diameter, for MSCs cultured at P5 for 20% ( ), 5% ( ) and 
2% ( ) oxygen cultures. Data represents median + inter-quratile range; Mann-Whitney U-
test:*p < 0.05. 
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A.2 Determination of the amount of DNA per MSC using Hoescht 
33258 and Picogreen assay 
 
The amount of DNA per MSC was determined through lysis of MSCs ranging from 5 
x 104 – 2 x 105 cells. The cells were lysed in either papain digest buffer (Table 4.1) for 
Hoescht 33258 assay or PBS + 0.2% Triton X-100 for Picogreen assay. The amount of 
DNA within the sample was calculated against known concentrations as described in 
sections 4.2.4 and 4.2.5. The amount of DNA within the sample was plotted against 
cell number and the gradients of the trendline represented the amount of DNA per cell 
dependent upon the DNA assay utilised. The amount of DNA per MSC using Hoescht 
33258 assay was 10.43 pg (Figure A.8), whilst Picogreen assay yielded 10.86 pg 
(Figure A.9).  
 
 
Figure A.8. The amount DNA yielded from different amounts of MSCs using Hoescht 33258 assay 
for determining the amount of DNA/cell (n = 6; y = (10.43x10-6)x – 0.03; R2 = 0.9936). 
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Figure A.9. The amount DNA yielded from different amounts of MSCs using Picogreen assay for 
determining the amount of DNA/cell (n = 6; y = (10.86x10-6)x – 0.056; R2 = 0.939) 
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A.3 Methodology for correcting cellular oxygen consumption rate 
 
Figure 2.9 shows that oxygen consumption within the biosensor plate reached 
equilibrium and detected no oxygen depletion after two hours in culture. This is 
indicative of oxygen ingress into the wells of the biosensor plate and was confirmed 
through analysis of cell-free oxygen depleted medium (Figure A.10). This is despite 
the use of a plate sealer and shows that it is not completely impermeable to oxygen. 
To correct the oxygen consumption data, the rate of oxygen ingress needs to be 
applied to the concentration of oxygen within each well. The methodology used to 
apply the oxygen ingress to the oxygen concentration data used within the thesis, has 
been described by Heywood et. al. (2010). 
 
 
Figure A.10. The oxygen ingress into a well of a 384-well biosensor plate containing cell-free 
oxygen depleted medium. Data represent mean + S.D. of n = 9. 
 
The rate of oxygen ingress (Figure A.10) into the well of the biosensor was measured 
from nine replicates for 24 hours. The oxygen ingress is assumed to follow a 
monomolecular growth curve that is described in equation A.1. 
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 ktt eCC  10                (A.1) 
 
Ct is the oxygen concentration at time point, t, along the ingress curve and C0 is the 
oxygen concentration upon equilibrium with atmospheric oxygen along the oxygen 
ingress curve. The term, k, represents the permeability constant for the biosensor 
wells. The rate of oxygen ingress into the plate may be calculated through equation 
A.2. 
 
 tCCkdt
dC
 0               (A.2) 
  
The term, dC/dt, represents the rate of oxygen ingress at each time point on the ingress 
curve. The regression line derived from plotting the ingress rate against the difference 
in atmospheric oxygen and ingress oxygen concentration at each time point along the 
curve is utilised to derive, k. The value of k, utilised within the present thesis was 
based upon nine replicates of cell-free oxygen depleted medium and was calculated to 
be 0.23 + 0.04.  
 
Using the value for the constant, k, and ingress rate equation, it may be determined 
that the cellular oxygen consumption rate at a particular time point may be calculated 
using equation A.3. 
 
 tCCkmdt
dC
 0              (A.3) 
 
In the case of equation A.3, dC/dt, is the rate of cellular oxygen depletion, whilst Ct is 
the oxygen concentration from the experimental cellular consumption data. The term 
k(C0 – Ct) represents the effect of oxygen ingress on the change in oxygen 
concentration within the well. The calculated values may be normalised to calculate 
the per cell consumption rate at each time point (Figure A.11).  
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Figure A.11. The change in per cell consumption rate with oxygen concentration for a sample of 
oxygen consumption data. Data corrected for oxygen ingress into the well for a sample. 
 
To calculate the parameter shown within the thesis, the per cell consumption rate data 
shown in Figure A.11, needs to be normalised to the corresponding oxygen 
concentration and then plotted as depicted in Figure A.12. The relationship described 
in Figure A.12, represents a Hanes-Woolf plot that is a linear form of the Michaelis-
Menten equation (equation A.4),  
 
C
VV
K
v
C m
maxmax
1
               (A.4) 
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Figure A.12. A Hanes-Woolf plot for the data depicted in Figure A.11. The per cell oxygen 
consumption rate from the data was calculated to be 99 fmol/hr/cell (y = 0.0101x + 0.0179; R2 = 
0.995). 
 
The term, C, represents oxygen concentration, whilst v represents oxygen 
consumption rate. The maximum rate of per cell oxygen consumption is defined as 
Vmax and Km indicates the oxygen concentration at which the cellular consumption is 
half-maximal. Therefore, the derived oxygen consumption rate is the reciprocal of the 
gradient of best fit line from the Hanes-Woolf plot, as depicted in Figure A.12. This 
analysis was applied to all data within the thesis for calculation of cellular oxygen 
consumption rate.  
 
The following tables and figures are the corrected oxygen consumption data for data 
presented within this thesis. These figures and tables are referred within the thesis 
where appropriate.  
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Table A.1. Oxygen ingress corrected oxygen consumption rate and per cell consumption rate for 
data shown in Table 2.9. Data represent the mean + S.D. of n = 9. 
 Oxygen consumption rate (nmol/hr) Oxygen consumption rate/cell (fmol/hr/cell) 
Cell 
number 
(x105) 
P2 P3 P4 P2 P3 P4 
2 21.9 + 5.8 21.2 + 2.7 20.3 + 4.4 109.3 + 28.8 106.1 + 13.4 101.7 + 21.9 
1.5  17.4 + 2.9 17.6 + 4.0 15.9 + 3.3 115.7 + 19.2 117.7 + 26.5 106.1 + 22.0 
1  9.8 + 1.8 10.9 + 2.0 9.7 + 1.6 98.3 + 17.7 109.2 + 20.0 97.0 + 15.7 
0.5  4.7 + 1.2 5.1 + 1.2 4.9 + 1.4 94.0 + 23.1 102.6 + 23.5 97.8+ 28.3 
 
 
 
Table A.2. Oxygen ingress corrected oxygen consumption and per cell consumption rate for data 
shown in Table 3.2. Data represent the mean + S.D. of n = 9. 
Inhibitor 
Oxygen consumption rate 
(nmol/hr) 
Oxygen consumption rate/cell 
(fmol/hr/cell) 
Control 14.6 + 2.6 97.5 + 17.7 
50mM 2-Deoxy-D-glucose 20.6 +  5.1 137.2 + 33.9 
10mM sodium azide 3.7 + 1.6 24.5 + 10.5 
 
 
 
Table A.3. Oxygen ingress corrected oxygen consumption and per cell consumption rate for data 
shown in Table 3.5. Data represent the mean + S.D. of n = 9. 
Inhibitor 
Oxygen consumption rate 
(nmol/hr) 
Oxygen consumption rate/cell 
(fmol/hr/cell) 
Control 14.8 + 2.1 98.9 + 13.9 
1 M CCCP 32.4 + 4.7 216.1 + 31.3 
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Figure A.13. Oxygen ingress corrected data for the change in per cell oxygen consumption rate 
for cultured control (-TGF-3) and chondrogenic (+TGF-3) MSC pellets. Data represent mean + 
S.D. of n = 6: Control ( ) and Chondrogenic ( ).  
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Figure A.14. Oxygen ingress corrected data for the change in per cell oxygen consumption rate 
for cultured control and osteogenic MSC samples. Data represents mean + S.D. of n = 6: Control 
( ) and osteogenic ( ). 
 
 
 
Table A.4. Oxygen ingress corrected oxygen consumption and per cell oxygen consumption rate 
for data shown in Table 4.2. Data represent the mean + S.D. of n = 9. 
 
Oxygen consumption rate/cell (fmol/hr/cell) 
Conditions Day 7 
Untreated 
Day 7  10mM 
sodium azide 
Day 21 
Untreated 
Day 21  10mM 
sodium azide 
Control osteogenic 90.4 + 12.5 32.5 + 5.01 88.2 + 9.1 16.7 + 4.2 
Osteogenic  105.7 + 18.8 25.7 + 8.40 98.1 + 21.1 20.9 + 4.9 
Control pellet 13.7 + 2.2 4.3 + 0.9 17.8 + 3.9 6.1 + 2.7 
Chondrogenic pellet 11.8 + 4.7 4.7 + 1.3 17.3 + 2.8 7.7 + 2.3 
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Figure A.15. Oxygen ingress corrected data showing the estimated proportions of ATP 
production generated from oxdiative phosphorylation ( ) and glycolysis ( ) by human MSCs 
differentiated towards osteogenic and chondrogenic lineages on (a) day 7 and (b) day 21 during 
culture under normoxic conditions. 
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Figure A.16. Oxygen ingress corrected per cell oxygen consumption rate for human MSCs pre-
cultured at 20%, 5% and 2% oxygen. Data represent mean + S.D. of n = 6; Bonferroni corrected 
student t-test: * p< 0.05. Donor data are presented in Appendix A.4, Figure A.18b. 
 
Table A.5. Oxygen ingress corrected oxygen consumption, glucose consumption and lactate 
production rate of MSCs for data shown in Table 5.3. Data represent mean + S.D. of n = 6. Donor 
data are presented in Appendix A.4, Tables A.8 and A.9. 
Oxygen consumption 
rate/cell (fmol/hr/cell) 
Glucose consumption 
rate/cell (fmol/hr/cell) 
Lactate production rate/cell 
(fmol/hr/cell) 
Expansion 
oxygen 
tension Control 
Sodium 
azide 
Control 
Sodium 
azide 
Control 
Sodium 
 azide 
20% 109.3 + 17.9 38.6 + 10.5 225.4 + 41.4 182.1 + 42.7 649.52 + 109 686.9 + 156.6 
5% 60.8 + 19.1 32.9 + 12.8 262.4 + 53.3 235.3 + 27 783.7 + 173 734.9 + 234.8 
2% 62.5 + 23.4 35.2 + 14.9 328.8 + 47.4 321.1 + 41.8 874.4 + 132.8 863.52 + 186.8 
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Figure A.17. Oxygen ingress corrected data showing the estimated proportions of ATP 
production generated from oxidative phosphorylation ( ) and glycolysis ( ) for cells cultured 
under 20%, 5% and 2% oxygen conditions using data from Table A.5. Donor data are presented 
in Appendix A.4, Figure A.21. 
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A.4 Donor results for data shown in Chapter 5 
 
Figure A.18. The per cell oxygen consumption rate for human MSCs pre-cultured at 20%, 5% 
and 2% oxygen for (a) uncorrected and (b) corrected consumption rates. Data represent mean + 
S.D. of n = 3 for donor A ( ) and donor B ( ). Bonferroni corrected student t-test: *p < 0.05. 
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Figure A.19. The per cell (a) glucose consumption and (b) lactate production rate for human 
MSCs pre-cultured at 20%, 5% and 2% oxygen. Data represent mean + S.D. of n = 3 for donor A 
( ) and donor B ( ). Bonferroni corrected student t-test: *p < 0.05. 
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Table A.6. Oxygen (uncorrected) and glucose consumption and lactate production rate for donor 
A MSCs pre-expanded at 20%, 5% and 2% oxygen with or without the presence of 10 mM 
sodium azide. Data represent mean + S.D. of n = 6.  
Oxygen consumption 
rate/cell (fmol/hr/cell) 
Glucose consumption 
rate/cell (fmol/hr/cell) 
Lactate production rate/cell 
(fmol/hr/cell) 
Expansion 
oxygen 
tension Control 
Sodium 
azide 
Control 
Sodium 
azide 
Control 
Sodium 
 azide 
20% 75.4 + 2.0 21.4 + 4.6 215.1 + 43.8 223.1 + 23.8 712.7 + 92.2 787.0 + 73.8 
5% 33.0 + 1.8 13.8 + 1.9 259.8 + 75.5 218.2 + 11.5 849.4 + 202.4 743.7 + 91.0 
2% 45.3 + 4.6 15.2 + 1.4 320.5 + 42.3 297.7 + 38.4 850.6 + 191.6 821.5 + 105.1 
 
 
 
 
 
Table A.7. Oxygen (uncorrected) and glucose consumption and lactate production rate for donor 
B MSCs pre-expanded at 20%, 5% and 2% oxygen with or without the presence of 10 mM 
sodium azide. Data represent mean + S.D. of n = 6.  
Oxygen consumption 
rate/cell (fmol/hr/cell) 
Glucose consumption 
rate/cell (fmol/hr/cell) 
Lactate production rate/cell 
(fmol/hr/cell) 
Expansion 
oxygen 
tension Control 
Sodium 
azide 
Control 
Sodium 
azide 
Control 
Sodium 
 azide 
20% 64.0 + 9.4 16.9 + 1.5 235.8 + 40.0 145.4 + 23.0 586.4 + 90.5 588.6 + 96.5 
5% 33.5 + 4.1 15.0 + 2.6 280.4 + 35.9 266.9 + 51.1 790.1 + 156.5 807.6 + 299.1 
2% 37.9 + 13.6 17.3 + 5.0 337.0 + 54.7 344.5 + 31.7 898.3 + 27.1 905.6 + 243.1 
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Table A.8. Oxygen (corrected) and glucose consumption and lactate production rate for donor A 
MSCs pre-expanded at 20%, 5% and 2% oxygen with or without the presence of 10 mM sodium 
azide. Data represent mean + S.D. of n = 6.  
Oxygen consumption 
rate/cell (fmol/hr/cell) 
Glucose consumption 
rate/cell (fmol/hr/cell) 
Lactate production rate/cell 
(fmol/hr/cell) 
Expansion 
oxygen 
tension Control 
Sodium 
azide 
Control 
Sodium 
azide 
Control 
Sodium 
 azide 
20% 99.4 + 11.4 40.8 + 25.2 215.1 + 43.8 223.1 + 23.8 712.7 + 92.2 787.0 + 73.8 
5% 65.1 + 23.1 39.3 + 10.4 259.8 + 75.5 218.2 + 11.5 849.4 + 202.4 743.7 + 91.0 
2% 56.6 + 14.9 33.5 + 18.0 320.5 + 42.3 297.7 + 38.4 850.6 + 191.6 821.5 + 105.1 
 
 
 
 
 
Table A.9. Oxygen (corrected) and glucose consumption and lactate production rate for donor B 
MSCs pre-expanded at 20%, 5% and 2% oxygen with or without the presence of 10 mM sodium 
azide. Data represent mean + S.D. of n = 6.  
Oxygen consumption 
rate/cell (fmol/hr/cell) 
Glucose consumption 
rate/cell (fmol/hr/cell) 
Lactate production rate/cell 
(fmol/hr/cell) 
Expansion 
oxygen 
tension Control 
Sodium 
azide 
Control 
Sodium 
azide 
Control 
Sodium 
 azide 
20% 119.2 + 18.4 36.3 + 11.9 235.8 + 40.0 145.4 + 23.0 586.4 + 90.5 588.6 + 96.5 
5% 56.6 + 14.9 26.4 + 12.5 280.4 + 35.9 266.9 + 51.1 790.1 + 156.5 807.6 + 299.1 
2% 77.0 + 13.9 36.8 + 12.6 337.0 + 54.7 344.5 + 31.7 898.3 + 27.1 905.6 + 243.1 
 
                                                                                                                A: Appendix A.4  
 - 253 -  
 
Figure A.20. Representative graphs showing the estimated proportions of ATP production 
generated from oxidative phosphorylation ( ) and glycolysis ( ) for MSCs pre-cultured under 
20%, 5% and 2% oxygen conditions for (a) donor A and (b) donor B. Data is derived from results 
shown in Tables A.6 and A.7.  
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Figure A.21. Representative graphs showing the estimated proportions of ATP production 
generated from oxidative phosphorylation ( ) and glycolysis ( ) for MSCs pre-cultured under 
20%, 5% and 2% oxygen conditions for (a) donor A and (b) donor B. Data is derived from results 
shown in Tables A.8 and A.9. 
 
                                                                                                                A: Appendix A.4  
 - 255 -  
 
Figure A.22. The change in GAG/DNA in chondrogeneic MSC pellets from (a) donor A and (b) 
donor B, expanded and differentiated under 20% control  [-TGF-3] ( ), 20% [+TGF-3] ( ), 
5% ( ) and 2% ( ) oxygen conditions. Data represent mean + S.D. of n = 3 for both donors A 
and B; Bonferroni corrected student t-test: *p < 0.05. Control cultures were significantly 
different to 20% (+TGF-3 treated), 5% and 2% oxygen cultures at each time point (*p < 0.05) 
for both donors.  
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Figure A.23. Alkaline phosphatase activity of human MSCs pre-cultured and differentiated in 
osteogenic medium under 20%, 5% or 2% oxygen conditions from (a) donor A and (b) donor B. 
Data represent mean + S.D. of n = 6; 20% control ( ), 20% osteogenesis ( ), 5% osteogenesis 
( ) and 2% osteogenesis ( ). 
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